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SUMMARY
Cell signaling pathways are complex biochemical systems at the core of cellular information
processing. The dynamics of these signaling systems in response to internal and extracellular
cues plays a critical role for proper cell functioning. While we have learned much about
signaling at the cell population level, no two cells are the same, and cell-to-cell variability
can have complex and important consequences for signaling in both individual cells and the
cell population as a whole. In many contexts, cells perform essentially identical functions
despite their differences, whereas in other contexts, especially in cancer, cell-cell differences
in state propagate to differences in function.
The overall goal of this dissertation was the creation of mathematical and computational
tools for the study of cell-to-cell variation in signaling and to use these tools to increase
our understanding of when single cell differences do, or do not, make a meaningful differ-
ence. To address this goal we designed new methods of single-cell analysis, including a
computational framework termed single-cell ordinary differential equation modeling (SCO-
DEM) that overcomes the prior experimental trade-off between continuous and multiplexed
single-cell measurements of signaling. We tested SCODEM against increasingly demanding
datasets, which were all represented in a satisfactory fashion. After the initial analysis
of cell-to-cell variability, we analyzed targeted inhibition, protein overexpression and an
epithelial-mesenchymal transition. Throughout this process, we provided illustrative exam-
ples of how our modeling framework may be used to identify operating principles and limits
of signaling systems, which is a first step toward proposing novel therapeutic targets.
The work presented here provides new tools for analyzing cellular heterogeneity and
increases our understanding of how differences in cell state effect function by showing in-
tracellular signaling is primarily deterministic at the single cell level. The application of
these tools to the dramatic phenotype shift during an epithelial-mesenchymal transition in
murine breast cancer cells confirmed that stochasticity plays a much smaller role than had






Cells may be considered as biochemical systems whose states can be broadly defined by the
relative locations and concentrations or abundances of molecular components at a point in
time. Single-cell measurement technologies have shown that individual cells, even within
what may classically be considered a homogeneous cell population or sample, exhibit con-
siderable variation in state (Farlik et al., 2015; Macosko et al., 2015; Sachs et al., 2005;
Wang and Bodovitz, 2010). This variation among cells within a population has meaningful
consequences for the functional responses of individual cells. For example, cell-to-cell vari-
ation in state leads divergent receptor-induced apoptotic responses in cells from genetically
identical populations (Spencer et al., 2009). In cancer and other diseases, genetic alterations
modify the expression or function of cellular components, which can result in increased cel-
lular variation and create cells with aberrant functional responses to microenvironmental
inputs compared to healthy cells (Cohen et al., 2008; Altschuler and Wu, 2010). Microenvi-
ronmental changes associated with disease can further increase heterogeneity in cell states
and inputs and, consequently drug responses (Meacham and Morrison, 2013; Burrell and
Swanton, 2014). However, variation in cell state alone is not a sufficient prerequisite for
differential responses (Bendall et al., 2011), and despite the clear role of cell-to-cell varia-
tion in the generation of differential cell fates, a precise definition of when, where and what
variation plays a functional role remains an open question across many contexts (Altschuler
and Wu, 2010; Snijder and Pelkmans, 2011).
1.2 Intracellular Signaling
This dissertation focuses on the role of cellular variation in the specific subsystem of intra-
cellular signaling. Intracellular signaling pathways are complex biochemical systems at the
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core of cellular information processing, and the dynamics of these signaling systems in re-
sponse to extracellular cues plays a critical role for proper cell functioning (Dolmetsch et al.,
1997; Kholodenko, 2006; Selimkhanov et al., 2014). Signals are transduced by modulating
the enzymatic activities and local concentrations of signaling mediators such as protein ki-
nases. Variation in the relative expression of signaling components can lead to differential
signaling responses and cell fates (Cohen-Saidon et al., 2009). As a consequence that is
of particular importance here, many cancers are caused by aberrant expression or function
of signaling proteins (Sever and Brugge, 2015) that alter normal input-output signaling
responses, and the increased heterogeneity in cell states within tumors can result in drug
resistance (Dagogo-Jack and Shaw, 2018; Shaffer et al., 2017).
1.3 Methods to Study Cell-to-Cell Variation in Signaling
While cell-to-cell variation plays a clear role in cell responses to signaling inputs (Shaf-
fer et al., 2017; Spencer et al., 2009), the prediction and analysis of single-cell signaling
responses remains a significant challenge. This is due, at least in part, to the complex
interconnected structure of signaling networks and the generally non-linear nature of the
associated reaction dynamics (Papin et al., 2005; Hengl et al., 2007). Reverse engineering
such complex systems requires simultaneous observations of multiple components, for in-
stance, in the form of multivariate or ‘multiplexed’ measurements over time (Kolitz and
Lauffenburger, 2012; Spiller et al., 2010). However, all current experimental methods face
a trade-off between the ability to observe the state of many system variables as a snapshot
at an individual point in time, which alone cannot characterize response, and the option of
monitoring the state of one or few variables continuously in time, which cannot characterize
how system components interact to drive response.
Mathematical and computational modeling approaches can complement experimental
approaches by providing a formal framework for the representation and analysis of signaling
systems and are in principle able to bridge the gap between snapshot data and system
responses (Spiller et al., 2010). However, they require quite detailed a priori knowledge of
the involved signaling networks, as well as very comprehensive data. As this dissertation
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demonstrates, these data must be obtained at a single-cell level to reveal the information
necessary to characterize intercellular variability. The following subsections provide a brief
review of experimental and computational methods used to characterize single-cell variation
in intracellular signaling.
1.3.1 Experimental Methods
Single-cell measurements are necessary to characterize cell-to-cell variation in a sample and
can generally be characterized as continuous, i.e., longitudinal measurements of live cells,
or as snapshots, which are fixative or destructive in nature and observe a cell at only an
individual point in time.
Continuous Methods
Live-cell methods typically use dyes, for example, to monitor calcium signaling (Chung
et al., 2011), or genetically encoded sensors for protein modifications to study signaling.
Förster resonance energy transfer (FRET) is a common genetically encoded sensor that
relies on proximity-based energy transfer between two fluorophores and has been used to
image the activation and localization of signaling proteins at the single-cell level (Grant
et al., 2008; Ryu et al., 2015). Challenges in applying FRET to study signaling include
low signal-to-noise ratio and inaccurate characterization of signal degradation due to stable
‘on’ configurations (Komatsu et al., 2011; Regot et al., 2014). Additionally, FRET methods
require the use of two separate measurement channels (wavelengths), which reduces the
ability to multiplex measurements as most microscopes are limited to four channels. An-
other type of genetically encoded fluorescent biosensor is the Kinase Translocation Reporter
(KTR). KTRs are constructed using nuclear targets of kinases and, upon phosphorylation
by their target kinase, translocate from the nucleus to the cytoplasm. KTRs have become
popular due to the straightforward calculation of signal, cytoplasmic to nuclear ratio (C/N),
and their use of only a single measurement channel, which enables multiplexing up to three
such reporters on conventional microscopes (Regot et al., 2014). A major drawback is that
KTRs cannot be used to measure the activities of kinases that do not translocate to the
nucleus upon activation. Compared to FRET, KTRs have been shown to be less sensitive at
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low signaling inputs with slightly delayed dynamics of activation, but improved inactivation
dynamics and larger dynamic range (Gillies et al., 2017). Finally and most importantly,
both FRET and KTR sensors can suffer from a limited dynamic range and, due to the
necessity of genetic expression, have limited direct applicability to characterizing signaling
responses in primary samples.
Snapshot methods
Compared to live-cell methods, experimental single-cell snapshot methods are better able
to quantify the systems-level state of intracellular signaling by measuring more components
simultaneously. Generally, these methods rely on antibodies to measure the relative abun-
dances and post-translational states of signaling proteins. While microfluidic techniques
have been used to develop single-cell western blots, multiplexing is relatively low at 11
channels and the detection limit is relatively high at 30,000 molecules (Hughes et al., 2014).
The most common multiplexed single-cell snapshot methods applied to signaling studies are
flow cytometry, and more recently, mass cytometry (Sachs et al., 2005; Bandura et al., 2009;
Bodenmiller et al., 2012). Flow cytometry measures antibodies labeled with fluorophores
and has been used to measure up to 17 molecular markers simultaneously (Perfetto et al.,
2004). Due to technical challenges such as spectral spillover between measurement channels,
however, flow cytometry is usually limited in dimensionality to around 10 markers. Mass
cytometry, by contrast, uses antibodies labeled with isotopes of heavy metals not other-
wise present in biological samples. Individual cells are atomized, ionized and the isotopes
are separated and measured using time-of-flight mass spectrometry (TOF-MS). The high
specificity of TOF-MS results in greatly reduced spillover between channels and routinely
enables the simultaneous measurement of up to 50 markers (Bendall et al., 2012; Spitzer
and Nolan, 2016). Currently, mass cytometry represents the state of the art for experimen-
tally characterizing intracellular signaling at a systems level; details are shown in Chapter
2 (Lun et al., 2017) of this dissertation.
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1.3.2 Computational Methods
Computational methods have been used for assessing bulk population-level data, in an at-
tempt to overcome the trade-off between continuous and snapshot measurements, and to
analyze the complex non-linear nature of intracellular signaling systems. In the case of snap-
shot measurements, a mathematical model of the underlying system is reverse-engineered
and used to infer the characteristics of continuous trajectories. The underlying biochemical
reactions of cell signaling networks are most commonly modeled by a system of determinis-
tic ordinary differential equations (ODEs). Although biochemical reactions are fundamen-
tally stochastic in nature, the use of deterministic models in signaling is generally justified
by the presence of kinases and other reaction components in abundances (Geiger et al.,
2012) sufficient to smooth out the stochastic variability in reactions (Goutsias, 2007; Filippi
et al., 2016). Thus, forward-simulation of the ODE model generates continuous trajectories
of state variables, such as the phosphorylation states of signaling proteins on a population
level. Snapshots of simulated trajectories are then compared to experimental measurements
to determine model quality and infer model parameters.
Computational Methods of Modeling Heterogeneity
Population-level models have been quite successful in the past but, by their nature, can-
not take cell-to-cell variations in a sample into account. This failure to quantify variation
in signaling components is intrinsic and mandates the development of entirely different ap-
proaches based on single-cell measurements (Bronstein et al., 2015), and especially snapshot
measurements that permit highly multiplexed observations. Current methods for assessing
variation in signaling dynamics use parametric distributions to represent single-cell snap-
shot data (Hasenauer et al., 2011, 2014; Filippi et al., 2016; Loos et al., 2018). Model
simulations are used to determine trajectories of both the population mean and variance,
which describe the most basic features of the distribution shape and statistically quantify
the appropriateness of the model quality. The most recent methods (Filippi et al., 2016;
Loos et al., 2018) use a sigma-point, or sigma-point Kalman filter (SPKF), approach (Van
der Merwe, 2004) to approximate the time-dependent change of distribution parameters.
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Specifically, given a model g, the change in distribution parameters is estimated by the
optimal choice of a set of sigma-points, which are points selected from the distribution and
weighted to characterize its mean and covariance (see Figure 1.1).
The use of parametric distributions offers increased information but complicates model
inferences by adding parameters that must be inferred from data. For example, if a sample
contains more than one meaningful population, the modeler must first determine the number
of (sub)populations and their associated mixing and shape parameters before pursuing the
original task of inferring a reaction model to describe population dynamics. These and other
aspects of cell-cell heterogeneity have the consequence that parametric descriptions rapidly
become computationally and statistically intractable. In the case of cancer, which is of pri-
mary interest here, typical samples contain complex mixtures of subpopulations (Chevrier
et al., 2017), thus requiring complex mixture distributions. The number of mixture dis-
tribution parameters grows as a polynomial function of model state variables, that is, the
number of signaling network components, and quickly leads to an infeasible inference prob-
lem. Furthermore, distributional parametric methods do not explicitly consider single-cell
trajectories. Due to these and other limitations, and despite the gradually increasing ability
of producing or acquiring multiplexed single-cell datasets, parametric methods of modeling
heterogeneity have only been applied to experimental data corresponding to states of one
or two dimensions (Filippi et al., 2016; Loos et al., 2018). This restriction is unacceptable
for our purposes, which suggests abandoning parametric for non-parametric methods that
we discuss below.
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Figure 1.1: Illustration of sigma-point approximation for mean and covariance
compared to sampling. Propagation of a random variable x by a nonlinear function
g such that y = g(x). (a) Direct propagation of many samples xi, given by yi = g(xi),
illustrates the true distribution. (b) Propagation of sigma-points χ, given by Y)i = g(Xj ,
that are used to estimate mean and covariance. Figure adapted from (Van der Merwe, 2004)
1.4 Comparing Multivariate Distributions
Model fitting generally amounts to minimizing the difference between experimental ob-
servations and results generated by model simulations. In the case of a bulk-population
measurement at a time point, for example, the goal is often to minimize the L2 norm,
that is, the squared Euclidean distance, between each experimental observation and the
corresponding model simulation result at the given time point. In the case of multiplexed
single-cell data at a time point, this goal may be extended to minimizing the difference
between the measured and the simulated multivariate distributions. Notably, this exten-
sion implies the assumption that accounting for additional distribution features beyond the
mean will provide additional information on the structure and function of the system of
interest. Current methods that approximate observations by parametric distributions have
use maximum likelihood estimation (MLE) to identify such model parameters that model
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simulations generate a set of distribution parameters that maximize the likelihood of con-
curring with the data for each time point (Filippi et al., 2016; Loos et al., 2018). Specifically,
these methods have considered the mean and variance (Filippi et al., 2016) or, very recently,
mean and covariance (Loos et al., 2018) parameters of the distributions. Advantageously,
the gradient of the likelihood function for normal and log-normal distributions can be solved
analytically, which speeds up many optimization methods, as demonstrated in Loos et al.
(2018). Parametric methods, however, become very cumbersome when the chosen distri-
butions are no longer normal or log-normal. Furthermore, the determination of the precise
number, mixing and form of distributions remains a challenging problem, because these
distributions are more often than not unknown in biological samples.
In contrast to parametric statistics, nonparametric ’distribution-free’ statistical tests
are constructed without assumptions regarding the parametric form of the distributions
considered. Thus, the difference between two samples consisting of complex mixtures of
subpopulations may be characterized without the necessity to define the mixtures a priori.
In this work, we present a reaction modeling framework based on simulating trajectories for
many individual cells that, together, represent empirical multivariate distributions analo-
gous to experimental measurements at corresponding time points (see Chapter 3). In this
context, each comparison between simulated and measured multivariate distributions can be
reduced to a two-sample test, using distribution-free statistics. Numerous distribution-free
two-sample tests for multivariate distributions have been proposed over the past decades.
A non-exhaustive list may begin with an extension of quantile-quantile plots to a multi-
variate quantile-quantile test (Dhar et al., 2014). Non-bipartite matching uses the minimal
distance between pairs of points across distributions (Rosenbaum, 2005). Multivariate gen-
eralizations of the Smirnov maximum deviations test and the Wald-Wolfowitz runs test
are based on using the minimal spanning tree (MST) of sample points as a generalization
of the univariate sorted list (Friedman and Rafsky, 1979). An approximate extension of
the Kolmogorov-Smirnov (K-S) test to the multivariate case was proposed in Justel et al.
(1997). The multivariate earth movers distance (EMD) method first finds an efficient com-
partmentalization, which corresponds to binning in a histogram, of the probability mass
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distribution and, subsequently, computes the minimal cost to transform one distribution
into the other by moving probability mass, based on a distance metric such as the L2 norm
(Rubner et al., 2000). The final example uses the maximum mean discrepancy (MMD),
which is the largest difference in expectations over functions in the unit ball of a reproduc-
ing kernel Hilbert space (RKHS) (Gretton et al., 2012a). Notably, both the approximate
K-S test and EMD are special cases of the MMD taken over function classes other than the
RKHS (Gretton et al., 2012a); all of these tests are fundamentally related to the idea of the
K-S test, which has been in use for many decades.
For the purpose of fitting reaction model dynamics to time course data, an appropriate
test must be both computationally efficient and discriminatory. Efficiency is necessary as
model fitting generally requires very large numbers of comparisons. Discrimination must
be considered for each test as an associated functional definition of distance or similarity
between distributions, which may perform better or worse in guiding a parameter search
algorithm. With these considerations in mind, MMD has been shown to perform well
compared to other methods across a broad range of distribution shapes and incurs relatively




, given sample numbers n and m from
each distribution; indeed, it may even be approximated in linear time, if necessary. Thus,
MMD becomes the basis for the non-parametric single-cell reaction modeling framework we
develop in Chapter 3.
1.5 Epidermal Growth Factor Signaling
In this work, we study signaling in the epidermal growth factor receptor (EGFR) pathway.
EGFR signaling controls cell growth, motility, survival, differentiation, and metabolism
(Citri and Yarden, 2006). The EGFR signaling network is highly studied and the reaction
structure is described in the literature in multiple levels of detail (see, for example, Kholo-
denko (2006)). EGFR signaling network proteins (e.g., EGFR, HER2, ERK, and AKT) are
affected by gene copy number alterations that deregulate protein abundances and/or func-
tions in a number of cancer types (Govindarajan et al., 2007; Eralp et al., 2008a; Han et al.,
2015). Intriguingly, targeted treatments for EGFR network-related cancers have had more
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limited success than expected, which is due, at least in part, to cell-cell variation in tumor
cell states (Wellbrock and Arozarena, 2016; Caunt et al., 2015). The vast body of prior
knowledge and the functional significance of EGFR signaling provide a solid basis upon
which to test our methodological developments. We take a broad approach to studying how
variation in cell states affects signaling in the EGFR network by considering populations
of wild-type cells, cell populations that include a broad and continuous range of signal-
ing protein overexpression and, finally, cell populations both before and after a phenotypic
transition (see next section). Relevant descriptions of the EGFR signaling network itself
may be found in the introductions of subsequent chapters.
1.6 Epithelial Mesenchymal Transition
The epithelial-to-mesenchymal transition (EMT) is a developmental program that naturally
occurs in embryogenesis and wound healing. During this transition, polarized epithelial cells
de-differentiate into a mesenchymal phenotype characterized by loss of cell-cell adhesion
junctions, increased capacity for migration and invasion, and resistance to apoptosis (Fu
et al., 2018). In cancer, EMT plays a major role in the generation of small cancer stem
cell (CSC) subpopulations that exhibit both increased drug resistance and the ability to
regenerate tumors post treatment (Shibue and Weinberg, 2017; Du and Shim, 2016). Cells
with an EMT signature, for example, have specific resistance to drugs targeting EGFR
signaling pathways, such as EGFR and PI3K/AKT inhibitors (Byers et al., 2013).
1.7 Objectives and Summary
The overall goal of this dissertation is to develop mathematical and computational methods
for the study of cell-to-cell variation in signaling, and to use these tools to increase our
understanding of when single cell differences do, or do not, make a meaningful difference. To
address this goal, we take a progressive approach. The complexity of modeling frameworks
moves from descriptive statistical measures to mechanistic reaction models, and the range
of cellular variation increases from wild-type cells to mixtures of wild-type and protein-
overexpressing cells and ultimately to cells before and after the dramatic phenotypic change
induced by EMT.
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Although cell-to-cell variation is an undisputed observation in signaling systems, our
overarching hypothesis is that most of this variation is not random. Expressed differently,
our hypothesis is that effective signaling is so important for the cell that the signaling
program is primarily deterministic at the single-cell-level, and thus reliably repeatable.
Pursuing this hypothesis, we design new methods of single-cell analysis and apply them
to increasingly demanding scenarios, in which the apparent heterogeneity increases. Ul-
timately we show that a minimal mechanistic model with constant structure and nearly
identical parameter values is able to explain the dramatic changes in signaling function
across different scenarios, including EMT. The model results even pinpoint specific molecu-
lar processes that are responsible for the remaining variation, which is incomparably smaller
than had been postulated based on earlier data analyses. The fact that a single model can
explain substantial changes in signaling function suggests a much higher role of determin-
istic functioning and a much more reduced role of stochasticity than previously assumed.
The chapters of this dissertation are arranged as follows:
Chapter 2: This chapter describes a novel experimental and statistical framework for
high-throughput systems-level analysis of protein expression-dependent effects on signaling.
We use this framework and overexpression of 20 protein kinases to study EGFR network
signaling in 360 conditions with a panel of 35 antibodies. We identify previously unreported
signaling relationships and illustrate effects of altered protein abundance or concentration
on signaling dynamics.
Chapter 3: This chapter describes a novel ODE-based computational modeling approach
to infer multivariate single-cell signaling dynamics from multiplexed single-cell snapshot
data. This method overcomes the experimental trade-off between multiplexing and time-
series measurements of cell response. We use our method to study EGF signaling in the
MAPK/ERK pathway in the context of both wild-type populations as well as complex mix-
ture populations, generated using the experimental techniques established in Chapter 2.
We show how protein overexpression can reveal complex kinetic effects that are sufficient to
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explain the altered observed dynamics discussed in Chapter 2. We also show that the vari-
ation in signaling responses across wild-type cells is generally much less than the variation
in cell states, yet sufficient to drive subpopulation-dependent drug responses. Finally, we
provide an illustrative example of how single-cell reaction models may be used to identify
novel treatment strategies.
Chapter 4: In this chapter, we use established data-driven network inference methods
and the single-cell ODE modeling method developed in Chapter 3 to study EGF signaling
in the ERK and AKT pathways before and after EMT. We show that, given observations
of appropriate initial cell states, a single reaction-based model of signaling with constant
structure and near-constant parameters is sufficient to represent differences in EGF signaling
across EMT.
Chapter 5: This final chapter summarizes our contributions to the body of scientific
knowledge and discusses future directions.
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CHAPTER II
INFLUENCE OF NODE ABUNDANCE ON SIGNALING NETWORK
STATE AND DYNAMICS ANALYZED BY MASS CYTOMETRY1
2.1 Abstract
Signaling networks are key regulators of cellular function. Although the concentrations of
signaling proteins are perturbed in disease states, such as cancer, and are modulated by drug
therapies, our understanding of how such changes shape the properties of signaling networks
is limited. Here we couple mass cytometry-based single-cell analysis with overexpression of
tagged signaling proteins to study the dependence of signaling relationships and dynamics
on protein node abundance. Focusing on the epidermal growth factor receptor (EGFR)
signaling network in HEK293T cells, we analyze 20 signaling proteins during a one hour
EGF stimulation time course using a panel of 35 antibodies. Data analysis with BP-R2,
a measure that quantifies complex signaling relationships, reveals abundance-dependent
network states and identifies novel signaling relationships. Further, we show that upstream
signaling proteins have abundance-dependent effects on downstream signaling dynamics.
Our approach elucidates the influence of node abundance on signal transduction networks
and will further our understanding of signaling in health and disease.
2.2 Introduction
Signaling networks are at the core of cellular information processing and transform external
signals into cellular responses. Signals are transduced by modulating enzymatic activities
mainly via protein phosphorylation, and cells implement sophisticated mechanisms, such as
feedback loops, pathway crosstalk, and differential enzyme localization, to integrate signals
1This chapter is adapted from: Lun, XK*, Zanotelli, VRT*, Wade, JD*, Schapiro, D, Tognetti, M,
Dobberstein, N and Bodenmiller, B. (2017) Influence of node abundance on signaling network state and
dynamics analyzed by mass cytometry. Nature Biotechnology , 35(2):164-172. *Conceptualization of
analysis, performance of analysis.
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and drive cellular processes and physiological outputs. The abundance of individual signal-
ing pathway components (nodes) is central to the activity and output of a signaling network
(Wolf-Yadlin, 2006). Changes in node abundance are tightly regulated and control biolog-
ical programs such as stem cell differentiation and embryogenesis (De Los Angeles, 2015).
Abundance deregulation of particular signaling network nodes via genomic, transcriptional,
or post-transcriptional regulatory defects (Feinberg, 2007; Bywater et al., 2013; Silvera
et al., 2010) underlies human diseases, the prime example being cancer (Santarius et al.,
2010). Copy number alterations of genes encoding critical proteins (Govindarajan et al.,
2007; Eralp et al., 2008a; Han et al., 2015), independent of mutations that constitutively
change enzymatic activity (Davies, 2002), drive progression of many cancer types. Genomic
instability in cancer cells causes abnormally broad distributions of signaling protein abun-
dances in a given tumor (Wang et al., 2015), yet the consequences of the protein abundance
levels on signaling properties is poorly understood limiting our ability to rationally design
therapies.
The epidermal growth factor receptor (EGFR) signaling network is affected by gene
copy number alterations that deregulate protein abundances (e.g., of EGFR, HER2, ERK
and AKT) in a number of cancer types (Govindarajan et al., 2007; Eralp et al., 2008b;
Han et al., 2015). EGFR signaling controls cell growth, motility, survival, differentiation,
and metabolism (Citri and Yarden, 2006). Many drugs target the activity of the EGFR
signaling network (Tebbutt et al., 2013; Roberts and Der, 2007). The receptor tyrosine
kinase (RTK) function of EGFR is activated by its dimerization upon ligand binding. EGFR
auto-phosphorylation recruits adaptor proteins that typically activate the MAPK/ERK and
AKT signaling pathways. The MAPK/ERK branch activates the GTPase RAS, which
triggers a kinase phosphorylation cascade consisting of RAF, MEK, ERK, and p90RSK.
The output of the MAPK/ERK branch is transcription of genes regulating growth and
division (Mendoza et al., 2011; Olayioye et al., 2000). Signal transduction through the
AKT branch starts by PI3K activation, producing PIP3, which recruits AKT and PDK1
to the plasma membrane. PDK1 phosphorylates AKT (Mendoza et al., 2011; Manning
and Cantley, 2007), which mediates signaling through the mTORC1 complex to modulate
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translation via p70S6K and 4EBP1 (Manning and Cantley, 2007). Other AKT targets are
GSK3β, PRAS40, and TSC2. The AKT pathway controls cell survival, proliferation, and
migration (Manning and Cantley, 2007). STAT proteins and the PKC pathway can also be
activated by EGFR-mediated signaling (Bowman et al., 2000; Oliva et al., 2005). EGFR
signaling involves crosstalk and feedback loops both internally (e.g., active ERK attenuates
upstream RAF or MEK signaling via negative feedback) (Mendoza et al., 2011) and with
other signaling pathways (e.g., WNT and TGF-β pathways) (Kim et al., 2007; Massague,
2003).
Classically, two approaches are used to characterize the effect of proteins on signal
transduction. The first approach analyzes cell populations. Here, western blotting, mass
spectrometry, RNA-microarrays, and synthetic lethality screens are used to identify sig-
naling relationships (Zhang, 2005; Kim, 2012; Corcoran, 2013). Protein-protein interaction
analyses are used to determine which proteins in a network directly interact (Kim, 2012;
Tewari, 2004). Population-based methods yield a comprehensive view of signaling but are
difficult to use in analysis of protein abundance dependencies due to inherent limitations:
Proteins must be expressed at different abundances or cells must be sorted to yield a non-
continuous abundance titration. Such methods result in a large number of samples and
cell-to-cell protein abundance variations within each sample remain masked. The second
approach studies signaling relationships in single cells. Here fluorescence microscopy and
flow cytometry (FACS) are used with a variety of assays, including proximity ligation assay
(PLA)(Sundqvist, 2013) or fluorescence resonance energy transfer (FRET)(Aoki, 2013).
These approaches allow study of signaling relationships and dynamics through time and
space; however, only a few signaling nodes can be measured simultaneously.
A recently developed single-cell analysis technology, called mass cytometry, allows for
the simultaneous measurement of over 40 signaling nodes in single cells using metal-isotope
tagged antibodies (Bodenmiller et al., 2012; Bendall, 2011). This capability makes mass
cytometry uniquely suited to comprehensively query the function of nodes in signaling
networks within heterogeneous cell populations. Mass cytometry is quantitative and, in
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combination with mass-tag cellular barcoding (MCB), a powerful screening tool (Boden-
miller et al., 2012). Algorithms to analyze multiplexed single-cell mass cytometry data allow
quantification of signaling relationships, therefore helping to decipher the highly complex
network behaviors that operate even in simple biological systems (Krishnaswamy, 2014).
Here, we coupled protein overexpression with mass cytometry to measure the effect of
varying node abundance on the activation state and signaling relationships of an unstimu-
lated EGFR signaling network, as well as the signaling dynamics of the network in response
to EGF stimulation. We exploited the finding that transient protein overexpression in a
cell population typically produces a continuous abundance range of the target protein over
four orders of magnitude. We overexpressed 20 central EGFR signaling network proteins
individually in human embryonic kidney (HEK) 293T cells, sampled during an EGF stim-
ulation time course over 60 minutes totaling 360 conditions. An average of 11,000 cells per
condition was analyzed with a panel of 35 antibodies to provide a comprehensive single-cell
proteomic EGFR network analysis. To identify signaling relationships in this dataset, we
developed a statistical measure that we call ’binned pseudo R-squared’ (BP-R2) that reca-
pitulated known signaling relationships and identified relationships that were to the best
of our knowledge - not described previously. Thus, our experimental and computational
approach enables study of how the strength and dynamics of signal transduction are tuned
by node abundances.
2.3 Results
2.3.1 Analyzing continuous protein abundance dependencies
To systematically identify and characterize protein abundance-dependent signaling relation-
ships, dynamics, and network activation states, we exploited the variation and large dynamic
range of protein abundance induced by transient transfection and used mass cytometry to
quantify the abundance of the transfected protein of interest (POI) in conjunction with com-
prehensive signaling network readouts in single cells. We cloned POIs genes into vectors
containing a cytomegalovirus (CMV) promoter and a GFP-tag sequence (Couzens et al.,
2013) to transiently overexpress GFP-tagged POIs in HEK293T cells (Figure 2.1a). The
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tagged protein abundance was measured by mass cytometry using an anti-GFP antibody
(Figure 2.1a). Ordering the measured cells based on the GFP signal provided a continuous
POI titration (Figure 2.1b). Typically, not all cells were transfected, yielding an internal
control for every experiment. To measure the single-cell EGFR signaling network states, we
designed and validated a panel of 35 antibodies that mostly detect phosphorylation sites on
signaling proteins (Supplementary Tables 1-3 online in Lun et al. (2017)). These data were

















































































































Figure 2.1: Workflow of abundance-dependent network analysis. (a) Experimen-
tal workflow. Signaling POIs are cloned into vectors containing a CMV promoter and a
GFP-tag sequence to transiently overexpress GFP-tagged POIs in HEK293T cells. We
quantify anti-GFP antibody as readout of POI-GFP abundance, together with other 35
markers, by mass cytometry. (b) Data analysis workflow. Cells were ordered based on the
GFP signal, providing a continuous POI titration, which was then coupled to other sig-
naling markers to determine the abundance dependencies of network activation state and
signaling dynamics in the network after transfection. The network in the illustration does
not represent an actual biological example.
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To validate our system we confirmed that, first, the GFP tag was reliably detected
by mass cytometry (Figure A.1); second, the GFP tag did not affect the localization and
activity of the POI (Figures A.2, A.3; Supplementary Table 4 and Supplementary File
1 online in Lun et al. (2017)); third, POI expression levels were linearly related to GFP
abundance, validating GFP as readout of the total POI abundance (Figure A.4a, c); fourth,
POI overexpression for 18 hours (i.e., the time point of our experiments) did not alter the
underlying network structure (Figure A.4b, c); fifth, the antibody-based GFP quantification
by mass cytometry was comparable to FACS (Figure A.5); sixth, the cell culture media
and cell detachment did not alter signaling processing in the EGFR network (Figures A.6,
A.7); and, seventh, the levels of the GFP-tagged POIs were stable during the 1-hour EGF
stimulation time course (Figure A.8, Supplementary Video 1 online in Lun et al. (2017)).
We also found that the method is robust and highly reproducible as evidenced by the high
concordance between the three individual experiment replicates (Figure A.9, Supplementary
File 2 online in Lun et al. (2017)).
2.3.2 KRASG12V and MEK1DD abundance effect on signaling
We first studied a well-known signaling circuit: Constitutively active mutants of KRAS and
MEK1 (KRASG12V and MEK1DD) lead to ERK phosphorylation and activate components
downstream in the MAPK/ERK pathway. As expected, we found that overexpression of
KRASG12V-GFP or MEK1DD-GFP increased phosphorylation on Thr202 and Tyr204 of
ERK1/2 (Figure 2.2a). Our approach also elucidated the abundance-dependent effects on
these signaling relationships: The relationship between KRASG12V-GFP and p-ERK1/2
was bow-like as high levels of KRASG12V-GFP corresponded to reduced phosphorylation
of ERK1/2. By contrast, the MEK1DD-GFP abundance relationship with p-ERK1/2 was
monotonic as p-ERK1/2 increased with MEK1DD-GFP expression (Figure 2.2a). These




































































































































































































































































































































































































































































































































































































































































































Figure 2.2: MAPK/ERK pathway mutants induce oncogenic signaling. (a)
Biaxial plots of GFP, representing the abundance of the overexpressed mutant POIs, ver-
sus abundance of phosphorylation on Thr202/Tyr204 on ERK1/2. Constitutively active
KRASG12V-GFP shows a downregulation on Thr202/Tyr204 on ERK1/2 at the highest
levels of KRASG12V-GFP. Constitutively active MEK1DD-GFP directly phosphorylates
Thr202/Tyr204 on ERK1/2, and the abundance of the POI-GFP is correlated with amount
of ERK1/2 phosphorylated at these sites. The FLAG-GFP control does not affect ERK
phosphorylation sites. (b) The abundances of measured phosphorylation sites are plotted
over the range of the KRASG12V-GFP and MEK1DD-GFP expression. Phosphorylation
sites of the same pathway (e.g., on ERK1/2 and p90RSK, AKT and GSK3, or p38 and
JNK) show similar trends. An individual experiment is shown here. Plots for 3 replicates
are shown in Figure A.9b-e. (c) Strong single-cell correlations within biaxial plots indi-
cate co-regulated phosphorylation sites. (d) Unchanged and reduced correlations indicate
unrelated phosphorylation sites. (e) and (f) Heat maps showing for all pairs of measured
markers the change in Fisher-transformed Spearman correlation values for overexpression
of (e) KRASG12V-GFP and (f) MEK1DD-GFP when compared to the FLAG-GFP overex-
pression control. (g) and (h) BP-R2 scores and Spearman correlations of bin medians for
all measured markers in cells where (g) KRASG12V-GFP or (h) MEK1DD-GFP was overex-
pressed overlaid on a literature-based graph of canonical signaling pathways (Roberts and
Der, 2007; Mendoza et al., 2011; Massague, 2003; Kim, 2012; Cardaci et al., 2012; Rawlings
et al., 2004; Xu et al., 2014; Nyati et al., 2006; Mitra et al., 2005; Hendriks et al., 2014).
Strong relationships identified from the BP-R2 analysis are plotted on the signaling maps
as colored circles. The sizes of circles indicate relationship strengths quantified by BP-R2.
The directionalities of relationships, as judged by Spearman correlation of bin medians, are
shown by the color of the circles (positive correlation indicates that cells show generally
increasing marker levels, and a negative correlation indicates decreasing marker levels as
POI-GFP levels increase). For (e) to (h), data from 3 individual experiment replicates were
used.
Next, we analyzed the impact of KRASG12V-GFP and MEK1DD-GFP abundance on all
measured phosphorylation sites. We divided the measured cells into 10 bins according to
the GFP signals and plotted the bin medians (Figure 2.2b, Figure A.9b-e). This analysis
revealed that the phosphorylation site abundances on ERK1/2 and its direct downstream
target Ser380 of p90RSK had similar relationships to the abundances of KRASG12V-GFP
or MEK1DD-GFP. Phosphorylation of AKT on Ser473 and its direct target Ser9 of GSK3β
also had parallel trends and showed reduced levels when the MAPK/ERK signal peaked,
suggesting inter-pathway regulation. We also observed increased JNK phosphorylation on
Thr183/Tyr185 induced by the KRASG12V mutant (Figure 2.2b) as reported previously
(Zhou, 2010). This shows that our approach recapitulates known signaling relationships
and identifies abundance-determined signaling responses.
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We then systematically evaluated signaling relationships between all pairs of measured
markers modulated by KRASG12V-GFP or MEK1DD-GFP overexpression. We exploited
the fact that overexpression of one protein increases signaling (i.e., phosphorylation levels)
and thus expands the dynamic range of many measured markers (Figure 2.2c). This enabled
the use of correlation analysis to distinguish signaling relationships (high correlation) from
biological and technical noise (low correlation). For example, overexpression of KRASG12V-
GFP resulted in an increased Spearman correlation between p-ERK1/2 and p-p90RSK
compared to control (Figure 2.2c), whereas ERK-independent phosphorylation sites, such
as Tyr551 of BTK/ITK, showed low correlation with p-ERK1/2 levels in both control and
overexpression conditions (Figure 2.2d).
Identifying changes in pairwise Spearman correlations for all measured markers in the
KRASG12V-GFP and MEK1DD-GFP overexpression data compared to the FLAG-GFP con-
trol enabled systematic analysis of signaling relationship patterns (Figure 2.2e, f). Phos-
phorylation levels of proteins in the MAPK/ERK pathways showed strong increases in
correlation, and pathway members clustered together (Figure 2.2e, f, green squares). We
also observed that phosphorylations of MAPK/p38 pathway members and STAT proteins
(STAT1 and STAT5) were increasingly correlated with levels of MAPK/ERK pathway mem-
bers as MEKDD-GFP levels increased (Figure 2.2f, purple rectangle), indicating crosstalk
between MAPK and STAT pathways. These results reveal relationships among many mea-
sured markers and show that increases in correlation reflect pathways and grouped biological
processes.
2.3.3 Automated analysis of abundance-induced signaling
Spearman correlation analysis can uncover strictly monotonic relationships between phos-
phorylation levels on signaling proteins; however, protein abundance-dependent signaling
responses can be complex (Figure 2.2a, see KRASG12V). We therefore developed a density-
independent measure termed ’binned pseudo R-squared’ (BP-R2) to quantify the strengths
of relationships between the abundance of a POI and measured phosphorylation sites. BP-
R2 creates 10 bins across the POI-GFP expression range and calculates the relationship
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strength considering bin medians and the global mean (Figure 2.3a, b, Methods, Supple-
mentary Software online in Lun et al. (2017)). Using the BP-R2 values for all negative
controls, a cutoff for strong signaling relationships was determined (Figure 2.3c). Bench-
marking BP-R2 in identifying strong signaling relationships from the overexpression datasets
showed that BP-R2 outperformed methods often used for this task (Krishnaswamy, 2014;
Redell, 2013) (Figure A.10a, b). The strong relationships identified by BP-R2 were plotted
in a two-dimensional layout guided by canonical pathways (Figure 2.2g, h). The direction-
ality of measured signaling relationships was determined by Spearman correlation of the bin
medians (Figure 2.3b, Methods). A positive correlation indicates that cells show generally
increasing marker levels and a negative correlation indicates generally decreasing marker
levels as POI-GFP levels increase.
Analysis of KRASG12V-GFP and MEK1DD-GFP overexpression versus all measured
markers using BP-R2 revealed strong, positively correlated relationships of MEKDD-GFP
to downstream MAPK/ERK pathway nodes. KRASG12V-GFP levels, although also pos-
itively correlated with MAPK/ERK nodes, exhibited the same, but weaker relationships
(Figure 2.2a, b, g, h). Together, these results suggest that feedback regulation of upstream
MAPK nodes differs between the studied mutants. Additionally, this network view revealed
that MEK1DD-GFP abundance had a strong positive impact on nodes in the MAPK/p38
pathway; the previously observed KRASG12V-induced phosphorylation of JNK (Zhou, 2010)
was dependent on KRASG12V abundance (Figure 2.2g, h). These results show that overex-
pression of signaling proteins, in conjunction with BP-R2 and correlation analysis, identifies
known relationships and is a valid platform for discovery of signaling relationships in a com-
prehensive and abundance-dependent manner.
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Figure 2.3: Binned pseudo R2 (BP-R2) analysis. (a) BP-R2 analysis considers de-
viation from bin median versus the global mean of bin medians. (b) Examples of BP-R2
and Spearman correlation of bin medians values. The top left and top right plots show
examples of positive and negative Spearman correlations of bin medians. The top left and
bottom left plots show replicates of the same overexpression condition and how a (suppos-
edly) increased noisiness affects the BP-R2 values. The bottom right plot shows a complex
signaling relationship with the corresponding BP-R2 value. The BP-R2 metric detects com-
plex arbitrary relationship (bottom right). (c) Density distribution of the median BP-R2
values for the 700 POI-GFP-marker relationships from the negative controls (FLAG-GFP,
untransfected) and the 3500 POI-GFP-marker relationships of the signaling node overex-
pression conditions. Cutoff for strong signaling relationships were determined at a median
BP-R2 value of 0.11, the highest median BP-R2 of the negative controls.
23
2.3.4 Node abundance dependency analyses of the EGFR network
To study the node abundance dependency of signaling relationships and dynamics in the
EGFR signaling network, we overexpressed 20 EGFR-related signaling proteins individually
in HEK293T cells (Table 2.1). Each of the 20 GFP-tagged POIs was validated in previous
studies (Supplementary Table 5 online in Lun et al. (2017)) and in our system (Figures A.2
and A.3, Supplementary File 1 online in Lun et al. (2017)). 18 hours after transfection,
we treated cells with EGF and quantified signaling by mass cytometry over a 60-min time
course. To exclude signaling relationships caused by channel-to-channel spillover, we applied
a stringent experimental filter (Figure A.11, Methods). The median marker intensities
during the time course are shown in Figure A.12a. Based on these data we performed two
sets of analyses. In the first, we used BP-R2 analysis and Spearman correlations to evaluate
how the abundance of overexpressed proteins influenced phosphorylation at the measured
sites (Figure 2.4, Figure A.12b and Supplementary Files 2-4 online in Lun et al. (2017)). In
the second, we examined how features of signaling dynamics depend on protein abundance
(Figure 2.5).
In the first analysis, strong and broad signaling responses to overexpression were identi-
fied for the upstream kinases PDK1-, GSK3β-, SRC-, and ASK1-GFP without EGF stimula-
tion (Figure 2.4. Overall, we identified 59 strong signaling relationships in the unstimulated
conditions. Overexpression of many kinases induced strong and positively correlated signal-
ing relationships with their own phosphorylation (Figure 2.4, Supplementary File 4 online
in Lun et al. (2017)). Overexpression of CRAF-, KRAS-, p70S6K-GFP, and others only
induced signaling responses upon EGF stimulation (Figure 2.4). Notably, under stimulated
conditions, KRAS-, CRAF-, and MEK1-GFP levels negatively correlated with phospho-
rylation levels of downstream kinases p-ERK1/2 and p-p90RSK (Figure 2.4). Activating




Figure 2.4: Analysis of dynamics of EGFR signaling. HEK293T cells overexpressing
GFP-tagged signaling proteins listed in Table 2.1 were treated with EGF for 0, 5, 15,
30, and 60 min. Strong abundance-dependent signaling relationships (Figure 2.3c) are
plotted on the signaling map with circle sizes and colors indicating strengths (BP-R2 score)
and directionalities (Spearman correlation of bin medians), respectively. The miniaturized
network is the same as used in Figure 2.2. Overexpression of S6-GFP did not induce any
strong signaling relationships (data not shown). For all analyses, data from 3 individual
experiment replicates were used.
Table 2.1: Overexpressed signaling proteins.





















To systematically assess signaling relationships identified by BP-R2, we used the lit-
erature curated signaling network, SIGNOR (Perfetto, 2016). For each relationship, we
computed the shortest signed directed path length according to the SIGNOR network
(Supplementary Table 6 online in Lun et al. (2017)). We found that 76% of the strong
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relationships identified in the unstimulated conditions had paths with a maximum of three
steps, highlighting that our approach identifies rather direct signaling relationships. Only 14
abundance-dependent relationships with four or more path steps were identified. Compari-
son of our strong signaling relationships with literature indicated that many EGF signaling
connections that we identified were previously reported. We also propose many relation-
ships that have – to our knowledge – not been previously reported, for example: p90RSK
to PDK1 (Ser241), GSK3β to SHP2 (Tyr580), JNK1 to MAPKAPK2 (Thr334), p110 to
MKK3 (Ser189), p110α to MKK6 (Ser207), ASK1 to PDK1 (Ser241), ASK1 to GSK3β
(Ser9), and ASK1 to AMPKα (Thr172) (Table 2.2).









SRC p-BTK/ITK 1 6
SRC family kinases phosphorylate
BTK (Hendriks et al., 2014)
SHP2 p-S6 -1 5 Known regulation (Marin, 2008)
ASK1 p-PDK1 1 5 Potential novel relationship
SRC p-PLCγ2 1 5
SRC family kinases
activates PLCγ2 (Hendriks et al., 2014)
ASK1 p-AMPK 1 4 Potential novel relationship
GSK3β p-SHP2 1 4 Potential novel relationship
p90RSK p-PDK1 1 4 Potential novel relationship
JNK1 p-STAT1 1 4 JNK activates STAT1 (Wei, 2014)
JNK1 p-MAPKAPK2 1 4 Potential novel relationship
p110α p-MKK3/6 1 4 Potential novel relationship
HRAS p-SMAD2/3 1 4 Known crosstalk (Massague, 2003)
ASK1 p-GSK3β 1 4 Potential novel relationship
PDK1 p-S6 -1 4
Overexpression-induced
negative regulation
p70S6K p-S6 -1 4
Overexpression-induced
negative regulation
Phosphorylation levels of many members of the MAPK/ERK pathways showed com-
plex relationships (i.e., measured phosphorylation levels varied over the analyzed POI-GFP
range and the relationships did not fit linear, sigmoidal, or quadratic models) with levels
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of POI-GFPs upon EGF stimulation. These relationships can be explained by abundance-
dependent modulation of the signaling dynamics in response to EGF. Thus, in the second
set of analyses we examined how signaling dynamics, as quantified by amplitude and peak-
time, depended on abundance of an overexpressed protein (Figure 2.5). In order to view
signaling trajectories as functions of protein abundance, we binned the POI-GFP levels into
10 bins (Figure 2.5a, Supplementary File 2 online in Lun et al. (2017)). This allowed tracing
the signaling trajectories of cells with similar protein overexpression levels (i.e., those in the
same bin) over the EGF stimulation time course (Figure 2.5b, Supplementary File 5 online
in Lun et al. (2017)). Strong and robust changes in signaling amplitudes (Figure 2.5c-i) and
peak-times (Figure A.13) were found. Notably, the maximum amplitudes were independent






































































































































































































































































1 2 3 4 5 6 7 8 9 10Bin:








EGF: 0min 5min 15min 30min 60min
EGF: 0min 5min 15min 30min 60min


































BP-R2=0.10 BP-R2=0.15 BP-R2=0.07 BP-R2=0.02 BP-R2=0.06
BP-R2=0.03 BP-R2=0.25 BP-R2=0.12 BP-R2=0.04 BP-R2=0.03
BP-R2=0.11 BP-R2=0.28 BP-R2=0.56 BP-R2=0.48 BP-R2=0.38
28
Figure 2.5: Analysis of node abundance-dependent EGFR signaling dynamics.
(a, b) Schematic plots of amplitude and peak-time analysis. (a) The x-axis (i.e., over-
expressed protein as determined by the GFP measurement) was split into 10 bins. (b)
Median phosphorylation abundance in each bin was plotted on the y-axis versus time (x-
axis) to visualize abundance dependency of signaling dynamics. (c, d) Mass cytometry
ion counts (arcsinh transformed, Methods) measured for p-p90RSK (y-axis) as a function
of ion counts measured for abundance of CRAF-GFP (x-axis) and EGF stimulation time.
The same layouts for (e, f) ERK2-GFP abundance-determined p-p90RSK levels and (g, h)
p-ERK1/2 levels are shown. (i) Heat map showing protein abundances with strong influ-
ences on signaling amplitudes with color indicating normalized signaling amplitudes. Only
overexpressed proteins with an amplitude-ratio higher than 3 fold for more than two of the
three replicates were identified as strong influences and are included in the heat map. For
(a) to (h), representative examples from the 3 individual experiment replicates are shown.
Other replicates are presented in Supplementary File 5 (online in Lun et al. (2017)). In (i),
all replicate data are shown.
We found that high CRAF-GFP and KRAS-GFP abundance strongly reduced signaling
amplitudes of p-ERK1/2 and p-p90RSK (Figure 2.5c, d, i), whereas high abundance of
MEK1-GFP strongly reduced amplitudes and delayed peak-times for p-p90RSK (Figure
2.5i, Figure A.13). Overexpression of ERK2-GFP led to complex abundance-dependent
responses of p-p90RSK and p-ERK1/2 after EGF stimulation (Figure 2.5e-h). p-ERK1/2
amplitudes increased and peak-times delayed as a function of ERK2-GFP abundance level
(Figure 2.5g-i, Figure A.13). Intermediate abundance levels of ERK2-GFP also delayed
the p-p90RSK peak-times relative to low ERK2-GFP abundance, whereas cells with high
ERK2-GFP levels exhibited minimal p-p90RSK signaling dynamics (Figure 2.5e, f, i, Figure
A.13). Overexpression of p90RSK-GFP modulated the signaling amplitude of its potential
crosstalk phosphorylation site, Ser241 of PDK1, in an abundance-dependent manner, and
increasing expression of p90RSK increased p-PDK1 amplitudes (Figure 2.5i). Thus, we
observed abundance-dependent signaling dynamics across the range of overexpression levels.
Overexpression of upstream signaling proteins (KRAS-, CRAF-, MEK1-, and ERK2-GFP)
in the MAPK/ERK pathway led to reduced signaling amplitudes and delayed peak-times
of their downstream targets. These observations show that our approach can quantify the




Here we present an approach coupling transient overexpression with mass cytometry-based
single-cell measurements to characterize signaling network activation states and signaling
dynamics over a quasi-continuous, high dynamic range of protein abundance. To highlight
the utility of our approach, we present a comprehensive single-cell proteomic analysis of the
EGFR network that enabled an analysis of abundance-dependent effects of signaling proteins
on state and dynamics of the signaling network. We evaluated the effects of overexpressing
20 EGFR network key nodes with a 60-minute EGF stimulation time course. In each of the
360 conditions, we measured the effect of a POI over a four order of magnitude abundance
range on 35 markers by mass cytometry providing a unique and valuable quantitative single-
cell resource of abundance dependencies of EGFR signaling.
Previously, the heterogeneity of protein levels after transient transfection was considered
problematic. Here, we took advantage of this cell-to-cell variation as it results in a contin-
uous titration of protein abundance over four orders of magnitude. Untransfected cells also
provided an internal control for each experiment. We used the multiplexing capabilities
of mass cytometry to characterize abundance dependencies of signaling network state and
dynamics. Applied to the EGFR signaling network, our approach recapitulated known re-
lationships, suggested previously not described ones, and revealed the intricate modulation
of signal amplitudes and peak-times as functions of continuous protein abundance.
Our approach contributes to the understanding of signaling on several levels. First, the
approach can be used to study uncharacterized proteins and to suggest additional roles
to characterized ones. Second, we were able to directly relate POI abundance with the
comprehensive analysis of signaling dynamics in response to stimulation. Such analyses are
necessary for understanding of differential signal processing in identical cell types and in
disease states characterized by heterogeneity in protein expression such as cancer. Third,
the overexpression yields a large dynamic range of signaling activity and can reveal signal-
ing relationships masked by stochastic processes and technical noise under otherwise simi-
lar conditions, facilitating the computational analysis of signaling relationships. Fourth, we
present a metric termed BP-R2, which allows the quantification of the strengths of arbitrary
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shaped signaling relationships. BP-R2 was superior to state-of-the-art methods for analy-
sis of our dataset. Fifth, and finally, we were able to infer protein abundance-dependent
signaling kinetics from single-cell snapshot data.
Our approach recapitulated known oncogenic signaling behaviors induced by the consti-
tutively active mutants KRASG12V and MEK1DD and identified novel abundance-dependent
signaling relationships. For example, p-ERK1/2 was attenuated in cells with highly overex-
pressed KRASG12V-GFP, potentially due to negative feedback loops or senescence (Xu et al.,
2014). Overexpression of the wild-type KRAS-GFP and MEK1-GFP did not induce down-
stream signaling activation, suggesting that mutations on KRAS or MEK1 are the main
drivers of oncogenic signaling. Further, our approach allows study of abundance-dependent
signaling dynamics. In the MAPK/ERK pathway, high abundance of upstream signaling
mediators KRAS, CRAF, MEK1, or ERK2 reduced amplitudes and delayed peak-times of
downstream phosphorylation sites. One possible explanation is that the signal transduction
is determined by the competition between active and inactive forms of a signaling protein
for substrates. Overexpression increases the total abundance but may reduce the percentage
of the active form.
KRAS amplification has been identified in many cancer types. Amplification, however,
is not correlated with the phosphorylation of ERK1/2 (Rahman, 2013). Rather, KRAS
amplification mediates resistance to inhibitors targeting growth pathway related kinases,
including EGFR, MET and MEK1/2; KRAS knockdown diminishes the drug resistance
(Valtorta, 2013; Cepero, 2010; Little, 2011). Our results indicate that due to reduced down-
stream signaling amplitudes in response to EGF stimulation, the dependency of cells on the
MAPK/ERK pathway may decrease upon KRAS overexpression, suggesting a mechanism
for cancer cell resistance to inhibitors.
Comparing the identified strong signaling relationships with those in the SIGNOR
database, we propose previously not described signaling relationships, e.g.: 1) Our data
suggest that p90RSK potentially forms a positive feedback loop and activates the upstream
signaling protein PDK1. 2) GSK3β has been identified as a central signaling controller and
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has multiple substrates (Cohen and Frame, 2001); our results suggest that SHP2 is a po-
tential direct or indirect target of GSK3β. 3) We also propose that JNK1 is a MAPKAPK2
activator. 4) PI3K and MKK3/6 are known to be regulated by RAC1 (Shin et al., 2005);
our results suggest PI3K activates MKK3/6 independently. 5) Recent studies indicate that
ASK1 contributes in negative regulation of PDK1 through phosphorylation on Thr254 of
PDK1 (Seong et al., 2010); We observe ASK1 overexpression-induced PDK1 phosphoryla-
tion on Ser241, inducing PDK1 activity and downstream GSK3β phosphorylation on Ser9.
6) In addition to the known AMPK-mediated ASK1 activation (Lee et al., 2010), our data
indicates ASK1 activation of AMPK via phosphorylation on Thr172. 7) We have also
observed negative correlations between the abundance of p70S6K or PDK1 to the phospho-
rylation level of S6 (Ser235/Ser236), indicating overexpression-induced-negative feedback
regulations.
Our method has several limitations. First, we do not measure the endogenous expression
level of the POI. However, exogenous expression is linearly correlated with the total protein
level (Figure A.4a), validating GFP as readout of the total POI. Second, all results in mass
cytometry rely on antibodies; for this work, all antibodies were thoroughly validated (Sup-
plementary Table 3 online in Lun et al. (2017)). Third, we do not measure the abundance
range of the studied proteins in cancer cells, however, proteome studies of cancer cells and
databases such as PaxDb (Wang et al., 2015) indicate a range similar to those studied here.
Fourth, high expression levels of a protein kinase may induce non-specific phosphorylation;
however, our data allows choosing the analyzed expression range in silico, thus such effects
can be excluded.
The approach described here provides a method to study how the abundance variance
of signaling proteins in different tissues and cell lines results in distinct signaling behav-
iors. The application of our approach to synthetic biology, stem cell biology, developmental
biology, and cancer-related processes, such as the epithelial-mesenchymal transition, will
enable quantitative identification of key proteins and signaling determinants in cell differ-
entiation at phenotypical switching points. We envision that determining which signaling





All raw data are available at http://www.cytobank.org/bodenmillerlab and http://
www.bodenmillerlab.org/.
Cloning
DNA sequences of the genes of interest were provided in entry clones by William Hahn
and David Root (Yang et al., 2011) (via Addgene and NEXUS Personalized Health Tech-
nologies at ETH Zurich). Destination vectors, including pDEST pcDNA5 FRT TO-eGFP,
pDEST 5’ Triple Flag pCDNA5 FRT TO and pDEST 3’ Triple Flag pcDNA5 FRT TO,
were kindly provided by Dr. Anne-Claude Gingras at Lunenfeld-Tanenbaum Research In-
stitute, Toronto, Canada (Couzens et al., 2013). Expression vectors encoding the FLAG-
or GFP-tagged fusion proteins were generated via Gateway Cloning and sequenced before
transfection.
Cell culture
HEK293T cells, obtained from ATCC, were cultured in DMEM (D5671, SIGMA), supple-
mented with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml strepto-
mycin. For cell passaging or harvesting, cells were incubated with 1X TrypLETM Express
(Life Technologies) for 2 minutes at 37◦C.
Transfection and stimulation
HEK293T cells were seeded at the density of 0.7 million per well in 6-well plates. After
24 hours, cells were transfected with 2 µg plasmid and 4 µl of jetPRIME (PolyPlus) per
well with the standard protocol provided by the manufacturer. At 18 hours after trans-
fection, EGF (Peprotech) was added to a final concentration of 100 ng/ml. At 20 minutes
before a given EGF stimulation time point, 5-Iodo-2-deoxyuridine (IdU) was added to the
medium at the final concentration of 10 µM. At 2 minutes before a given EGF stimulation
time point, medium was replaced by 1X TrypLE to induce cell detachment. At the time
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point, paraformaldehyde (PFA, from Electron Microscopy Sciences) was added to the cell
suspension to a final percentage of 1.6%, and cells were incubated at room temperature
for 10 minutes. If EGF stimulation was not necessary in the experiment, cells were di-
rectly harvested and crosslinked with PFA. Crosslinked cells were washed twice with cell
staining media (CSM, PBS with 0.5% BSA, 0.02% NaN3) and after centrifugation, ice-cold
methanol was used to resuspend the cells, followed by a 10-minute permeabilization on ice
or for long-term storage at -80◦C. Three individual experiment replicates were performed
for each experiment. In each replicate, the experimental procedures were performed on
different days.
Cell sorting
HEK293T cells overexpressing FLAG-GFP were detached from the plates as described above
and resuspended in the FACS buffer (PBS with 0.5% BSA and 5 mM EDTA). Cells were
sorted with BD FACSAria III Cell Sorter into GFP low, intermediate, and high levels with
the strategy indicated in Figure A.5.
Live cell imaging
HEK293T cells were seeded in CultureWellTM Chambered Coverglass (Thermo Fisher Sci-
entific) pre-coated with fibronectin. Transfection of FLAG-GFP was performed as described
above. At 18 hours after transfection, cells were imaged with a Leica DMI 6000 inverted
microscope at 37◦C and 5% CO2. Images were taken every 2 minutes for 1 hour.
Immunofluorescence staining
Cells were cultured in 16-well glass chamber slides (Thermo Fisher Scientific). Transfection
was done as described above. Before staining, culture medium was removed, and the slide
was then washed with PBS. To crosslink cells, 4% PFA was added, and cells were incubated
at room temperature for 20 minutes. Slides were washed with PBS three times, and cells
were permeabilized for 5 minutes with 0.1% TritonX-100 dissolved in PBS at room tempera-
ture. After washing three times with PBS, cells were incubated in blocking buffer (10% goat
serum diluted in PBS) for 30 minutes at room temperature. Primary (anti-GFP, FM264G,
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BioLegend, 1:200) and secondary (Goat anti-Rat Alexa Fluor® 568, 1:500, supplemented
with Hoechst 33342 at a final concentration of 100 µg/ml) antibodies were diluted in block-
ing buffer and applied to slides. A total protein stain of Alexa Fluor 647 Succinimidyl Ester
(Life Technologies) was used to indicate cell outlines. Cells were washed three times with
PBS after each incubation step. Slides were mounted with ProLong Gold Antifade Reagent
(Life Technologies) before imaging with a CLSM Leica TCS SP8 microscope.
Antibody conjugation
The MaxPAR antibody conjugation kit (Fluidigm) was used to generate isotope-labeled
antibodies using the manufacturers standard protocol. After conjugation, the antibody
yield was determined based on absorbance of 280 nm. Candor PBS Antibody Stabilization
solution (Candor Bioscience GmbH) was used to dilute antibodies for long-term storage at
4◦C.
Barcoding and staining protocol
Formalin-crosslinked and methanol-permeabilized cells were washed three times with CSM
and once with PBS. Cells were incubated in PBS containing barcoding reagents (102Pd,
104Pd, 105Pd, 106Pd, 108Pd, 110Pd, 113In and 115In) at a final concentration of 100 nM for 30
minutes at room temperature and then washed three times with CSM (Bodenmiller et al.,
2012). Barcoded cells were then pooled and stained with the metal-conjugated antibody
mix (Supplementary Table 1 online in Lun et al. (2017)) at room temperature for 1 hour.
The antibody mix was removed by washing cells three times with CSM and once with PBS.
For DNA staining, iridium-containing intercalator (Fluidigm) diluted in PBS with 1.6%
PFA was incubated with the cells at 4◦C overnight. On the day of the measurement, the
intercalator solution was removed, and cells were washed with CSM, PBS, and ddH2O.




EQTM Four Element Calibration Beads (Fluidigm) were added to cell suspensions in a 1:10
ratio (v/v). Samples were analyzed on a CyTOF2 (Fluidigm). The manufacturers standard
operation procedures were used for acquisition at a cell rate of 500 cells per second. After
the acquisition, all FCS files from the same barcoded sample were concatenated (Boden-
miller et al., 2012). Data were then normalized, and bead events were removed (Finck et al.,
2013) before doublet removal and de-barcoding of cells into their corresponding wells using a
doublet-filtering scheme and single-cell deconvolution algorithm (Zunder et al., 2015). Sub-
sequently, data was processed using Cytobank (http://www.cytobank.org/). Additional
gating on the DNA channels (191Ir and 193Ir) and 139La/141Pr was used to remove remained
doublets, debris and contaminating particulates.
Data visualization and analysis
Bi-axis scatter plots
Bi-axis scatter plots were generated in Cytobank (http://www.cytobank.org/).
Data preprocessing
Raw data was transformed using the inverse hyperbolic sine transform with a cofactor of 5:
data = arsinh(dataraw/5)
Except where use of raw data values is specifically noted, all visualizations and analyses
were performed using transformed data.
Data binning
For data binning, the range between the lower and upper 2.5% of observations was divided
into ten equal bins: bin1,...,bin10. The observations in the lower and upper 2.5% were
assigned to the lowest and highest bins, respectively. In order to be able to compare
expression levels between samples within a time course replicate, all observations of the
time course were used to determine the binning.
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Correlation analysis
Spearman correlation (rij) was calculated between all marker pairs (i, j) for each replicate
and condition. Fishers z-transformation:
zi,j = artanh(rij)
was used to compare pairwise correlation coefficients across conditions. For each overex-
pressed POI, the change in correlation matrix was calculated by subtracting the median
z̃ij value (across replicates) of the FLAG-GFP controls from the median z̃ij value (across
replicates) of the overexpression condition.
∆z̃ij = z̃ij overexpression − z̃ij FLAG-GFP
The resulting matrix of differences in Fisher-transformed correlation values was hierarchi-
cally clustered using the Ward method and Euclidean distances (Ward, 1963).
BP-R2
Relationships between overexpression levels and markers can include non-monotonic rela-
tionships that are not properly captured with correlation metrics such as Spearman cor-
relation. Furthermore, although the shapes induced by an overexpression were highly re-
producible, the number of cells with a given expression intensity level were not. Thus,
in order to quantify the strength of arbitrarily shaped relationships between markers and
overexpression levels over the whole overexpression range, a density agnostic metric termed
binned pseudo R-squared (BP-R2) was developed. For this metric, the middle 95% of POI-
GFP levels over a time-course experiment was divided into 10 equal-width bins. Bins with
less than 25 cells were discarded. For each bin i, the median of a measured marker (ỹi)
was calculated. Additionally, the overall mean of the medians of all the 10 bins (µỹ) was
calculated. Then, for each bin, we computed the sum of squared deviations from the bin
medians and the sum of squared deviations from the overall mean of medians. These values















Following the rationale of classical R-squared statistics, BP-R2 quantifies the average re-
duction in squared deviations per bin when modeling the data as piecewise constant within
each bin (based on the bin medians) compared to using the mean over all bin medians. The
BP-R2 metric represents the relationship strength between a marker and the overexpressed
signaling protein relative to the overall variability of the marker. By using the median
instead of mean, the BP-R2 selects unimodal relationships with low noise over noisy, mul-
timodal relationships. Notably this measure works with arbitrary interaction shapes and is
largely robust against density inhomogeneities. In order to aggregate the sample replicates,
we considered the median BP-R2 value across the experimental triplicates.
Threshold determination
We observed many relationships with low BP-R2 between overexpressed proteins and mea-
sured phosphorylation markers, even within control samples (overexpression of FLAG-
GFP). We propose that such weak relationships are more likely to result from indirect
biological mechanisms; therefore, we focused on relationships that were stronger than all
relationships seen in the controls (FLAG-GFP overexpression and untransfected cells). We
chose the maximum median (across replicates) BP-R2 of all controls (FLAG-GFP overex-
pression and untransfected cells) as a cutoff. Relationships that had a median BP-R2 higher
than this threshold were considered as sufficiently strong to be of interest.
Kinetic analysis
For each overexpression condition, replicates of EGF stimulation time courses were pro-
cessed, stained, and measured together. Simultaneous processing enabled direct quantita-
tive comparisons of the measured POI-GFP counts in these time courses. Samples repre-
senting all time points in a time course replicate were combined and binned by POI-GFP
intensity as described in the Data binning section. As the binning was performed over all
38
samples of the same time course, the range of GFP intensity of bins with the same bin index
directly corresponds to cells with similar abundance levels of POI-GFP in each of the differ-
ent time points. As POI-GFP levels stay quasi-constant over the timescale of the 60-minute
time course (Figure A.8, Supplementary Movie 1 online in Lun et al. (2017)), tracking how
the median marker levels in a specific bin change over the time course reflects the kinetics
of cells with a similar abundance level upon stimulation. Thus, the kinetic responses over a
range of cells with low-abundance to high-abundance POI can be compared and analyzed
using classical signal processing readouts such as signal response amplitude and peak-time.
For this analysis, only POI-GFP marker pairs with at least one strong relationship over the
time course were considered.
Amplitude analysis
The response amplitude for each binned abundance level was calculated using raw counts.
For each measured marker and time point, the median marker level of each POI-GFP bin
was divided by the median level of the marker in the corresponding bin of the unstimulated
sample (EGF 0 min) to calculate amplitude as a fold change. The amplitude for each
bin was identified as the maximum fold change over all time points. Robust and strong
abundance-dependent changes were identified by comparing the amplitude ratio between
the second highest and the second lowest bin amplitude. Of those identified as robust and
strong, overexpressed proteins with an amplitude ratio higher than 3 fold for at least 2 of
the 3 replicates were identified as interesting and plotted as a heat map.
Peak-time analysis
Interesting examples of overexpression changes were defined by identifying the time point
with maximum amplitude for each bin (referred to as the peak time). Consistent and robust
examples were selected by the following criteria: Monotonically increasing or decreasing




To compare the consistency between the strong signaling relationships detected by BP-R2
analysis with the relationships predicted by the SIGNOR database (Perfetto, 2016), the
python NetworkX (Hagberg et al., 2008) package was used to construct a sign-directed
SIGNOR network from the UniProt entries of overexpressed POIs and measured phospho-
proteins. NetworkX also calculates a shortest path length within the sign-directed network.
Antibodies may bind to the same phosphorylation sites on more than one protein from a
family, making the mapping between antibodies and UniProt entries ambiguous. In this
case, the shortest path value was calculated between the overexpressed POI and any possible
antibody targets.
The analysis was performed including the directionalities of signaling relationships as
identified by the Spearman correlation of the bin medians in our analysis, and by exploiting
the SIGNOR annotations in the following way: Simple paths between the overexpressed
protein and the targeted phosphorylation sites were analyzed, starting from the shortest
path to longer paths, until a sign-consistent path was found. To identify sign consistency,
all edges in the SIGNOR network were classified as positive, negative, or ambiguous based
on the SIGNOR Effect annotation: down-regulates = negative, up-regulates = positive,
something else = ambiguous. In cases for which there were multiple interaction types pos-
sible for an edge (positive and negative), the overall sign was taken to be ambiguous. In
cases where the last edge was annotated to be affecting exactly the residue (SIGNOR an-
notation Residue) measured by the phospho-specific antibody through (de)phosphorylation
(SIGNOR annotation Mechanism), the directionality sign of this edge was determined to be
phosphorylation = positive, dephosphorylation = negative or the inverse in cases the anti-
body was measuring the non-phospho site (e.g., Ser33/37/Thr41 on β-catenin). Measured
phosphorylation sites responsible for inactivating a protein (e.g., Ser9 on GSK3β) were also
signed as phosphorylation = negative. A path was determined to be sign consistent if the
product of the signs of all its edges was in accordance with the relationship direction as
measured by the Spearman correlation over the bins.
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Systematic spillover exclusion
A stringent spillover filter was applied to systematically remove strong signaling relation-
ships potentially affected by channel-to-channel spillover: For any measured channel that
had events with ion counts over 500, we checked for spillover due to, first, isotope impurity
(channels with isotopes of the same metal); second, mass resolution (-1 and +1 channels);
and, third, oxidation (+16 channels). Any strong relationships (BP-R2) with GFP and
markers from these sets of channels were selected for additional verification experiments, in
which the staining was done in three groups:
1. All antibodies in a set
2. All antibodies in a set except for the one that potentially causes spillover
3. Only the antibody potentially causing spillover
When spillover-induced background contributed to over 10% of the actual ion counts, the
channel was discarded from further analysis (Figure A.11).
Based on our spillover exclusion protocol, we found the following channels were affected
by spillover. They were excluded from the analysis performed in this manuscript, and should




















VARIATION IN SINGLE-CELL SIGNALING DYNAMICS IS
DETERMINED BY INITIAL CELL STATE1
3.1 Abstract
Diseased cells display abnormal variations in protein expression and function. In particular,
cell-to-cell differences in signaling components can lead to qualitatively different functional
responses within a cell population, for instance, in cancer. Understanding the origins of
this response heterogeneity is hampered by the inability of time-lapse methods to measure
multiple pathway components simultaneously. Here we present a computational method to
infer single-cell signaling trajectories from multiplexed snapshot data and use it to analyze
signaling dynamics in the extracellular signal-regulated kinase (ERK) pathway. The results
demonstrate that the pathway is tuned to transmit signal duration, rather than signal
amplitude. We predict and subsequently confirm the existence of cells that are insensitive
to a chemical inhibitor of ERK signaling. Finally, we use ERK overexpression to explore
signaling rate functions within an abnormal disease expression range. Taken together, our
results show cell-to-cell variation in MAPK/ERK signaling responses depends primarily on
initial cell state.
3.2 Introduction
Cell signaling pathways are complex biochemical systems at the core of cellular information
processing, and the dynamics of these signaling systems in response to extracellular cues
plays a critical role for proper cell functioning (Dolmetsch et al., 1997; Kholodenko, 2006;
Selimkhanov et al., 2014). Signals are transduced by modulating the enzymatic activities
and local concentrations of signaling mediators such as protein kinases. Cell-to-cell varia-
tion in expression of signaling components, even within a clonal cell population, can lead to
1This chapter is adapted from a manuscript currently in revision after peer review at Cell and has the
following author list: Wade, JD, Lun XK, Bodenmiller B, Voit EO.
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different responses and functional outcomes, such as proliferation versus apoptosis (Spencer
et al., 2009). In cancer and other diseases, genetic alterations change the expression or
function of signaling components, increasing cellular variation and creating cells with aber-
rant signaling responses compared to healthy cells (Altschuler and Wu, 2010). In addition,
microenvironmental differences can further increase mixtures of cancer cell subpopulations
that qualitatively differ in their molecular expression profile (cell state) and, consequently,
drug responses (Meacham and Morrison, 2013; Burrell and Swanton, 2014). In such cases,
one cell subpopulation may strongly respond to a particular drug treatment while another
is insensitive (Burrell and Swanton, 2014).
The MAPK/ERK signaling cascade controls multiple cellular decisions, including cell
motility, growth, proliferation, differentiation and survival (Anjum and Blenis, 2008; Santos
et al., 2007). Multiple receptor types can activate the cascade, where “signal” passes from
RAF to MEK to ERK protein kinases through activating phosphorylations. Activated
ERK then regulates transcription and translation by phosphorylating multiple transcription
factors and downstream kinases, such as p90RSK (Caunt et al., 2015). The expression
and/or function of ERK pathway components is altered in many cancers and the pathway
is a common target of cancer drugs (Samatar and Poulikakos, 2014; Caunt et al., 2015). Due
to variation in tumor cell states, however, targeted therapies have had more limited success
than expected (Wellbrock and Arozarena, 2016; Caunt et al., 2015). Successful therapies,
therefore, must account for variation in expression of signaling components and its effects
on signaling dynamics at the single-cell-level.
To characterize cell-to-cell variation in signaling dynamics, the changes in abundances or,
ideally, concentrations of signaling molecules within individual cells must be observed over
time. This characterization is experimentally possible through live-cell imaging methods
such as Förster resonance energy transfer (FRET), kinase translocation reporters (KTRs)
and activity-dependent dyes that measure the activation states of signaling molecules (Ryu
et al., 2015; Regot et al., 2014; Dolmetsch et al., 1997). However, cell signaling networks
consist of numerous interacting components, whereas live-cell methods are currently limited
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to observation of one pathway component at a time (Bunt and Wouters, 2017). As an al-
ternative, multiplexed single-cell methods, such as fluorescent and mass cytometry, are able
to characterize the state of signaling networks in a more comprehensive manner by simulta-
neously measuring up to 50 components (Lin et al., 2015; Giesen et al., 2014; Bodenmiller
et al., 2012; Lun et al., 2017), but require fixation and can provide only a snapshot of single
cell states. Expressed differently, such snapshot methods are unable to follow the signaling
dynamics of an individual cell over time, thus losing the critical link between initial cell
state and response to stimulus.
Computational methods have been used at the cell population-level to overcome the
trade-off between continuous and snapshot measurements. In the case of snapshot mea-
surements, a mathematical model of the underlying system is reverse-engineered and used
to infer the characteristics of continuous trajectories. The underlying biochemical reac-
tions of cell signaling networks are most commonly modeled by a system of deterministic
ordinary differential equations (ODEs). The use of deterministic models in biochemical
processes such as signaling is generally justified by the large abundance of reaction com-
ponents, which smooths out stochastic variability in reactions (Wang et al., 2015; Filippi
et al., 2016). Thus, forward-simulation of the ODE model generates continuous trajecto-
ries of state variables, such as the phosphorylation states of signaling proteins on a cell
population level. Snapshots of simulated trajectories are then compared to experimental
measurements to determine model quality and infer model parameters.
Population-level models, however, do not account for single-cell variations in a sample,
despite their well-established importance. This failure to account for variation in signaling
components is intrinsic and mandates the development of new approaches based on single-
cell measurements (Bronstein et al., 2015); especially snapshot measurements, since these
enable highly multiplexed observations. Current methods to model variation in signaling
dynamics use parametric distributions to represent single-cell snapshot data (Hasenauer
et al., 2011, 2014; Filippi et al., 2016), where model simulations describe trajectories of
additional higher-order distributional moments, beyond the mean (e.g., variance), which
describe features of the distribution shape and statistically quantify the appropriateness of
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the model quality. Use of parametric distributions, however, complicates model inference by
adding parameters that must be inferred from data. As the number of parameters rapidly
increases with the number of state variables (e.g., signaling network components) and/or as
samples contain increasingly complex mixtures of subpopulations (distributions), paramet-
ric problem formulations rapidly become computationally and/or statistically intractable.
Currently, these problems are addressed by ignoring cross-moments (e.g., covariance) (Hase-
nauer et al., 2014; Filippi et al., 2016), although these feature characterize how variables
co-depend and contain valuable information unique to single-cell data (Sachs et al., 2005).
Furthermore, parametric methods do not account for single-cell trajectories. Due to these
limitations and despite the increased ease of acquiring multiplexed single-cell datasets, para-
metric methods have only been used to model two-dimensional experimental (Hasenauer
et al., 2014; Filippi et al., 2016) or simulated (Hasenauer et al., 2011) data.
Here we propose a novel ODE modeling approach to infer multiplexed single-cell sig-
naling trajectories from snapshots of multiplexed single-cell time-course data that does not
depend on parametric distributions. Our methodology uses an ODE system to simulate
the trajectories of many individual cells, rather than distribution parameters, and applies
a distribution-free, rather than parametric, statistical test to compare experimental and
simulated snapshots and inform model fitness. This decouples the number of model param-
eters from the number of model variables or subpopulations. Additionally, our approach is
straightforward to implement, fits easily within current modeling frameworks and quantifies
latent (unmeasured) sources of variation in cell state that contribute to a signaling process
and may subsequently be used to discover new biology.
We use our approach to study single-cell variation within the MAPK/ERK signaling
cascade in HEK293T cells stimulated with epidermal growth factor (EGF). In addition to
normal signaling responses, we analyze a condition with drug treatment and, as the pro-
gression of many cancers is related to protein overexpression, a disease state where protein
expression has been altered. Ultimately, we show: that, given initial cell states, single-cell
variation in signaling responses can be described deterministically; that, while each level
of the MAPK/ERK pathway has a fold-change response independent of other factors, the
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entire pathway is tuned to robustly transmit signal duration; that the kinetics for “disease”
cell states cannot necessarily be inferred from “normal” cells; and, that our methodology
may be used to find predictors of drug response. Our results reinforce the importance of
considering signaling-dynamics at the single-cell level for understanding variation in cellular
responses and illustrate the usefulness of our technique to do so.
3.3 Results
3.3.1 Inference of signaling trajectories from multiplexed single-cell snapshots
Determining sources of cell-to-cell variation in signaling responses requires two components:
the cell state variables that determine signaling response, and single-cell signaling trajecto-
ries to characterize response. Unfortunately, current experimental methods cannot capture
both simultaneously; for instance, measurements of single-cell trajectories generally lack the
dimensionality to observe variables driving differential response (Figure 3.1a), while higher-
dimensional snapshot measurements lack the time-dependent single-cell dynamics needed
to quantify response (Figure 3.1b).
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Figure 3.1: Motivation and workflow of single-cell ODE approach. (a) Motiva-
tion. One-dimensional (X1) time-lapse measurements (dots) cannot explain the cause of a
bimodal signaling response. Red and blue represent two subpopulations. (b) Experimen-
tal workflow. Multiplexed cross-sectional experimental snapshots characterize a dynamical
process of single cells in multiple dimensions, but cannot measure response. Bi-axial plots
represent two-dimensional projections of n-dimensional distribution snapshots. (c) Com-
putational workflow. Steady-state measurements at t0 are used to initialize a set of ODE
model instances, one for each cell. Differences between simulated and measured snapshots
of n-dimensional cell state distributions are compared to optimize model parameters. (Time
points t1 and t2 are also compared, but shown smaller for simplicity).
To characterize continuous multiplexed single-cell signaling trajectories and study the
origins of cell-to-cell differences in signaling response, we developed a combined experimen-
tal and computational framework, called single-cell ordinary differential equation modeling
or SCODEM (Figure 3.1b-c). Unlike parametric methods that use an ODE system to de-
scribe the trajectories of a distribution, SCODEM uses an ODE system to describe the
trajectory of an individual cell. The simulations of many cells, then, combine to represent
the trajectory of an empirical (rather than parametric) distribution, which can be compared
to experimental data using non-parametric statistical methods. To quantify the distance
between experimental and simulated snapshots and inform model fitness, we used maximum
mean discrepancy (MMD) (Gretton et al., 2012a), a distribution-free two-sample test for
multivariate distributions. The use of distribution-free statistics for model fitting has major
advantages over previous (parametric) approaches to model cellular variation in signaling.
First, it decouples the number of free model parameters from the number of cells or sub-
populations. This makes any single-cell modeling problem similar in parameter number to
a corresponding classical population model. The second advantage is use of information in
the complex multi-dimensional structure of multiplexed single-cell data in a manner that
does not depend on statistical assumptions or parameters. Thus, without assuming the
shapes or numbers of cell populations, MMD can successfully discriminate between dif-
ferences in distributions otherwise missed by parametric statistical methods (Figure 3.2).
Finally, SCODEM is relatively easy to implement: single-cell models are instantiated us-
ing single-cell measurements, and simulation of many cells fits within ensemble modeling
frameworks.
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Figure 3.2: Advantage of non-parametric methods to compare distributions.
Distributions D1 and D2 have equal mean and variance, but unequal covariance. D2 and
D3 have equal mean, variance and covariance, but different higher-order structures. Meth-
ods based on these parameters fail to differentiate distributions D1, D2 and D3. MMD
successfully differentiates D1, D2 and D3. Abbreviations: Var., variance; cov., covariance.
3.3.2 Multiplexed single-cell trajectories of the MAPK/ERK pathway signal-
ing
Single-cell variation in signaling can be described deterministically.
MAPK/ERK pathway signaling is deregulated in many cancers, and pathway components
are common drug targets (Samatar and Poulikakos, 2014). The success rates of pathway
targeted therapies have been limited, however, at least in part due to variation in tumor
cell responses (Wellbrock and Arozarena, 2016; Caunt et al., 2015). To study cell-to-cell
differences in MAPK/ERK signaling responses, we used mass cytometry to measure multi-
dimensional single-cell snapshots of cell states, including total and active MEK, ERK, and
p90RSK, to characterize signaling at six time points during a one hour time course of
HEK293T cells stimulated with EGF. Then, we used a subset of these data to construct an
SCODEM model of the pathway. Although the true pathway involves many reactions, we
condensed it to a model structure that minimized the number of parameters that cannot
be obtained from experimental data, yet should have remained representative. The model
includes active RAF and both the active and inactive states of MEK and ERK to repre-
sent the core pathway. The model also includes active and inactive p90RSK, which is a
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downstream target of ERK (Figure 3.3a). For model fitting, we used the six-dimensional
cell-state snapshot measurements of total and active MEK, ERK and p90RSK of approx-
imately 500 cells subsampled from each time point. To qualitatively assess model fit, we
simulated an independent subset of single cells and compared snapshots of the continuous
trajectories to the experimental snapshot measurements. The strong agreement between
both one-dimensional population statistics and distribution shapes (Figure 3.3b-c) and high-
dimensional distribution structure, visualized by combinatorial two-dimensional projections
for each time point (Figure 3.3d), confirm the model is able to represent the system for the
conditions measured. This result shows that deterministic simulation of signaling in single-
cells, based on a mechanistic model, is sufficient to reproduce the variation in signaling
observed in multiplexed single-cell measurements.
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Figure 3.3: Single-cell model of the RAF-MEK-ERK-p90RSK pathway. (a) Dia-
gram of the pathway model annotated with kinetic parameters, which are to be inferred from
measurements of total and active forms of MEK, ERK and p90RSK. (b) Simulated single-
cell trajectories for active proteins compared to measured population statistics. Yellow and
green circles (or lines) are mean and standard deviation of the data (or the simulations) at
each presented time point. Orange boxplots are middle 50 (bar) and 90 (line) percent of data
with a horizontal line at median, while events outside 90% range are dots. (c) Smoothed
marginal (one-dimensional) distributions of data (green) and simulation (orange). (d) (Top
left corner) Example plot comparing two-dimensional projections of multi-dimensional data
(green) and simulated results (orange) at a given time point. Results along the X-axis are
mirrored about 0, so that distance from origin always positive in the x-direction. Symmetry
about the y-axis is a visual measure of good model fit. (Main panel) Summary of model fit
to data in multidimensional space: Columns represent time points and rows exhibit different
2-dimensional projections of cell state. (e) Model validation. Model simulations reproduce
the relationships between signaling proteins and GAPDH, which were not used in fitting.
Relationships shown as in (d). Abbreviations: Sim., Simulation; Std, standard deviation.
Model units: scaled concentrations ( described in Appendix B).
Single-cell trajectories predict an additional cell-state dimension.
To validate our model, we predicted the multi-dimensional relationship between simulated
signaling proteins and a measured cell-state variable not used in model fitting. Namely,
we measured GAPDH abundance as a reference of cell volume (Rapsomaniki et al., 2018)
(Figure B.1) but did not include this information in our model calibration, rather assuming
each cell to have the same size (see Appendix B). GAPDH does not change during the time-
period of the experiment (Figure B.2) and should not directly affect the signaling reactions.
It can therefore be represented in the model as a constant for each cell during simulation
(Figure 3.3a). To test the predictive ability of our model, we simulated continuous signaling
trajectories in cells (starting at steady state) and compared snapshots of the relationships
between GAPDH and signaling proteins with those from independent snapshot experiments
(Figure 3.3e). Because GAPDH was not used in modeling fitting, these joint relationships
between signaling proteins and GAPDH in simulated trajectories are true predictions of the
model. The clear agreement between model predictions and experimental snapshots (Figure
3.3e) lends strong support to the inferred single-cell trajectories and their subsequent use
to quantify and analyze cellular responses (Figure 3.4).
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Figure 3.4: Sources of single-cell variation in signaling response. (a) Definition of
signal response features for each single-cell trajectory. Amplitude: maximum absolute in-
crease in signal. Duration: length of time-period where signal is greater than half-maximal.
(b) Averaging cells by quantile of GAPDH expression shows the strong linear relation-
ship between cell volume and signal amplitude (example using Q = 20 quantiles shown).
(Upper Middle) Smoothed histogram of GAPDH (black line) divided into 20 quantiles by
GAPDH expression. The colored panels represent each quantile from low (blue) to high
(red) GAPDH expression. Cells in each quantile bin are averaged for the analysis. (Lower
Left) Average trajectory of cells in GAPDH quantile q colored by quantile. (Lower Middle)
Regression of average amplitude versus average GAPDH (triangles) colored by quantile q
of GAPDH. Orange dots are individual-cell observations. (Right) A summary of the r2Q
of regression for each signaling protein as a function of median cells per quantile (based
on number of quantiles Q) of GAPDH. The violet cross intersected by gray dashed lines
represents R2Q five cells per quantile. Horizontal orange dashed line is R
2 of regression using
single-cell values (i.e. without averaging). (c) ERK cascade amplifies relative activity and
transmits signal duration. (Left) r2 of partial linear regression between all pairs of single-
cell features, controlling for GAPHD by partial least squares. (Right) Graphical summary
of key information using MAPK/ERK pathway structure. Amplitude depends on initial
state, but is not transmitted through the ERK cascade. Signal duration is transmitted
through cascade. Circles represent fold-increase in signal and are colored by R-squared
between initial value and signal amplitude of protein at corresponding level of the pathway.
Abbreviations: -p and -pp as in Figure 3.3a; Dur., Duration; Amp., Amplitude. Model
units: scaled concentrations.
3.3.3 Sources of variation in signaling response of the MAPK/ERK pathway
Variation in ERK pathway signaling has been attributed to extrinsic (unmeasured) variation
upstream of MEK (Filippi et al., 2016). The lack of continuous multiplexed measurements,
however, has left the source of variation in signaling an open question. To determine
sources of variation in ERK pathway signaling, we used the multiplexed single-cell signaling
trajectories provided by our model. We used peak amplitude and duration (Figure 3.4a) as
metrics of signaling response for each pathway component RAF, MEK, ERK and p90RSK.
We then added the eight resulting signal response features (two features times four signaling
proteins) to the state space of each cell at the steady state to generate a 19-dimension
distribution of cell state and signaling responses. Using regression, the combined cell-state-
cell-response distribution was able to explain major sources of variation in the response
metrics of the ERK pathway.
55
Cell volume explains a large portion of the single-cell variation in peak amplitude.
We hypothesized that cell volume could confound results based on abundance measure-
ments. To test this, we quantified the relationship between signal amplitude and cell vol-
ume using paired linear regression of each signaling protein versus GAPDH. The resulting
R2 values show that GAPDH explains approximately 40% (R2 = 0.40) of the variation
in ERK and p90RSK amplitude, and nearly one quarter of the variation in MEK ampli-
tude (R2 = 0.23). To determine the sensitivity of these relationships to measurement error
(as GAPDH is only an approximate measure of cell volume, for example), we grouped
and averaged cells with similar GAPDH abundance (by quantile) and repeated the regres-
sion. We found that the coefficient of determination as a function of the cells per quantile
(R2Q, where Q equals the number of quantiles) rapidly increased when averaging even few
cells, which illustrated the strong linear relationship between cell volume and amplitude
(Figure 3.4b). For example, averaging groups of approximately five cells by GAPDH abun-
dance (using Q = 145 quantiles) increased the R2Q between GAPDH and the signaling
amplitude of MEK, ERK and p90RSK to 0.46, 0.71 and 0.69, respectively (Figure 3.4b).
Because each cell in our model was assumed to have the same size, the linear relationship
between cell volume and amplitude could be directly explained by concentration, which
equals abundance/volume. Thus, cell volume does confound abundance measurements and
concentration-based measurements would greatly reduce the observed single-cell variation
in signaling amplitude compared to measurements of protein abundance.
Initial phosphorylation state is the best predictor of signal amplitude.
The variation in phospho-protein abundance at peak signaling times is a classical example
of cell-to-cell variation in signaling. To study the relationships between signaling amplitude
and pathway components, we calculated the coefficient of determination (r2) for each pair
of cell-state and response features, controlling for GAPDH (Figure 3.4c). For each signaling
protein, MEK, ERK and p90RSK, the initial activity level strongly predicted the signaling
amplitude (r2 > 0.5). Thus, the fold-increase in signal, defined as peak amplitude divided by
initial activity, was much less variable than peak signal amplitude across the cell population.
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For ERK, this agrees with previous live-cell studies (Cohen-Saidon et al., 2009). Indeed,
we found initial activity was the best of all possible predictors of signaling amplitude for
MEK and ERK (Figure 3.4c). These results show that, starting from a steady state where
signaling is constant, the ERK signaling cascade is tuned such that each node amplifies
EGF signal relative to steady-state, independent of the upstream signaling amplitude, and
accounting for the normal steady-state level greatly reduces variation in signaling amplitude
across a population.
MAPK/ERK signaling cascade transmits signal duration, not amplitude.
Signal strength and duration are commonly presented as being transmitted by the ERK
pathway (Shaul and Seger, 2007). Somewhat contrary to this idea, however, we found
that the amplitudes of MEK and ERK are not strongly correlated to the amplitude of
their upstream activators RAF (r2 = 0.08) and MEK (r2 = 0.08), respectively (Figure
3.4c). Thus, signaling amplitude is not reliably transmitted by the MAPK/ERK cascade.
The amplitude of downstream p90RSK, however, does depend on the amplitude of ERK
(r2 = 0.66) slightly more than on any other cell feature. In contrast to amplitude, the
signal duration of RAF, MEK and ERK are all tightly coupled (r2 > 0.89; (Figure 3.4c).
The duration of p90RSK signaling, however, is not obviously predicted by any one cell
feature. The high-fidelity transmission of signal duration through the core RAF/MEK/ERK
signaling unit, combined with the low transmission of information on peak amplitude in
favor of constant fold-change signal amplification, shows that the MAPK/ERK signaling
cascade operates in a way to robustly transmit signal duration, rather than signal amplitude.
3.3.4 The model predicts cell states insensitive to drug treatment.
Because variation in cancer cell state, exclusive of genetic variation, can lead to correspond-
ing variation in drug response and treatment failure (Shaffer et al., 2017), we tested the
ability of our model to predict variation in signaling during acute inhibition. We simu-
lated an experiment treating cells for 30 minutes prior to EGF stimulation with CI-1040
(PD184352), a once promising small-molecule MEK inhibitor that however failed to show
sufficient anti-tumor activity in a phase II clinical trial (Chang-Yew Leow et al., 2013).
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Specifically, CI-1040 works by non-competitively (i.e., independent of kinase-substrate bind-
ing) blocking the ability of active MEK to phosphorylate ERK (Allen et al., 2003). We used
the biochemical interpretation of non-competitive inhibition (Sebolt-Leopold et al., 1999)
to simulate EGF signaling under a range of CI-1040 concentrations (Appendix B; Figure
B.3). Using fold-increase in phospho-ERK to quantify cell activation, the model revealed
cells that remained responsive to EGF under non-saturating concentrations of the MEK
inhibitor (Figure B.3). To test this model prediction, we performed the corresponding ex-
perimental inhibition/stimulation time-course. Although the time-scale of activation was
slower than that predicted by our model, a subset of CI-1040 treated cells showed increased
phospho-ERK after EGF stimulation as predicted.
Inhibition has secondary kinetic effects.
We hypothesized the difference in dynamics between simulations and experiments was due
to secondary or indirect effects of the inhibitor. Using systematic model analysis and op-
timization, we identified a slightly expanded kinetic model of the inhibitor that represents
the inhibition data well (Figure 3.5; Figure B.4). In this expansion, the inhibitor slows
down not only the activation rate of ERK (k5), as classically expected, but also the inacti-
vation rate of ERK (k6) and both the activation (k3) and inactivation (k4) rates of MEK
(Figure 3.5a). Subsequently, we found that CI-1040 can indeed inhibit MEK activation by
RAF (Kramer et al., 2004). This reconciliation result illustrates the ability of SCODEM
to identify unintuitive secondary effects of kinetic modulators in the context of a complex
cellular system.
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Figure 3.5: Modeling MEK inhibition reveals characteristics of insensitive cells.
(a) Model diagram with parameters (red) modified by MEK inhibitor Cl-1040. (b) Dis-
tributions of fold-increases of ERKpp in EGF treated cells both with (red) and without
(gray) 30 min pre-incubation of CI-1040 MEK inhibitor. Fold-increase in signal amplitude
≥ 1.5 for Cl-1040 treated cells (blue hatch) and both population means (circles) shown.
(c) (Top panel) Simulated trajectories of ERKpp with 30-min pre-incubation of Cl-1040.
Trajectories with relative response ≥ 1.5 (chosen as greater than the minimal response of
stimulated cells not treated with inhibitor) in blue, all others gray. Summary statistics as
in Figure 3.3b. (Bottom panel) Example snapshots of data and simulation at 0 and 30 min
stimulation time-points, visualized as in Figure 3.3d (full 60-minute time course in Figure
B.4). Orange circles with blue outline show cells with ERKpp response ≥ 1.5. (d,e) Initial
cell state (x-axis) vs. relative signaling amplitude Erkpp with (d) and without (e) CI-1040
MEK inhibition (y-axis). Projection of marginal density of each axis and Spearman’s rho
shown. Dashed line corresponds to fold-increase Erkpp≥ 1.5, as in (b). (f) Distributions of
fold-increase in active ERK (as in b) for simulated treatment conditions. Circles represent
population mean. Kinetic parameter g4 shown in (a). Abbreviations: -p and -pp as in (a);
Sim., Simulation. Model units: scaled concentrations.
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Drug treatment sensitizes ERK response to initial MEK activity levels.
Contrary to snapshot measurements, the continuous multiplexed trajectories from our model
allowed us to identify not only a subset of cells insensitive to drug treatment (fold-increase
of active ERK greater than 1.5; Figure 3.5b-c), but associated initial cell states that we
used to predict single-cell drug response. To do this, we compared the fold-increase in
ERK signal to measurable cell features at steady state (before inhibitor treatment). The
model predicts that cells insensitive to CI-1040 inhibitor have high initial levels of active
MEK (MEKpp; Figure 3.5d). In cells not treated with inhibitor, however, initial MEK
activity did not predict ERK response (Figure 3.5e). Thus, our model predicts that use of
CI-1040 sensitizes the ERK response to MEK activity. Mechanistically, this is driven by
the ultrasensitive (Huang and Ferrell, 1996) (highly nonlinear) response of ERK to active
MEK (response curve in Figure 3.5d; driven by parameter g4 in Figure 3.5a; Appendix B),
which dominates the ERK activation reaction when CI-1040 treatment otherwise reduces
the forward reaction rate constant (parameter k5 is decreased; Appendix B). Importantly,
the ultrasensitivity of ERK response to MEK activity induced by CI-1040 may be leveraged
to further inhibit ERK signaling via a complementary inhibitory mechanism. For example,
a competitive MEK inhibitor or MEK/ERK scaffold inhibitor would be expected to decrease
the ultrasensitivity in the relationship between MEK and ERK (captured in parameter g4).
While neither a 20% decrease in g4 nor a further 20% increase in CI-1040 would meaningfully
increase inhibition of ERK activation, combination of a 20% decrease in g4 with the current
CI-1040 treatment would effectively abolish ERK response (Figure 3.5f). These results show
how SCODEM can be used to identify cell states less sensitive to drug treatment, and, with
subsequent analysis, how drugs targeting the same molecule, but different mechanisms, may
be used in a cooperative fashion.
3.3.5 Effects of ERK overexpression on MAPK/ERK signaling.
Many cancers are caused by mutations (Blume-Jensen and Hunter, 2001) and/or environ-
mental changes (Abu-Remaileh et al., 2015; Jeong et al., 2014) that greatly increase the
range of protein expression in a cell population and thereby alter signaling behavior (Lun
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et al., 2017). As overexpression of a known signaling protein should not change the struc-
ture (kinetic rate functions) of the signaling system, we hypothesized that related signaling
changes should be a function of expression differences alone. We used SCODEM to test this.
Our model, however, was constructed primarily with power-functions to represent reaction
kinetics. Power-functions are local approximations of the “true” reaction functions and well
suited for normal operating ranges of protein expression, but may fail to represent large
ranges of expression as they do not saturate and reaction functions clearly cannot increase
without limit. (Savageau, 1976; Voit, 2013) Therefore we added saturating functions to the
model to limit the range of reaction rate increase (Figure 3.6a).
With this alteration, we modeled an experimental protein overexpression system (Lun
et al., 2017), based on transient transfection of ERK2-GFP, which randomly introduces ad-
ditional ERK to cells and increased the range of ERK expression by two orders of magnitude
(Figure 3.6b). We then measured the signaling dynamics in response to EGF stimulation.
To account for our assumption that high values of ERK could saturate reactions, we used
these overexpression data to fit the added parameters. As a validation, we independently
simulated the combination of overexpression and stimulation experiments. Initiating the
model with a sample of cells at steady state taken from non-overexpression experiments, we
simulated transfection by random addition of ERK to each cell according to a representative
distribution (Figure 3.6c; Appendix B). Next, we simulated EGF signaling. As before, we
qualitatively compared snapshots of the simulated and experimental six-dimensional signal-
ing state distributions at each time point using combinatorial projections (Figure 3.6d). The
striking resemblance of the complex distributions in simulated and experimental snapshots
supported subsequent analysis and illustrates that even highly heterogeneous cell samples




Figure 3.6: Kinetic effects of ERK overexpression. (a) A non-saturating power-law
function (red) is often a good approximation of a saturating kinetic function (blue) through-
out a “normal” range of substrate concentration, yet fails when the substrate concentration
is increased beyond the normal range. Green space represents error (ε) between functions.
(b) Experimental transient transfection of ERK2-GFP results in a wider distribution of total
ERK (green) compared to control (blue). (c) Simulated random addition of ERK (sampled
from a censored gamma distribution (red)) to control cells (blue) in the model (orange)
closely resembles the ERK distribution of experimental overexpression (green). (d) Com-
parison of simulated (orange) and measured (green) time-course of EGF stimulation under
ERK overexpression (format as in Figure 3.3d). See Figure B.5 for single-cell trajectories
and marginal distributions as in Figure 3.3b-c. Red boxes are distributions shown in Panel
(e). (e) Explanation of specific distributions in red boxes from Panel (d). (Left and Center)
Illustration of kinetic mechanisms that generate distribution shapes. (Right) illustrates the
connection between the phoshpo-p90RSK-low subpopulation across different projections of
the state-space. Abbreviations: Sim., simulation; Fold-in., fold-increase; Inhib., inhibition.
Model units: scaled concentrations.
We analyzed our model to determine the consequences of ERK overexpression on signal-
ing and found that overexpression affects not just ERK activation, but the reaction kinetics
of the entire MAPK/ERK pathway. The range of ERK overexpression where each effect is
dominant, however, varied (Figure 3.6e). Specifically, beginning at moderate levels of over-
expression, the reaction deactivating ERK (i.e. the ERK phosphatase) begins to saturate
and leads to greatly increased levels of active ERK. Moderate to high levels of overexpres-
sion reduced the strength of the negative feedback from ERK to RAF, which slows the decay
in input signal. At high levels of ERK overexpression, both the activating and inactivating
reactions of MEK and ERK were slowed, an effect consistent with competitive inhibition,
and also leads to longer signal duration of active ERK. Surprisingly, high levels of ERK
also completely inhibited p90RSK activation in cells with slowed ERK activation. Because
p90RSK activation requires dissociation from inactive ERK (Roux et al., 2003), however,
competition (Levchenko et al., 2000) between active and inactive ERK for inactive p90RSK
may explain the inhibitory effect of high ERK overexpression. As saturating functions were
generally not needed to represent “normal” cells (as in Figure 3.3), our results show how
protein overexpression can have complex kinetic effects, and these effects cannot necessarily
be observed in “normal” cells, even with single-cell measurements. Our results also show
the ability of SCODEM to capture complex kinetics from appropriate measurements for use
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in modeling, even when measurements are made in a mixed cell population.
3.4 Discussion
The trade-off in single-cell experiments between measuring either the dynamics of a few cell
states or snapshots of many cell states has been a barrier to understanding how cell-to-cell
variation in expression affects signaling dynamics. Here, we present a combined experi-
mental and computational approach (SCODEM) to infer multiplexed signaling trajectories
from snapshot data, thus bridging this gap. We applied this approach to EGF signaling
in the MAPK/ERK pathway of HEK cells. The highlights are: (1) cell-to-cell variation in
signaling can be described deterministically, given the initial state of each cell; (2) cell vol-
ume is a significant contributor to the variability observed in single-cell measurements; (3)
signal duration is reliably transmitted through the RAF/MEK/ERK cascade, whereas sig-
nal amplitude is a fold-change response. More generically, we demonstrate that SCODEM
enables us to study variability in cellular responses to drug treatments and in disease.
Use of SCODEM requires several considerations. The first is genetic variation within
a sample. In this study, we assume a monoclonal cell population, which justifies identical
biochemical parameters across cells. In cases where enzymatic activity, in addition to ex-
pression, drive differences in response, this assumption might fail. However, the parameters
in the kinetic models used in SCODEM have a direct functional interpretation, which helps
prevent unrealistic choices of numerical values. Furthermore, single-cell measurements of
both protein expression and genotype may be used to inform enzymatic parameters in these
cases. A second consideration is the direct reliance on single-cell measurements as model
inputs, which can increase errors in estimates for low signal ranges and complicate normal-
ization across channels (Appendix B). Third, our distribution-free approach to model fitting
should also be applicable gene network models, although stochastic reaction kinetics may
be necessary to simulate single-cell trajectories. Finally, the ease of applying SCODEM
to larger networks is determined primarily by the ability to measure the initial (steady-
state) values of the model’s state variables (i.e., network components), as unmeasured state
variables necessarily have values that must be either assumed or inferred (Appendix B).
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Single-cell snapshot measurements reveal variation in cell states. Our question, how-
ever, is how variation in cell states relates to variation in cell responses. Here, we show
for the MAPK/ERK pathway that: (1) the variation in signaling responses is much less
than variation in the signaling components; and (2) the variation in unmeasured signal-
ing components can be algebraically determined by appropriately analyzing experimental
measurements with a deterministic model (Appendix B). These results suggest that the
structures of both the signaling and expression systems cooperate to reduce variation of
cell responses within a population. A clear example is the strong correlation between cell
volume, protein abundance and signaling amplitude, which is reasonably explained by iso-
metric scaling of signaling components as cells grow. Expressed differently, a large amount
of variation in single-cell measurements is explainable and therefore coordinated, and signal-
ing systems are structured in such a manner that cells can tolerate the remaining noise and
mount appropriate responses in a robust manner. The result secondarily suggests caution
before unexplained variation in cellular systems is attributed to randomness.
While our results demonstrate the well-coordinated maintenance of signaling response
characteristics, they also show that this coordination can be impaired in diseases such as
cancer, which are associated with mutations that alter the cellular control of protein expres-
sion. We demonstrate such system failure with an overexpression system that reveals how
cells operating in abnormal regions of the expression space can have drastically altered sig-
naling response characteristics. Critically in these cases, “normal” cells operate within their
physiologically constrained state-space, whereas “mutated” cells enter new state-space re-
gions where reaction functions and consequent cellular responses might qualitatively change
behavior. This insight suggests that cellular systems must be studied both within and out-
side their normal operating conditions to enable reliable predictions of signaling responses
in disease. Such analyses of signaling in deregulated systems are facilitated by tightly
connected experimental and computational analyses, for instance, by combining a protein
overexpression system with mass cytometry and SCODEM as done here.
Predicting how individual cells in a tumor will respond to treatment is substantially
confounded by single-cell variation in state and environment. Additionally, observations
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of primary tumor cells are generally limited to snapshot measurements. We show how
an appropriately calibrated single-cell ODE model may be used to predict single-cell drug
responses from single snapshot measurements, and how one inhibitor may subsequently
sensitize cells to another inhibitor with the same target but a different mechanism of action.
We demonstrate this capability only with a rather simple model and with measurements
under culture conditions, but our study nonetheless represents proof of principle that single-
cell ODE modeling can deepen our understanding of differential cellular responses.
3.5 Methods
Quantifying ERK pathway signaling dynamics in response to EGF
Samples were fixed at {0,5,10,15,30,60} minute time points after stimulation with EGF
and measured by mass cytometry (the 0-minute sample was not stimulated). Time points
were chosen as appropriate to characterize EGF signaling dynamics in the pathway (Lun
et al., 2017). Abundance of both total and active proteins were measured for the core
pathway components MEK, ERK and p90RSK, as well as markers for cell volume (GAPDH),
cell cycle (IdU, Cyclin B1, pHH3) and cell death (cleaved PARP), were measured using a
validated panel of antibodies. The full antibody panel is in Table B.4.
Cell culture
HEK293T cells, obtained from ATCC, were cultured in DMEM (D5671, SIGMA), supple-
mented with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml strepto-
mycin. For cell passaging or harvesting, cells were incubated with 1× TrypLE Express (Life
Technologies) for 2 minutes at 37 ◦C. Purity and sterility of the cell line were certified by
ATCC. Mycoplasma was not detected with the LookOut Mycoplasma PCR Detection Kit
(Sigma-Aldrich).
Cloning
DNA sequences of the genes of interest were provided in entry clones by William Hahn
and David Root (Yang et al., 2011) (via Addgene and NEXUS Personalized Health Tech-
nologies at ETH Zurich). Destination vectors, including pDEST pcDNA5 FRT TO-eGFP,
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pDEST 5’ Triple Flag pCDNA5 FRT TO and pDEST 3’ Triple Flag pcDNA5 FRT TO,
were kindly provided by Anne-Claude Gingras at the Lunenfeld-Tanenbaum Research In-
stitute, Toronto, Canada (Couzens et al., 2013). Expression vectors encoding the FLAG-
or GFP-tagged fusion proteins were generated via Gateway Cloning and sequenced before
transfection.
Transfection and stimulation
HEK293T cells were seeded at a density of 0.7 million cells per well in 6-well plates. After
24 hours, cells were transfected with 2 µg plasmid and 4 µl of jetPRIME (PolyPlus) per
well with the standard protocol provided by the manufacturer. At 18 hours after trans-
fection, EGF (Peprotech) was added to a final concentration of 100 ng/ml. At 20 minutes
before a given EGF stimulation time point, 5-Iodo-2-deoxyuridine (IdU) was added to the
medium at the final concentration of 10 µM. At 2 minutes before a given EGF stimulation
time point, medium was replaced by 1× TrypLE to induce cell detachment. At this time
point, paraformaldehyde (PFA, from Electron Microscopy Sciences) was added to the cell
suspension to a final percentage of 1.6%, and cells were incubated at room temperature
for 10 minutes. If EGF stimulation was not necessary in the experiment, cells were di-
rectly harvested and crosslinked with PFA. Crosslinked cells were washed twice with cell
staining media (CSM, PBS with 0.5% BSA, 0.02% NaN3) and after centrifugation, ice-cold
methanol was used to resuspend the cells, followed by a 10-minute permeabilization on ice
or for long-term storage at -80◦C.
MEK inhibition by CI-1040
The MEK1/2 inhibitor CI-1040 (Selleckchem) was pre-dissolved in DMSO at a concentration
of 10mM and added to the cell culture plates at the final concentration of 0.5 µM for




The MaxPAR antibody conjugation kit (Fluidigm) was used to generate isotope-labeled
antibodies using the manufacturer’s standard protocol. After conjugation, the antibody
yield was determined based on absorbance of 280 nm. Candor PBS Antibody Stabilization
solution (Candor Bioscience GmbH) was used to dilute antibodies for long-term storage at
4◦C.
Barcoding and staining protocol
Formalin-crosslinked and methanol-permeabilized cells were washed three times with CSM
and once with PBS. Cells were incubated in PBS containing barcoding reagents (102Pd,
104Pd, 105Pd, 106Pd, 108Pd, 110Pd, 113In and 115In) at a final concentration of 100 nM for 30
minutes at room temperature and then washed three times with CSM (Bodenmiller et al.,
2012). Barcoded cells were then pooled and stained with the metal-conjugated antibody
mix at room temperature for 1 hour. The antibody mix was removed by washing cells three
times with CSM and once with PBS. For DNA staining, iridium-containing intercalator
(Fluidigm) diluted in PBS with 1.6% PFA was incubated with the cells at 4◦C overnight.
On the day of the measurement, the intercalator solution was removed, and cells were
washed with CSM, PBS, and ddH2O. After the last washing step, cells were resuspended
in ddH2O and filtered through a 70-µm strainer.
Mass cytometry analysis
EQ Four Element Calibration Beads (Fluidigm) were added to cell suspensions in a 1:10 ratio
(v/v). Samples were analyzed on a Helios mass cytometer (Fluidigm). The manufacturer’s
standard operation procedures were used for acquisition at a cell rate of approximately
500 cells per second. After the acquisition, all FCS files from the same barcoded sample
were concatenated (Bodenmiller et al., 2012). Data were then normalized, and bead events
were removed (Finck et al., 2013) before doublet removal and de-barcoding of cells into their
corresponding wells using a doublet-filtering scheme and single-cell deconvolution algorithm
(Zunder et al., 2015). Cytobank (http://www.cytobank.org/) was used for additional gating
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on the DNA channels (191Ir and 193Ir) and 139La/141Pr to remove remaining doublets,
debris and contaminating particulates. Data were then exported as .fcs files for subsequent
analysis.
Spillover correction
Due to panel design, channel-to-channel spillover as a function of mass resolution (1 and
+1 channels) and oxidation (+16 channels) was only possible in two cases:
1. From channel 143Nd (total ERK) to 144Nd (ppMEK) and 159Tb. (GAPDH)
2. From channel 149Sm (total p90RSK) to 150Sm (total MEK).
Spillover between channels 149Sm and 150Sm was not significant for the measured count
ranges and ignored. Due to events with very high counts in 144Nd (from ERK overexpres-
sion), spillover from 144Nd was compensated using an estimated 2.2% spillover correction
to channels 144Nd (+1) and 159Tb (+16).
Data normalization and scaling for use in modeling
Experimental measurements were normalized for comparison across independent experi-
ments and measurements. Before use in modeling, measurement channels were linearly
scaled to satisfy biological constraints and facilitate direct physical interpretation of re-
sulting model parameter values. Cells used in fitting and visualization of results were
subsampled to reduce unnecessary computational cost. A full description of normalization,
scaling and subsampling is presented in Appendix B.
ODE integration and solver speed-up
The ODEMEX CVode wrapper for Matlab (Vanlier et al., 2012) was used to compile MEX
files in C++ using numerical integrators from the SUNDIALS CVode package (Lawrence
Livermore National Laboratory, Livermore, CA).
Parameter optimization
Parameter optimization was performed using a combination of global and local search meth-
ods. Given a user defined starting region, systematic global search with local refinement was
69
performed using the ESS and MULTISTART algorithms in the MEIGO optimization toolbox
(Egea et al., 2014). Further local refinement was based on the unconstrained local search
algorithm fminsearch in the Matlab Optimization Toolbox (The MathWorks, Inc.).
Maximum mean discrepancy (MMD)
Maximum mean discrepancy (Gretton et al., 2012a) (MMD) is a distribution-free method
of testing the similarity between samples from two multivariate distributions, and has been
shown as both computationally efficient and effective when comparing empirical samples
from multivariate distributions (such as those derived from multiplexed single-cell data).
MMD represents the similarity between two distributions (e.g., experiment and simula-
tion snapshots) as the distance between the mean embeddings of distribution features in a
reproducing kernel Hilbert Space (RKHS). Depending on the kernel k associated with the
RKHS, infinitely many features may be used to compare the distributions (in contrast to,
for example, comparison of only a few features such as the mean and variance).
Let H be the unit ball in a RKHS with associated kernel k. Given m samples from
a distribution X and n samples from a distribution Y , then an empirical estimate of the
MMD between X and Y is

















MMD as defined in equation (1) is a biased test statistic, but will still be small if X = Y
(the true distributions are equal) and large if the distributions are far apart. Bootstrapping
can be used to generate a null distribution and determine the statistical significance of
the difference between the distributions, but is computationally expensive if performed
within an optimization routine. In this work, we are concerned with finding a model that
generates distributions similar to experimental measurements, but are less concerned with
the statistical significance of the model fit at any given step of the optimization algorithm (or
comparison of two alternative models). Thus, in the SCODEM procedure presented here,
it is sufficient to minimize the MMD between simulated and experimental distributions,
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without additional bootstrapping to determine statistical significance. We note that boot
strapping may be used to compare models after optimization, if desired.
Optimization objective (cost) function
Given discrete snapshot measurement at times t ∈ T , corresponding single-cell multiplexed
snapshot experimental measurementsDt of v variables (e.g., proteins) in n cells (Dt ∈ Rn×v),
and a set of n continuous single-cell simulated trajectories Y (t) of the v measurement




MMDb[H, Y (t), Dt] (2)
where kernel k associated with H (equation 1) is the Gaussian kernel:
k(x, x′) = e−
||x−x′||2
2σ2 . (3)
The parameter σ scales the width of the kernel and was chosen as the median distance
between points in the aggregate sample, which is the classical median distance heuristic for
selection of kernel bandwidth. For our calculations, the individual observations Y (t) and
Dt were transformed using a hyperbolic arcsin function (asinh). The MMD computation
was implemented in Matlab (The Mathworks) using code available at http://www.gatsby.
ucl.ac.uk/~gretton/mmd/mmd.htm.
Mathematical model of EGF signaling in the MAPK/ERK pathway
The ODE model structure included an input, RAF, MEK, ERK and p90RSK, as well as
the known negative feedback loop from ERK to active RAF (active ERK leads to removal
of active RAF). The input was modeled as a single bolus corresponding to addition of EGF.
Reaction steps in the MEK/ERK/p90RSK cascade were simplified to include molecular
states that were experimentally observable. For example, ERK is activated when it is
doubly phosphorylated on threonine 202 and tyrosine 204 (pT202/pY204) by active MEK
in a two-step process. However, only the active pT202/pY204 form of ERK was measured,
71
and the transition from inactive to active ERK was modeled as a single step. The full model
structure, equations and description are given in the Appendix B, as are the description of
CI-1040 in the model and the details of model expansion to represent ERK overexpression.
All algorithms were implemented in Matlab Release 2015b (The MathWorks, Inc.).
Model fitting
The 17 free parameters of the model were trained on a representative subsample of approx-
imately 500 single-cells from snapshot mass cytometry measurements during a 60-minute
time-course of EGF stimulation. Specifically, the six-dimensional cell-state distribution of
both total and active forms of MEK, ERK and p90RSK were used to inform model param-
eters.
Hyperbolic arcsin transformation
Where noted, data in some figures were transformed using a hyperbolic arcsin (asinh)
transformation, which displays values between 0 and 1 on an approximately linear scale,
and values greater than 1 on a log-like scale. This was done to better visualize highly
dispersed distributions.
Signaling metrics








Xi,j,t · dt (5)
In words, amplitude was the maximal increase in active protein and duration was the time
period active protein was above the half-maximal level. Fold-increase in active protein









MECHANISTIC MODEL RECONCILES SIGNALING DYNAMICS
ACROSS AN EPITHELIAL MESENCHYMAL TRANSITION1
4.1 Abstract
Intracellular signaling pathways are at the core of cellular information processing. The
state of these pathways and their inputs determines signaling dynamics and drives cell
function. Heterogeneous tissues, which are commonly encountered in cancer, comprise
many combinations of cell states and microenvironments that can lead to variations in cell
responses to treatments. Such context-dependent differences in signaling have traditionally
been explained by network rewiring. However, biochemical rationale suggests that rewiring
of signaling reaction networks should not be necessary. Here we address this conundrum
with an in vitro model of an epithelial mesenchymal transition (EMT), a biological program
implicated in increased tumor invasiveness, heterogeneity and drug resistance. We use mass
cytometry to measure EGF signaling dynamics in the ERK/AKT signaling pathways before
and after EMT and apply standard network inference methods, which clearly suggest EMT-
dependent network rewiring. However, a more realistic modeling approach that adequately
accounts for single-cell variation demonstrates that a single reaction-based pathway model
with constant structure and near-constant parameters is sufficient to represent differences
in EGF signaling across EMT. This result suggests that rewiring of the signaling network
is not needed and that a unifying reaction-based model may be used to represent signaling
in heterogeneous environments such as cancer.
4.2 Introduction
Intracellular signaling networks are biochemical systems that integrate spatio-temporal in-
formation regarding the intra- and extracellular state of a cell into functional programs
1This chapter is adapted from a manuscript and has the following author list: Wade, JD, Lun XK,
Zivanovic N, Bodenmiller B, Voit EO.
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that drive cellular decisions (Dolmetsch et al., 1997; Kholodenko, 2006; Selimkhanov et al.,
2014). Signals, such as extracellular ligand concentrations, are transduced by modulating
the enzymatic activities and local concentrations of signaling mediators, such as kinases,
within a cell. Traditionally, the unknown structures of signaling networks are reconstructed
from many biochemical experiments. They are then formalized as graphs where nodes repre-
sent active signaling molecules and directed edges represent interactions between molecules.
More recently, statistical modeling has been used to infer network structures in a data-driven
manner (Sachs et al., 2005).
In contrast to canonical interpretations of signaling networks as static structures, data-
driven approaches of network inference have suggested that the structure of signaling net-
works may strongly depend on context, including cell phenotype, type of input signal, and
treatment, for example, with an inhibitor, as well as a certain degree of additional cell-to-
cell variability (Hill et al., 2017; Petsalaki et al., 2015; Will and Helms, 2015; Brightman
and Fell, 2000). The context-dependence of signaling is of particular consequence in dis-
eases like cancer, where genetic errors lead to changes in the relative expression or function
(Creixell et al., 2015) of signaling proteins and in the local microenvironment, including
inputs, that result in signal responses that substantially differ from those of healthy cells
(Altschuler and Wu, 2010). Consideration of signaling network rewiring between contexts
has led to novel treatment regimens in tumor model systems (Lee et al., 2012). While useful,
data-driven network inference requires large quantities of data and some prior knowledge
to elucidate causative (i.e., directed) relationships, and these demands obviously increase
as more contexts are considered. However, even if contexts are considered, the results of
any typical network inference remain static representations of dynamic processes and are
fundamentally limited in their ability to allow model-driven predictions of cellular dynamics
and responses (Kolitz and Lauffenburger, 2012).
Unlike graph-based network models, mechanistic models of signaling capture both the
reaction network structure and the temporal dynamics of signaling, with residual noise at-
tributed to natural cell-to-cell variability or stochasticity. These models consist of sets of
reaction rate equations in the form of differential equations that describe how each signaling
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component changes over time as a function of the others, and all model components and
parameters have unique physical interpretations such as concentrations, binding affinities or
reaction rates (Aldridge et al., 2006). Properly calibrated mechanistic models can be used to
predict the cellular dynamics from a snapshot of cell state and to analyze the consequences
of observed or hypothetical alterations in the relative concentrations or activities of com-
ponents. The drawback of mechanistic models is that their construction relies on detailed
prior knowledge of the reaction network structure and on multiple, targeted experiments
that permit calibrating the models parameter values (Aldridge et al., 2006; Kholodenko,
2006). The need for detailed prior information presents a great challenge when multiple
contexts are to be considered, as in disease, due to clearly observed variations in network
function, which suggests the need for context-dependent model calibrations and possibly
for different, context-dependent network structures (Halasz et al., 2016; Kholodenko, 2006).
At the same time, biochemical reasoning suggests that the reaction structures themselves
should actually be fixed: two reactants may or may not present, but the kinetics of their
interaction itself should not change, unless other factors or modulators are altered. This rea-
soning, in turn, suggests an important consequence. Namely, given explicit observations of
signaling components and inputs across contexts, an appropriate mechanistic model should
be “context-explicit” by reconciling the entire range of context-dependent signaling dynam-
ics without network rewiring. In other words, it should in principle be possible to construct
a single mechanistic model that, combined with snapshots of individual cell states, would be
able to explain and predict signaling across many phenotypic contexts as they are present,
for example, in individual patient samples. In practice, however, the ability of a single
mechanistic model to represent signaling across cell phenotypes is often restricted, due to
ill-characterized differences in cellular milieu and gaps in knowledge, which are often con-
sidered as sources of natural stochasticity.
Here, for the first time, we use multiplexed single-cell data to calibrate a minimalistic
mechanistic model that is capable of consolidating differences in signaling dynamics across
two distinct cell phenotypes that at first glance appear to mandate context-based network
rewiring, namely, cells before and after an epithelial-mesenchymal transition (EMT). This
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developmental program enables polarized epithelial cells to de-differentiate into a dramat-
ically different mesenchymal phenotype that is characterized by loss of cell-cell adhesion
junctions, increased capacities for migration and invasion, and resistance to apoptosis (Fu
et al., 2018). EMT has been implicated in the generation of metastatic and resistant cancer
cell populations, and studies using both bulk (Desai et al., 2015) and single-cell data (Kr-
ishnaswamy et al., 2018) have demonstrated EMT-associated alterations in signaling. How
these alterations are implemented by the cell is so far unclear, but we demonstrate here that
they can be captured by a single mechanistic model. Such a model spanning the entirety
of EMT can become a potent tool for understanding and possibly manipulating signaling
responses across this critical transition.
To generate both epithelial and mesenchymal cell populations, we use the prviously es-
tablished and robust experimental model of TGF-β-inducible EMT in Py2T murine breast
cancer cells (Waldmeier et al., 2012). We then use mass cytometry to quantify simulta-
neously the epithelial or mesenchymal cell phenotype as well as both the total expression
and phosphorylation dynamics of multiple MAPK/ERK and PI3K/AKT signaling path-
way components in response to a typical proliferative signal, the stimulation with epithelial
growth factor (EGF). This combination of data permits us not only to develop a context-
explicit mechanistic model but also to compare our results directly with the current state
of the art. Thus, we begin by applying a classical network-inference method to the data,
which seems to suggest quite clearly that the network structure of the ERK and AKT
pathways is rewired in a phenotype-dependent manner. Then, using the same data and a
mechanistic single-cell modeling approach (Chapter 3) that is solidly based on the core prin-
ciples of biochemical systems modeling (Savageau, 1976; Voit, 2000, 2013), we construct, ab
initio, two models of the signaling pathway, one each for the mesenchymal and epithelial
cell phenotypes. Intriguingly, the results show that accounting for unmeasured contextual
variables allows us to consolidate the two mechanistic epithelial and mesenchymal models
into a single model with constant reaction structure, minimal changes in biochemical pa-
rameters, and very modest residual noise. This result presents proof-of-principle that no
true rewiring is necessary across EMT but that alterations in signaling processes during
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this dramatic transition in cell phenotype are instead the result of changes in the rela-
tive concentrations of signaling components that can be captured with a single mechanistic
model. More generally, our results suggest that further extending this type of single-cell
model development, combined with highly-multiplexed single-cell measurements of intra-
and extracellular states, has the potential of greatly reducing uncertainty that is other-
wise attributed to natural stochasticity, and improving our ability to predict and analyze
signaling responses in heterogeneous tissues and different disease contexts.
4.3 Results
The starting question for our analysis was the following: given that cells undergo a dramatic
change in phenotype that clearly includes signaling, must the signaling network be rewired
or are changes in the relative concentrations of signaling components alone sufficient to
explain the altered dynamics (Figure 4.1)? Specifically, we posed the hypothesis that a
single, mechanistic model with fixed reaction network structure and kinetic parameters,
calibrated with highly-multiplexed measurements of signaling protein state and expression,
should be able to reconcile the differences in signaling across phenotypes.
To test our hypothesis, we used an experimental model of EMT and focused on EGF
signaling dynamics in the MAPK/ERK and PI3K/AKT pathways, which are considered
proliferative, pro-growth and pro-oncogenic in response to epidermal growth factor receptor
(EGFR) input (Wee and Wang, 2017). We used mass cytometry to characterize individual
cell phenotype (epithelial or mesenchymal) as well as the levels of phosphorylated and total
signaling proteins. Specifically, we measured total and phosphorylated forms of Mek, Erk
and p90Rsk in the core Erk pathway, Akt and Gsk3β in the Akt pathway and ribosomal
protein S6 (S6), a downstream target of both Erk and Akt signaling, in 12 serial samples
from a time course of EGF stimulation (for full antibody panel, see Table C.4). In total,
our data set contains 31-dimensional measurements across 34 conditions: 13 time points for
EGF stimulation and 4 time points for unstimulated control EGF, both made at 2 EMT


























Figure 4.1: Conceptual overview. A phenotypic transition is associated with a changed
signaling response. A key question is whether this alteration requires network rewiring, with
the addition or elimination of edges, or whether the network structure can be constant, while
moderate differences in relative concentrations are sufficient to explain the differences.
4.3.1 Data-driven statistical network inference suggests that the AKT/ERK
signaling network is rewired in response to TGF-β treatment
To study signaling during an EMT, we used a model of TGF-β induced EMT in Py2T murine
breast cancer cells (Waldmeier et al., 2012; Krishnaswamy et al., 2018). Cells are normally
epithelial in visual and molecular phenotype; growing in monolayer with a homogeneous
cobblestone appearance and high expression of the epithelial marker E-cadherin. Chronic
treatment of cells with TGF-β causes cells to transition to a mesenchymal phenotype that
no longer grows in monolayer; it is defined by an elongated shape, loss of E-cadherin, and
acquisition of mesenchymal markers such as vimentin. As in previous studies, we defined
epithelial cells as E-cadherin-high, vimentin-low in samples untreated with TGF-β (day 0
samples). To generate a population of mesenchymal cells, samples were treated with TGF-β
at 24 hour intervals for three days (day 3 samples) and then selected as E-cadherin low,
vimentin high (Figure 4.2a; Figure C.1).
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Figure 4.2: Partial correlation-based network inference suggests that the
ERK/AKT signaling network is significantly rewired during EMT. (a) Overview
of an EMT model (top) including an illustration of the visual phenotype and a molecular
definition of epithelial and mesenchymal cells measured by mass cytometry at various time
points (bottom). (b) Partial correlation (ρXY ·Z) analysis of phosphoproteins is used to infer
the different network structures in epithelial and mesenchymal cells sampled across repli-
cates. The threshold for accepting an edge between X and Y is defined as ρXY ·Z ≥ |0.1|.
All values are Fisher z-transformed. (c) Time dependence of signaling strength in canonical
signaling edges. Blue and green represent epithelial and mesenchymal phenotypes, respec-
tively. Error bars represent standard deviation of partial correlation across replicates.
To assess whether statistical network inference would suggest that the ERK/AKT sig-
naling network becomes rewired during EMT, we employed the commonly used data-driven
approach of partial correlation analysis (Garmaroudi et al., 2010; Desai et al., 2015). The
partial correlation between all pairs of phosphoproteins in our panel for epithelial and mes-
enchymal cells is shown in Figure 4.2b (see Figure C.2 for the analysis including both
phospho- and total proteins). Partial correlation values with magnitudes greater than 0.1
(see Methods) were taken to define edges representing true interactions. In epithelial cells,
partial correlation recovered the canonical pMek-ppErk-pRsk-pS6 and pAkt-pGsk3β path-
ways (Mendoza et al., 2011; Manning and Cantley, 2007; Olayioye et al., 2000; Wee and
Wang, 2017); note that GSK3β phosphorylation at Serine9 is inhibitory. By contrast, the
canonical pAkt-pS6 (via p70S6 kinase) (Mendoza et al., 2011) and pRsk-pGsk3β (Manning
and Cantley, 2007) relationships were apparently attributed to pGsk3β-pS6 and ppErk-
pGsk3β, respectively. Crosstalk between pMek and pAkt has not been reported, but could
indirectly reflect known upstream crosstalk between PI3K3CA and the Raf activator Rac
(Ebi et al., 2013).
According to this analysis, EMT clearly appeared to have rewired the signaling network.
With the chosen cut-off, the mesenchymal cells appear to lose three (of seven) original edges
and gain six new edges. Compared to epithelial cells, the edges ppErk-pRsk, pGskβ-pS6
and pMek-pAkt are lost, while new edges pMek-pRsk, pMek-pGskβ, pMek-pS6, ppErk-
pAkt, ppErk-pS6 and pRsk-pGskβ are gained. Noticeably absent in mesenchymal cells is a
direct path from the AKT pathway to pS6. For different cut-offs, the results would change
somewhat (see Figure C.3), but significant EMT-dependent rewiring would be declared
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necessary in all cases.
Each apparent network wiring is a static representation of a signaling process that is
in truth dynamic. To assess this time dependence, we measured the signaling dynamics in
response to EGF stimulation. Specifically, we quantified the dynamics of network relation-
ships by calculating the partial correlation between widely documented canonical network
edges for each time point (Figure 4.2c). This analysis demonstrated a qualitatively different
dynamics of the pMek-ppErk edge, as well as differential strengths in most edge relation-
ships, when comparing cells before and after EMT. Notably, EGF stimulation revealed at
certain time points two canonical edges that were missed at the steady state: the ppErk-
pRsk edge in mesenchymal cells and the pAkt-pS6 edge in epithelial cells. Taken together,
the dependence of the network structure on context, such as stimulation, time and cell
phenotype, illustrates that a purely statistical analysis, even if it is based on distributions
of single cell data, can be misleading as a tool for predicting signaling responses. We will
see next that mechanistic modeling with finer resolution remedies this shortcoming.
4.3.2 Mechanistic model with constant network structure represents hetero-
geneity of epithelial and mesenchymal ERK/AKT signaling
We hypothesized that a mechanistic model with constant reaction network structure, but
context- (e.g., phenotype-) dependent parameters, should be able to fit the measured signal-
ing dynamics in both epithelial and mesenchymal phenotypes. Thus, using prior knowledge
from the literature, we constructed a reaction network model of the Raf-Mek-Erk-Rsk-
S6 and PI3K-Akt-Gsk3β,S6 pathways (Mendoza et al., 2011; Manning and Cantley, 2007;
Olayioye et al., 2000; Wee and Wang, 2017) that included pathway crosstalk at the level
of PI3K to Rac (Ebi et al., 2013) and RSK to Gsk3β (Manning and Cantley, 2007) (sum-
marized in Figure 4.3a). The reactions were modeled in canonical format (Savageau, 1976;
Voit, 2000, 2013) to minimize the inclusion of unmeasured reaction components, which is a
streamlining step that has worked well in many other contexts. Most notably, upstream sig-
naling components were not observed, causing us to aggregate all upstream components into
a single input with time delay (τ) and an unmeasured modifier variable, pRaf or PI3K, for
each pathway. As upstream components were not explicitly modeled (since they could not
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be obtained from, or even constrained by, data), it was immediately clear that changes in
these components, such as receptor expression and activation state, or their regulation (e.g.
altered membrane dynamics) across EMT, had to be represented by changes in parameters,
i.e., as magnitudes of pathway inputs.
In contrast to classical model calibration, which targets population averages for pa-
rameter estimation, we used a recent approach that uses single-cell data to explicitly model
single-cell variation and better constrain model parameters (Chapter 3). This approach sim-
ulates sets of individual cells, where the initial state of each cell is taken from a snapshot
measurement, and which, when taken together, represent an empirical multivariate distri-
bution analogous to those derived from multiplexed single-cell measurements (see Methods).
After model fitting, simulations of independently subsampled cells showed strong agreement
between model and data in both the marginal densities and parametric statistical features
such as the mean and covariance (Figure 4.3b-c, Figure C.4). Upon inspection, the shape
of distribution fits in mesenchymal cells is overall very good; it departs furthest from mea-
surements in the density of pAkt (Figure 4.3b), which may be explained by some additional
reaction components or modulators that change during EMT; an example could consist of
additional membrane-level variances due to cellular morphological switches. Overall, this
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Figure 4.3: Mechanistic model of EGF signaling in ERK and AKT pathways
with parameter fits to epithelial and mesenchymal cells. (a) Model reaction struc-
ture and measured variables used for both cell types, annotated with kinetic parameters.
(b) Marginal distributions of (log2 transformed) data (solid) and model simulations (orange
line) for dynamic signaling variables in epithelial (blue solid, left) and mesenchymal (green
solid, right) cells. Circles represent means. Marginal distribution at time t = 1 [min] not
shown for improved visual purposes (mean shown). (c) Data (symbols) and model simu-
lations (line) of covariance between signaling variables over time in both cell types. Black
bars represent the range of covariances across replicates. All values in (b,c) were calculated
by subsampling cells across experimental replicates.
4.3.3 Consolidation of ERK/AKT signaling in epithelial and mesenchymal
cells requires only minimal adjustments of mechanistic model param-
eters
Using our unifying reaction network structure, which has the potential of representing the
signaling dynamics in both cell phenotypes, we investigated to what extent the reaction
parameters could also be held constant across epithelial and mesenchymal cells. The origi-
nal closest-fit point estimates for the parameter sets differed with each cell type. However,
both cases admitted ranges of parameter values within which the data were fit very well,
and in most cases, these ranges overlapped between epithelial and mesenchymal cell models.
This quality of fit can be gleaned from a grid-based sensitivity analysis of how individual
parameter changes alter the quality of a model fit (Figure 4.4a). While these results are en-
couraging, univariate sensitivity analyses do not account for the potentially complex effects
of changing multiple parameters simultaneously. We therefore searched simultaneously for
complete, close-by parameter sets that minimized the differences in parameters between
epithelial and mesenchymal cells without decreasing model fitness (Figure 4.4b).
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Figure 4.4: Reconciliation of mesenchymal and epithelial model parameters.
(a) Sensitivity analysis of mesenchymal model parameter perturbations. Grid represents
parameter changes on log2 scale of epithelial parameters used in Figure 3. Circles repre-
sent mesenchymal parameters used in Figure 3 (normalized to epithelial parameters in log2
scale). If epithelial and mesenchymal parameters are equal, the circles are blue; otherwise
they are green. Grid color (color bar) represents percent increase in cost function for the
mesenchymal cell model given a corresponding parameter change. (b) Minimal parameter
difference between epithelial and mesenchymal parameter sets for constant mesenchymal
function cost. Red highlights those parameters associated with model inputs (input mag-
nitude or degradation). Scale and circle colors as in (a).
As we had hypothesized, based on generic biochemical reasoning, analysis of the mech-
anistic model revealed that only four out of 38 parameters require adjustments in values
during the transition from the epithelial (E) to the mesenchymal (M) state: First, I1, the
magnitude of the input to the ERK pathway, decreases from 5.3 (E) to 1.9 (M), approaching
the steady-state value of 1. Second, I2, the magnitude of the input to the AKT pathway,
increases by less than an order of magnitude from 8.1 (E) to 55 (M). Third, parameter h5
decreases from 0.3 (E) to 0.05 (M). This parameter is related to the sensitivity of pGsk3β
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dephosphorylation in response to increases in pGsk3β, and the decrease actually causes
just a minute 1% change in model quality (fitness). This result may not be surprising given
that (1) this parameter value has the direct interpretation of the reaction moving from near
zero-order (nearly saturated with respect to pGsk3β) to very near zero-order (even closer
to saturation), and (2) pGsk3β is generally higher in (M) as in (E), both at the steady state
and at the maximum. Finally, k13, which is related to the maximal rate of S6 phosphory-
lation, decreases from 10−7.8 (E) to 10−9.5 (M). This change is less clearly explained, but
could be related to altered expression of missing reaction components or differences in local
concentrations or diffusion rates. Taken together, almost all of the systems responses are
explained without evoking natural stochasticity.
As an independent model validation, we compared our findings with results of (Salt
et al., 2014) showing downregulation of ERBB3, an EGF receptor related to ERK path-
way activation, and upregulation of PI3KCA, which encodes the catalytic p110α subunit
of PI3K, during EMT. The results of these studies agree well with model predictions of
decreases or increases in ERK and AKT pathway inputs, respectively, which, as discussed
before, are all subsumed in the model inputs, due to insufficient information. This consis-
tency with independent observations supports our EMT-spanning model and provides clear
direction for additional variables that must be measured for a complete reconciliation of the
remaining model parameters across EMT.
4.4 Discussion
From a theoretical biochemical perspective, differences in signaling responses across cells
should be determined by relative differences in concentrations and states of reaction com-
ponents, rather than by substantial reaction network rewiring. We show, for the first time
to our knowledge, that this conjecture indeed applies to signaling in cells before and after
a phenotypic transition, such as EMT. To demonstrate this consistency, we generated very
informative data. Specifically, we measured twice as many state variables as had been used
to date to characterize the dynamics of a single-cell- or distribution-level mechanistic model
of signaling (Chapter 3). Given the ability of calibrated mechanistic models to analyze,
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simulate, and explain the dynamics from an initial snapshot of cell states, it was possi-
ble to initialize an appropriate model – or set of models – with single-cell measurements
from, for example, a tumor sample that contains multiple cell types. The proof-of-principle
we present here represents a large and important progression towards construction of such
tumor-level models.
To assess the conjecture of a single network structure encompassing different contexts,
we combined an in vitro model of EMT with multiplexed single-cell measurements and with
computational modeling to determine how EGF signaling in the ERK and AKT pathways
changes with cell phenotype. This approach included the generation of a rich single-cell
data set that is especially valuable for use with mechanistic modeling approaches due to
the uncommon inclusion of total markers that constrain variation in expression. For fair
comparisons, we first used a traditional data-driven approach of network inference based on
partial correlation, which suggested that the ERK/AKT signaling network had to be rewired
in a phenotype-dependent manner during EMT, thereby reflecting conclusions published in
the literature. In stark contrast, a more appropriate dynamic, mechanistic model with
constant network structure and near constant kinetic parameter values, calibrated with
state-of-the-art single-cell data, does not need rewiring: it is able to reconcile the variation
in signaling dynamics in both epithelial cells mesenchymal cells across EMT with minor
cellular adjustments. In other words, our results provide clear evidence that a properly
calibrated mechanistic model can represent signaling across a contextual change as large as
EMT, and that actual cells apparently do not need to rewire their signaling networks but
simply modulate their reaction components in a minor fashion to alter signaling.
While the ability to explain variation in signaling responses from an individual snapshot
of cell states is an exciting prospect, we emphasize the necessary considerations to apply
our approach. Primarily, these are the necessity to explicitly measure and model the pri-
mary sources of variation in system components that affect the signaling dynamics, which
could include not only levels or functional state of signaling proteins, but also other fea-
tures including the cells microenvironment. Thus, the main limitations are directly related
to the ability of measuring the appropriate variables, as well as the computational cost of
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fitting mechanistic models to increasingly large systems. These limitations, however, con-
tinually diminish as multiplexed single-cell measurement technologies and computational
infrastructure rapidly improve.
Taken together, a single mechanistic model with entirely constant reaction structure at
the single-cell level can reconcile the EGF signaling dynamics of the ERK/AKT signaling
network across an EMT. The only differences, which are without doubt associated with
the different signaling responses of the system at E and at M, are modest changes in the
magnitudes of pathway inputs and slight alterations in only two of the models 34 kinetic
parameters. This result clearly demonstrates that actual murine Py2T breast cancer cells
have no need for rewiring the reaction structure of their signaling network during EMT.
No mechanisms or processes have to be added and none have to be removed. In fact, it
appears that the signaling system is essentially deterministic and that the formerly assumed




Py2T cells were obtained from the laboratory of Gerhard Cristofori, University of Basel,
Switzerland (Waldmeier et al., 2012). Cells were tested for mycoplasma contamination
upon arrival and regularly during culturing and before being used for experiments. Cells
were cultured at 37◦C in DMEM (D5671, Sigma Aldrich), supplemented with 10% FBS, 2
mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin, at 5% CO2. For cell
passaging, cells were incubated with TrypLE Select 10X (Life Technologies) in PBS in a 1:5
ratio (v/v) for 10 minutes at 37◦C. For each experiment, cells were seeded at the density of
0.3 million cells per plate (100 mm diameter) and allowed to recover for 36 hours.
TGF-β stimulation
After reaching 60% confluence, cells were either mock treated or treated with 4ng/ml TGF-
β (Human recombinant TGF-β1, Cell Signaling Technologies) for 72 hours. Cell growth
medium and 4ng/ml TGF-β treatment were renewed every 24 hours until 24 hours before
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any EGF stimulation experiments. For each condition, three biological replicates were
cultured, harvested and analyzed.
Cell harvesting and EGF stimulation time course
For cell harvest, cells were washed two times with PBS and incubated with TrypLE Select
10X (Life Technologies) in PBS at a 1:5 ratio (v/v) for 10 minutes at 37◦C. Following cell
detachment, cells were mixed and resuspended in serum-free media and allowed to recover
from detachment for two hours at 37◦C and 5% CO2 with periodic shaking to avoid cluster
formation. After the recovery period, samples were taken to establish baselines. EGF
(Peprotech) was then added to a final concentration of 100 ng/ml and sampling continued
to characterize signaling dynamics. Samples were taken at {-10,-5,0,1,3,5,8,12,15,20,30,50}
minute time points relative to stimulation (t = 0) with EGF (the 0-minute sample was not
stimulated). At the time of sampling, paraformaldehyde (PFA, from Electron Microscopy
Sciences) was added to the cell suspension to a final percentage of 1.6%, and cells were
incubated at room temperature for 10 minutes. Crosslinked cells were washed twice with
cell staining medium (CSM, PBS with 0.5% BSA, 0.02% NaN3) and after centrifugation,
ice-cold methanol was used to resuspend the cells, followed by a 10-minute permeabilization
on ice or for long-term storage at -80◦C.
Metal-labeled antibody conjugation
The MaxPAR antibody conjugation kit (Fluidigm) was used to generate isotope-labeled
antibodies using the manufacturer’s standard protocol. After conjugation, the antibody
yield was determined based on absorbance at 280 nm. Candor PBS Antibody Stabilization
solution (Candor Bioscience GmbH) was used to dilute antibodies for long-term storage at
4◦C.
Barcoding and staining protocol
Formalin-crosslinked and methanol-permeabilized cells were washed three times with CSM
and once with PBS. Cells were incubated in PBS containing barcoding reagents (102Pd,
104Pd, 105Pd, 106Pd, 108Pd, 110Pd, 113In and 115In) at a final concentration of 100 nM for 30
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minutes at room temperature and then washed three times with CSM (Bodenmiller et al.,
2012). Barcoded cells were then pooled and stained with the metal-conjugated antibody mix
(Table C.4) at room temperature for 1 hour. The antibody mix was removed by washing
cells three times with CSM and once with PBS. For DNA staining, iridium-containing
intercalator (Fluidigm) diluted in PBS with 1.6% PFA was incubated with the cells at 4◦C
overnight. On the day of the measurement, the intercalator solution was removed, and
cells were washed with CSM, PBS, and ddH2O. After the last washing step, cells were
resuspended in ddH2O and filtered through a 70-µm strainer.
Mass cytometry analysis
EQ Four Element Calibration Beads (Fluidigm) were added to cell suspensions in a 1:10 ratio
(v/v). Samples were analyzed on a Helios mass cytometer (Fluidigm). The manufacturer’s
standard operation procedures were used for acquisition at a cell rate of approximately
500 cells per second. After the acquisition, all FCS files from the same barcoded sample
were concatenated (Bodenmiller et al., 2012). Data were then normalized, and bead events
were removed (Finck et al., 2013) before doublet removal and de-barcoding of cells into their
corresponding wells using a doublet-filtering scheme and single-cell deconvolution algorithm
(Zunder et al., 2015). Cytobank (http://www.cytobank.org/) was used for additional gating
on the DNA channels (191Ir and 193Ir) and 139La/141Pr to remove remaining doublets,
debris and contaminating particulates. Data were then exported as .fcs files for subsequent
analysis.
Gating epithelial and mesenchymal cells
Epithelial were gated as E-cadherin high / vimentin low in samples without TGF-β treat-
ment. Mesenchymal cells were gated as E-cadherin low / vimentin high in samples treated
for three days with TGF-β. Gating cut-offs are shown in Figure 4.2a. Treatment with
TGF-β for longer than three days increases the percentage of Py2T population that un-
dergoes EMT. Samples treated with TGF-β for three days also contained cells within the
“E-cadherin high / vimentin low” gate, but these were not considered contextually as ep-
ithelial cells.
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Data normalization and scaling for use in modeling
Experimental measurements were normalized for comparisons across independent experi-
ments and measurements. Cell events with greater than 20 counts for cleaved PARP were
removed as dead or apoptotic. Before using variables in modeling, they were linearly scaled
to satisfy biological constraints, such as the total units of a protein must be greater than or
equal to the units of the phosphorylated form (see Appendix C). Cells used in fitting were
subsampled across experimental replicates to reduce computational cost. A full description
of normalization, scaling and subsampling of data before use in modeling is presented in
Appendix C.
Partial correlation-based network inference
Given two random variables X and Y and a set of controlling variables Z = Z1, ..., Zn, the
partial correlation ρXY ·Z is a measure of the relationship between X and Y when the effects
of the Z = Z1, ..., Zn random variables have been accounted for. Mathematically, ρXY ·Z is
the correlation of the residuals eX and eY that result from a linear regression of X and Y
with Z, respectively.
To determine the cutoff for partial correlation-based network representations, thresholds
can be used to define a minimum p-value or correlation coefficient. In order to focus on
stronger relationships, we used a threshold on the partial correlation values. The choice of
ρXY ·Z ≥ |0.1| as the threshold was made as a qualitative boundary between maximizing
canonical and minimizing non-canonical signaling relationships in epithelial cells. Most
notably, this setting captured the edge between the ERK pathway and pS6, as well as some
form of crosstalk between the ERK and AKT pathways. The addition or subtraction of
edges based on other thresholds may be readily calculated from the heatmaps provided in
Figure 4.2 and, in the context of both total and phosphoproteins, in Figure C.2. Figure
C.3 illustrates the relationship between the partial correlation threshold and network edge
number. Heatmap labels were ordered by hierarchical clustering the epithelial population
values using single-linkage clustering and Euclidean distance.
92
Mechanistic model of ERK/AKT pathway response to EGF
We used the ‘Single-cell ODE modeling’ (SCODEM) approach as described in Chapter
3. Briefly, cells are assumed to have the same population-level kinetic parameters, which
are determined by minimizing the maximum mean discrepancy (MMD)(Gretton et al.,
2012a), a statistical two-sample test of similarity for n-dimensional distributions, between
simulated and experimentally measured distributions. Cell-to-cell variation in unmeasured
components is captured in a subset of rate constants that are algebraically determined by
a combination of model structure, population-level parameters and steady-state measure-
ments. To fit individual parameter sets for epithelial and mesenchymal cell populations, we
subsampled 500-1000 cells across the three replicates for each time point. Model equations
may be found in Appendix C.
Parameter optimization
Parameter optimization was performed using a combination of global and local search meth-
ods. First, 50,000 initial parameter sets were sampled from a user input parameter range.
Next, the 200 parameter sets with minimum model cost were selected. Finally, each pa-
rameter set was refined using multiple rounds of optimization using the unconstrained local
search algorithm fminsearch in the Matlab Optimization Toolbox (The MathWorks, Inc.).
The fminsearch algorithm begins with a broad search perspective before focusing on a
more precise local area; a regular re-initialization of the search improved results. Thus,
each round of optimization was run for 300 iterations. If at the end of a round, the cost
value had improved by at least two percent, another round was initialized using the pa-
rameter set output by the algorithm. Otherwise, the optimization was terminated. After
this local search approach, fminsearch was initialized a final time with the parameter set
corresponding to the lowest cost among the 200 solutions and run until the model cost
stabilized.
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Sensitivity analysis of mechanistic model parameters
A grid-based sensitivity analysis was performed in the context of the population parameters
Θ. The cells sampled for model fitting, either epithelial or mesenchymal, and the model
structure were held constant. Given the best-fit point estimate of the parameter set for
epithelial cells Θ∗e = θe,1, ..., θe,m, sensitivities were calculated as the change in cost function
F given a change in the jth parameter θe,j :
∆F
∆θe,j
where ∆θe,j was defined using a log2 fold-change range of [-8:0.25:3] when applied to the
best parameter θ∗e,j for epithelial cells. Notably, this definition implies that parameter
sensitivities for the epithelial and mesenchymal models were calculated using the same set
of values.
Reconciliation of mechanistic model parameters across EMT
Reconciliation between the best points estimates for epithelial and mesenchymal population
parameter sets Θ∗e and Θ
∗
m, respectively, was performed by finding the minimum difference
between all corresponding population parameters θe and θm without increasing the cost F
associated with either best-fit parameter set:
min |Θe −Θm|
subject to
F (Θe) ≤ F (Θ∗e)




Cell-to-cell variation has complex and important consequences for intracellular signaling.
In many contexts, cells are able to perform essentially identical functions despite their
differences, in other contexts, for example in cancer, cell-cell differences in state propagate
to differences in function. The overall goal of this dissertation was to develop mathematical
and computational methods for the study of cell-to-cell variation in signaling, and to use
these tools to increase our understanding of when single cell differences do, or do not, make
a meaningful difference. Here, we summarize our scientific contributions towards that goal
and discuss future directions related to our work.
5.1 Summary of Results
Chapter 2
In Chapter 2, we established a novel experimental framework that combines mass cytometry
with transient transfection to characterize protein expression-dependent effects on signaling
systems in a high-throughput manner. We used this framework to measure the effects of
independently overexpressing 20 protein kinases on signaling dynamics in the EGFR sig-
naling network for a total of 360 conditions; we measured an average of 11,000 cells per
condition with a panel of 35 antibodies that characterized the EGFR network signaling
state. To quantify the potentially complex relationships between protein abundance and
the state of kinases within the EGFR network in manner suited to these data, we devel-
oped a statistical measure called binned-pseudo R-squared (BP-R2), which identifies many
non-monotonic relationships that are not properly captured with correlation metrics such
as Spearman correlation. After benchmarking and validation, we used BP-R2 to identify
potentially novel relationships between signaling kinases and cases where protein overex-
pression altered signaling dynamics in an abundance-dependent manner.
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Chapter 3
In Chapter 3, we presented SCODEM: a novel distribution-free computational approach to
infer multiplexed signaling trajectories from snapshot single-cell data. Our approach suc-
cessfully overcame previous experimental limitations that forced a trade-off between con-
tinuous and multiplexed measurements. We applied SCODEM to study the consequences
of cell-cell variation for how the MAPK/ERK pathway responds to EGF; this included
application of the experimental framework developed in chapter 2.
We showed that: (1) cell-to-cell variation in signaling can be described deterministically,
given the initial state of each cell; (2) cell volume is a significant contributor to the variability
observed in single-cell measurements; (3) signal duration is reliably transmitted through
the RAF/MEK/ERK cascade, whereas signal amplitude is a fold-change response to the
initial protein state that is uncorrelated across the signaling cascade. More generically, we
demonstrated that SCODEM can be a valuable approach to studying reaction kinetics and
variability in cellular responses to drug treatments and in disease.
Chapter 4
In Chapter 2, we combined an in vitro model of EMT with multiplexed single-cell measure-
ments and mathematical modeling to determine how EGF signaling in the ERK and AKT
pathways changes with cell phenotype.
For the important case of an epithelial-mesenchymal transition we showed that signal-
ing network rewiring is not necessary. This result is in stark contrast to the outcomes of
traditional data-driven approaches of network inference, which suggest that the ERK/AKT
signaling network must be rewired in a phenotype-dependent manner during EMT. To ob-
tain this shift in paradigm, we used SCODEM and showed that an appropriate dynamic,
mechanistic model with constant network structure and near constant kinetic parameter
values is able to reconcile the variation in signaling dynamics in both epithelial and mes-
enchymal cells across EMT. This result provides clear evidence that a properly calibrated
mechanistic model can represent signaling across a contextual change as large as EMT,
and that actual cells apparently do not need to rewire their signaling networks but simply
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modulate the levels of their reaction components to alter signaling responses. This result is
not due to improved data, since we used exactly the same data with a traditional network
inference method, which suggested mandatory rewiring. Instead, it is the combination of
powerful single-cell data with an appropriate dynamic model capable of demonstrating that
no rewiring is needed.
5.2 Future Directions
Direct experimental validation of single-cell signaling trajectories
We developed the SCODEM framework (Chapter 3) in part because there are no current
experimental methods able to measure the state of many signaling components simulta-
neously and as continuous time series. Thus, direct experimental validation of our model
predictions of signaling trajectories in individual cells is currently not possible. Instead,
we validated our approach by (1) using methods of algorithm and model construction that
are firmly based on accepted assumptions derived from first principles and (2) applying the
methods to increasingly demanding examples of cellular heterogeneity, which failed to falsify
our results. Nonetheless, a true and more direct validation would be a direct experimental
characterization of the accuracy of trajectories in individual cells, which is currently not
possible, as there are no live-cell methods to observe what we have modeled, e.g., kinase
phosphorylation.
To circumvent this technological issue, we have begun to work in this direction by
combining ERK KTR reporters with cutting-edge multiplexed snapshot imaging methods
developed in the Pelkmanns group (Gut et al., 2018). Early results indicate that such a
combination of methods is possible in principle, and our preliminary data are quite interest-
ing. However, as is to be expected, these experiments have their unique challenges, which
will require dedicated methodological effort. While many of these challenges are technical
in nature and will be overcome with time, other challenges are fundamental to the use of
KTRs specifically, or of genetically encoded sensors in general, and extreme caution will
be needed before one can validly accept live-cell readouts as ground-truth. For example,
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our preliminary studies indicate an expression-dependent background signal and clear sat-
uration of the KTR cytoplasmic:nuclear ratio (C/N) readout in cells stimulated with EGF
at concentrations classically used to characterize signaling dynamics, which immensely re-
stricts the range of useable data. Additionally, preliminary modeling results have shown the
potential for the C/N ratio to oscillate even in cases where Erk phosphorylation is perfect
or near-perfectly adapted, although it is widely accepted that phospho-Erk levels do not
oscillate (Ferrell, 2016). The cause of these artefactual oscillations is not entirely under-
stood but may primarily be due to a combination of limited dynamic range and delays in
the reporter system related to nuclear import and export. These issues are not necessarily
insurmountable, but illustrate how such reporters introduce new uncertainties into the sys-
tem that will need to be constrained with innovative, precise experimental designs such as
those used to partially characterize the original JNK KTR (Regot et al., 2014).
Further optimization of SCODEM
After developing the SCODEM framework in Chapter 3, our primary focus turned to its
application to experimental data as a test of the algorithms underlying assumptions. To
this end, we evaluated and optimized the computational performance of SCODEM to the
point that suited our needs, which included the ability to run on a single workstation for the
problems we considered. However, several directions for improvement remain open. First,
and most obvious, is an expansion toward cluster computing. The multistart optimization
approach we used is parallelized; it is one of a few processes that could be distributed on a
cluster for algorithm speed-up. Second, optimized kernel choice could potentially improve
the ability of MMD to discriminate between distributions. Some work has been done on this
problem (Gretton et al., 2012b), and it would be interesting to see it tailored to the specific
distributions expected in single-cell data. Third, theoretical work could possibly determine
optimal sampling of the cell population for model fitting. The most expensive step in the
optimization routine is numerically solving the ODE system, which must be performed for
each simulated cell. Minimizing the number of cells needed for parameter estimation can
clearly speed-up the process. This number will certainly be dependent on the dimension of
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the system and the shape characteristics of the state-space distribution. Finally, it would
be interesting to investigate some hybrid combination of our framework with sigma-point
or generic particle filters as a method of increasing efficiency.
Continuous functional characterization of latent variability
The definition of a cellular phenotype generally involves a discretization of a continuous
space of cell states (see, for example Trapnell et al. (2014)). In Chapter 3 we used transient
transfection of ERK (as established in Chapter 2) to generate a continuous range of ERK
overexpressing cells. Then, rather than discretizing the expression space or relying on
mixture models, we found continuous functional representations to describe the effects of
ERK overexpression on signaling dynamics. This task was simplified by the controlled
nature of the experiment, the direct measurement of ERK abundance and some knowledge of
the reaction structures involved. Chapter 4 presented us with a similar, but less well-defined
situation. Namely, we know that cells make a continuous transition from an epithelial to a
mesenchymal phenotype. As many cell features change during this transition, we discretized
this continuous process of EMT into only the well-defined initial and end states and used a
model to infer EMT-related changes in variables that were not measured and thus modeled
as parameters. An interesting next question therefore is: Can we find a continuous function
that maps the change in unmeasured EMT-related variables to progression along an EMT
“trajectory”? Several algorithms are now available that attempt to infer developmental
trajectories or manifolds in the cellular state space from mass cytometry or single-cell RNA
data, for example (Trapnell et al., 2014; Krishnaswamy et al., 2018), and could be used to
further this exciting idea.
Application of reaction model-based single-cell trajectory inference in non-
signaling systems
Finally, a future project could be the application of the general principles of the SCO-
DEM modeling approach to systems beyond signaling, where single-cell simulations and
distribution-free two-sample testing are beneficial. For example, given current single-cell
experimental technologies, a promising extension could be in the domain of gene regulatory
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networks, perhaps by combining single-cell multiplexed RNA imaging methods, such as
MERFISH (Chen et al., 2015), with subsequent protein-level measurements via traditional
imaging methods, imaging mass cytometry (Giesen et al., 2014) or genetically encoded flu-
orescent reporter systems. We would expect simulations of cell ensembles to generate pop-
ulations for model fitting with multivariate two-sample tests such as MMD to remain an
effective approach. However, reaction components in transcription and translation reaction
processes are generally present in low copy number and are likely to be more appropri-
ately modeled as stochastic processes, which would require adaptations of our algorithms
toward, for example, stochastic differential equations or even agent-based models, as well as
necessarily enhanced computational resources. More generally, quantifying the relative con-
tribution of stochastic reaction noise to cellular fates remains an interesting open question
that such our methods could, perhaps, be used to address.
5.3 Closing Comments
This dissertation has provided an original framework to infer and analyze biochemical sys-
tems at the level of single cells, and resulted in a strong argument that intracellular sig-
naling is primarily a deterministic process at the single cell level. The tools, ideas and
results presented in this dissertation are hoped to inspire new avenues of thinking toward
understanding cellular decision making across many contexts including disease.
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APPENDIX A
SUPPLEMENTARY MATERIALS: INFLUENCE OF NODE
ABUNDANCE ON SIGNALING NETWORK STATE AND
DYNAMICS ANALYZED BY MASS CYTOMETRY1
A.1 Supplementary Figures
1Adapted from (Lun et al., 2017).
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Figure A.1: Technique validation. (a) Detection of GFP-N-terminal, FLAG-C-
terminal, and FLAG-N-terminal tagged proteins. All GFP-tagged fusion proteins, but
only 20 of the 25 FLAG-C-terminal tagged and only 22 of the 25 FLAG-N-terminal tagged
proteins, were detected using mass cytometry. (b) HEK293T cells overexpressing GFP-
GFP, FLAG-C-terminal-GFP, and FLAG-N-terminal-GFP fusion proteins were co-stained
with anti-GFP and anti-FLAG antibodies. The fusion protein FLAG-C-terminal-GFP was
detected by the anti-GFP antibody but not with the anti-FLAG antibody. This indicates
that in certain contexts the FLAG tag is not accessible to the anti-FLAG antibody. The
FLAG epitope may be masked due to protein folding or by the denaturation process that
is part of our experimental protocol.
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Figure A.2: GFP-tagged POIs have normal localization. HEK293T cells that over-
expressed the GFP-tagged POIs used in this study were imaged with confocal microscopy.
For each POI, the main panel shows the image in a given z-depth; the bottom panel and
the side panel shows x-z and y-z cross-sectional images, respectively. POI-GFP subcellular
localization was determined by overlapping with two control stains: Hoechst 33343 for the
nucleus and Alexa Fluor 647 carboxylic acid succinimidyl ester indicating the cell outline.
The POI-GFP localization was verified by comparison with information of the UniProt
subcellular localization database (Supplementary Table 4 online).
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Figure A.3: GFP tag does not disrupt catalytic activities of POIs. (a-d) Cat-
alytic activities of GFP-tagged POIs were compared with FLAG-C-terminal and FLAG-N-
terminal tagged POIs. The examples shown here indicate that the GFP tag did not alter
signaling relationships or signaling dynamics after EGF stimulation (the complete dataset
with comparison of all constructs used in this study is shown in Supplementary File 1 on-
line). (e) Heat map showing abundance-dependent signaling relationship strengths from
overexpressed POIs with three different tags as determined by BP-R2 analysis (Figure 2.3
and Methods). Measured markers showing at least one strong relationship in any of the con-
ditions were included in the heat map. Strong relationships were detected independently
of tag. BP-R2 values slightly vary for the 3 tags, due to the antibody accessibility and
differences in transfection efficiencies (Figure A.1).
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Figure A.4: Total protein antibody staining of HEK293T cells overexpressing a
GFP-tagged POI. (a) HEK293T cells transfected with KRAS-GFP, HRAS-GFP, MEK1-
GFP, ERK2-GFP, AKT1-GFP, GSK3β-GFP, or S6-GFP for 18 h were stained with anti-
total POI and anti-GFP antibodies. A linear regression analysis for each pair was performed
in the original scale. R2 ranges from 0.74 to 0.88, indicating the total POI is linearly
correlated with GFP and that the POI overexpression does not alter the expression of the
endogenous POI. (b) The same cells were stained with nine antibodies to quantify total
protein as well as with a GFP antibody. Median ion counts for all measured markers
are shown. Overexpression of a POI-GFP for 18 h does not cause notable changes in the
measured network nodes. (c) ERK2-GFP transfected HEK293T cells and the untransfected
control with or without EGF stimulation were stained for total-ERK and phospho-ERK
(Thr202/Tyr204). The dynamic range in the overexpression condition allows observation of
abundance-dependent signaling relationships. With total ERK staining, the same signaling
relationships as shown in the Supplementary Figure A.2b is recapitulated, verifying GFP
as an indicator of POI expression level.
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Figure A.5: Comparison of mass cytometry and flow cytometry (FACS).
HEK293T cells were transfected with the FLAG-GFP overexpression vector. With flow
cytometry, cells were gated into GFP low, medium, and high populations with the gating
strategy shown in the left panel. With mass cytometry, each of the three sorted popula-
tions was measured independently to determine the gating windows. Unsorted cells were
then assessed by the mass cytometry. The maximum difference in population percentage
between mass cytometry and flow cytometry was less than 3%.
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Figure A.6: Comparison of EGF stimulations in starved (FBS is absent) and
non-starved (FBS is present) cell culture conditions. HEK293T cells were stimulated
with EGF with or without FBS over a 1-h time course. In the non-starved condition basal
signaling states of the major MAPK/ERK or AKT pathway components were higher than
in starved conditions, but these elevated levels did not affect the signaling responses to the
EGF stimulation. Mean value of each sample is shown with circle. Standard deviation is
indicated by shaded area.
107
Figure A.7: TrypLE treatment time course. HEK293T cells were treated with Try-
pLE for 30 s, 1 min, 2 min, or 4 min with or without EGF stimulation for 5 min (time from
EGF addition to PFA crosslinking). Within the first 2-min TrypLE treatment (i.e., the
time after which we quenched cells in all experiments), only phosphorylation of Ser167/170
on MARCKS varied relatively. Mean value of each sample is shown with circle. Standard
deviation is indicated by shaded area.
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Figure A.8: Live imaging of GFP fluorescence at 18 to 19 h after HEK293T
cells were transfected with a FLAG-GFP construct. Quantification of the GFP in-
tensity showed a slight increase of 5.4% over the 1-hr time course. There was a fluctuation
in total GFP signal, indicating that the 5.4% increase is most likely attributable to tech-
nical variability of the measurement. The analysis of signaling relationships in our study
was performed based on a binning strategy on arcsinh transformed GFP ion counts (mass
cytometry). Thus, the measured change will not significantly affect the binning over the
time course. Standard deviation is indicated by shaded area.
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Figure A.9: Abundance-dependent signaling analyses performed in individual
experiment replicates are highly reproducible. (a) Different batches of HEK293T
cells were transfected with JNK1-GFP, P38α-GFP, PDK1-GFP, or p90RSK-GFP con-
structs, stained, and analyzed by mass cytometry on three different days. Highly consistent
signaling responses were observed among the three individual experiment replicates. Pan-
els (b) and (c) show analyses of representative phosphorylation sites in the MAPK/ERK,
AKT, stress pathways, and the STAT5 protein in cells in which (b) KRASG12V-GFP and
(c) MEK1DD-GFP was overexpressed. Panels (d) and (e) show all relationships that
passed the BP-R2 threshold (see Methods for details) for the (d) KRASG12V-GFP and (e)
MEK1DD-GFP overexpression experiments.
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Figure A.10: Benchmark of BP-R2 against other methods used to identify rela-
tionships in mass cytometry data. (a) Venn diagram of strong relationships detected
by BP-R2, Spearman correlation, and DREMI in our dataset using the same cutoff - the
99th percentile of the BP-R2 / Spearman correlation / DREMI score in the control groups
(FLAG-GFP overexpression and the untransfected cells). BP-R2 outperforms the other two
measures. (b) BP-R2, Spearman correlation, and DREMI measurements of signaling rela-
tionship strength between p-ERK1/2 and overexpressed ERK2-GFP. BP-R2 is suitable for
analyzing non-monotonic signaling relationships and outperforms the other two measures
in representing actual signaling activation status.
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Figure A.11: Analysis of signal spillover among mass channels. (a) Strategy to ex-
clude spillover among mass channels. When strong signaling relationships as determined by
BP-R2 were identified (measured phosphorylation of p70S6K in the p90RSK-GFP overex-
pression is shown here as a selected example), all other potentially affected channels (details
in Methods) were evaluated for spillover that might have led to a high BP-R2 value. Using an
experimental spillover filter (b), spillover-affected relationships were discarded. Here three
groups of antibody stains were performed simultaneously: First, all antibodies; second, all
antibodies except for the one that potentially causes spillover; third, only the antibody that
potentially causes spillover. If spillover induced background was over 10% of the actual ion
counts, the channel was discarded from the analysis.
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Figure A.12: Median intensities and BP-R2 analysis for all experimental condi-
tions. (a) Heat map of median intensities of all measured markers at 0, 5, 15, 30, and 60
min post-EGF stimulation in all overexpression conditions (Table 2.1). Data visualized as
log2 of the ratio of the median signals divided by the mean of median signals of the FLAG-
GFP controls at time point 0. (b) Heat map of BP-R2 values of all measured markers
versus GFP signals at 0, 5, 15, 30, and 60 min post-EGF stimulation in all overexpression
conditions.
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Figure A.13: Strong and robust changes in signaling peak times. Heat map of
consistent and robust examples for overexpression-induced phosphorylation site abundance
peak time changes after EGF stimulation for each of the three replicates.
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Figure A.14: Post-transcriptional constraint analysis of overexpressed POIs. (a)
Coefficient of variation (CV) was computed for each strong signaling relationship that had a
BP-R2 value above 0.11 (i.e., a strong signaling relationship), and CVs were plotted against
BP-R2. No correlation was observed. (b) Overexpression ranges (median value of GFP
in Bin10 minus the median value of GFP in Bin1) calculated for all POIs. (c) Maximum
amplitudes of phosphorylation sites were independent of the level of overexpression of the
POIs.
A.2 Supplementary Tables
All supplementary tables (1-6) may be found in the online methods (see (Lun et al., 2017)).
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APPENDIX B
SUPPLEMENTARY MATERIALS: VARIATION IN SINGLE-CELL
SIGNALING DYNAMICS IS DETERMINED BY INITIAL CELL
STATE
B.1 Introduction
Here, we provide additional details on the ‘single-cell ODE modeling’ (SCODEM) method
presented in the main text. This material includes a description of the experimental and
modeling workflow, methods for scaling and subsampling the raw experimental data for use
in modeling and, finally, the mathematical model structures used.
B.2 SCODEM
Single-cell ODE modeling is based on the assumption that the majority of variation observed
in the single-cell dynamics (trajectories) of a reaction system originates from and, therefore,
is explained by the cell-to-cell variation in the initial sate of the system. This assumption
entails that possibly stochastic reaction kinetics has a minor effect on dynamics and is the
main reason for applying SCODEM to study signal transmission rather than translation.
(We note, however, that the general single-cell modeling methodology presented here may
readily be adapted to study gene regulatory systems; by using stochastic differential equa-
tions, for example.) Thus, to predict the forward-time progression of system state variables
of a given system, we assume that knowledge of the variation in initial system states is
sufficient.
As an illustration, here we present a single step of the SCODEM approach in the simplest
case, namely, where we assume that a valid model structure of the system is known in the
form of an appropriate approximation of the system structure. Moreover, we assume that
all state variables in the model have been experimentally measured in a number of single
cells sufficient for statistically approximating the distribution structure of the underlying
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cell population(s). We will subsequently describe how SCODEM may be applied to more
realistic cases, as discussed in the main text, where we may not know all state variables
that should be included in a model or where we cannot experimentally measure some of the
state variables in the model.
B.2.1 SCODEM algorithm
We consider a dynamical biochemical system S. The states of S are characterized by the
vector of state variables X ∈ Rv and the system of ODEs defining Ẋ sufficiently approxi-
mates S. Given a vector of initial system states X0, a vector of system parameters Θ and a
vector of system inputs u, the solution of the ODE system Ẋ(X0,Θ,u) describes the time
evolution (dynamics) of the state variables X(t) representing system S.
Additionally, we consider multiplexed single-cell experimental snapshot data Dt mea-
sured at times t ∈ T such that the dataset {Dt, t ∈ T} characterizes the dynamics of the
system S. Specifically, an individual snapshot Dt is an n × v matrix of v state variables
observed in n cells at experimental time t. We assume that the number of cells n in each
measurement is sufficient to characterize the structure of the underlying “true” population.
In this simplest case, where the model structure is known, the SCODEM algorithm is
concerned with inferring the biochemical rate parameters Θ of the ODE system Ẋ(X0,Θ,u).
Any single step s of SCODEM is implemented in an optimization routine of the following
type:
Algorithm 1 Generic optimization step s of SCODEM
1: Input: Θs, {Dt, t ∈ T}, u
2: Output: Costs
3: procedure Integrate single-cell instances of ODE system




Ẋ(Dt0,k,Θs,uk)dt . simulate trajectory X̂k(t) of k







k=1 X̂k(t) . Combine n simulated single-cell trajectories to define trajectory
of empirical distribution
9: procedure Compare simulated and experimental distribution snapshots
10: Costs =
∑
t∈T MMD(X̂(t), Dt) . Sum maximum mean discrepancy values between
simulated and measured distributions at measurement times
11: end procedure
12: Output: Costs
B.2.2 Inference of latent cell-to-cell variation
In real applications of SCODEM, we typically do not know the full system structure of S
and/or cannot measure all relevant state variables. Expressed differently, the dimensionality
of the model X∗ or measurements D∗ is less than the full system. In either case, the
corresponding ODE model Ẋ∗(X∗0,Θ,u) that approximates S can naturally not account for
some source(s) of variation in initial cell states that may influence the system dynamics, and
the inference procedure may fail to reproduce the variation in system dynamics characterized
by snapshot measurements. If the unknown/unmeasurable model variables change on a time
scale qualitatively separable from the dynamics being studied, however, it is possible to infer
certain characteristics of the cell-to-cell variation in the unknown or unmeasured variables.
This inference is made possible by allowing some model parameters to vary across cells, and
by determining the values of these parameters by analytical solution of the steady-state
equations using experimental measurements.
Specifically, we take a parameter subset Φ ⊆ Θ and allow these parameters (Φk) to
vary across each cell k in a population, while keeping the remaining parameters the same
for all cells. For a given estimation of population parameters Θ, the individual cell values
of Φk are algebraically determined by steady-state solution of the ODE system using the
current estimate of population parameters Θ and steady-state measurements D∗t0,k of cell
k.
We use an example from our model to illustrate the procedure. We begin with the
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following differential equation for ERK activation:
˙ppERK = k5 ∗ ERKg3 ∗ ppMEKg4 − k6 ∗ ppERKh2 (7)
Because the kinetic order parameters g3, g4 and h2 are directly related to physical properties
of system components explicitly represented in the model as state variables, we assume they
do not change across the cell population (thus, {g3, g4, h2} ∈ Θ). If our reaction scheme for
ERK activation were complete, we would expect that the rate constant parameters k5 and
k6 to be the same across the population. Our reaction scheme, however, is an approximation
of the true reaction structure and does not include all known and unknown contributors to
the reaction; in particular, mono-phosphorylated ERK in the forward reaction and ERK
phosphatase in the reverse reaction. For our given experimental conditions, we begin with
the assumption that our model explicitly captures the primary state variables that change
their state on the same time scale. For instance, we assume that mono-phosphorylated ERK
may rapidly equilibrate and the phosphatase is constitutively active. If our assumption is
incorrect, our model will not be able to fit the data and we know our model structure must
be updated. By contrast, if our assumption is a valid approximation for our experimental
conditions, then we may use the parameters k5 and k6 to capture the sources of latent
cell-to-cell variation. Thus k5 and k6 are included in the single-cell parameters set Φk.
The single-cell parameter values k5,k, taken across all cells, capture variation in mono-
phosphorylated ERK and any unknown ERK activators, while k6,k capture the variation in
ERK phosphatase and any unknown ERK inactivators. Given some guess of Θ, which may
be set based on biological knowledge or determined by the optimization algorithm, we may
use the model structure from equation (7) and our measurement of cell k at steady state
(D∗t0,k) to infer some properties of single-cell parameter values k5,k and k6,k by solving the
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steady state equation:
Steady state⇒ 0 = ˙ppERKk = k5,k ∗ ERK
g3
t0,k













The parameters k5,k and k6,k are non-identifiable at the steady state due to the model
structure, and we only identify the ratio. If one parameter, say k5,k, is fixed, however,
the other (k6,k) is fully determined by the model structure, the current population-level
parameter values Θ, and the constraint that the system must be at a steady state with
the current (measured) combination of state variables. The fixed parameter k5,k, while
non-identifiable at the steady state, serves to scale the speed of the forward and reverse
reactions and can therefore be inferred from the time course measurements of the system
dynamics. If we assume the free parameter k6,k to be responsible for capturing all the cell-
to-cell variation in the ERK activation/inactivation reaction, then parameter k5,k can be
added back to the population-level parameter set (k5,k → k5 ∈ Θ). The result is that, first,
the number of unknown kinetic parameters for the reaction system describing the change in
active ERK is decoupled from the number of cells and, secondly, that the union of single-cell
parameter values k6,k for all cells k in the sample defines a distribution k6 that captures
the unmeasured/unknown sources of cell-to-cell variation in the reaction scheme. Given
additional measurement features, we may be able to determine further contributors to the
reactions of ERK activation by looking at single-cell correlations between these features and
the inferred distribution of k6 (k6,k across all n cells).
B.3 Data processing for use in modeling
SCODEM uses single-cell measurement values to instantiate ODE model instances. This
approach is advantageous because it is simple; however, it requires attention to errors in
individual cell measurements and, in the case of mass cytometry, rescaling and normalization
of measurement channels for use in modeling.
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B.3.1 Data exclusion criteria and resampling
Antibody labeling and cell staining was optimized to minimize the number of cell events
with zero or low ion counts in measurement channels used for modeling (e.g., total ERK).
Furthermore, measured cell events with fewer than 5 ion counts in modeled channels were
excluded. The choice of five counts was made as a trade-off between the number of dis-
carded events, which increases as the threshold increases, and the uncertainty of single-cell
measurements, which is a decreasing function of ion counts. Such thresholding may intro-
duce bias across samples if, for example, the active form of a protein is on average low in
abundance at one time point, but increases in abundance upon stimulation. In this case,
thresholding may remove many “low” cells from the first time point that ultimately should
represent some of the cells at later time point. To address this issue, we used a stochas-
tic model of mass cytometry measurement based on models of inductively coupled plasma
mass spectrometry (ICP-MS)(Ulianov et al., 2015). Specifically, we modeled the number
of measured ion counts X as a Gamma-Poisson mixture, which can be represented by a
negative binomial distribution X ∼ NB(r, p), where r represents the number of metal tags
in the cell before measurement and p is the probability of a given metal tag successfully
reaching the detector. This probability is a function of the instrument; in our case, it is
p = 1/5000. To avoid probability mass at zero, we first shifted all distributions by 10 ion
counts before resampling.
In ERK overexpression experiments, the number of ion counts measured could exceed
the linear response range of the mass cytometer. As nonlinearities in measurement violate
the optimization objective function as implemented, we excluded cell events with ion counts
greater than 10,000 before data resampling and modeling.
B.3.2 Data scaling
Mass cytometry provides relative values of protein abundance. Absolute values depend
on factors such as antibody labeling efficiency, antibody staining and detection sensitivity.
While relative differences between measured protein abundances can often be subsumed
into reaction parameters in a model, we rescaled measurements to physiological values.
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Average protein abundance values in HEK293T cells were obtained from the MaxQB
database (http://maxqb.biochem.mpg.de/mxdb/)(Geiger et al., 2012). The average of
iBAQ abundance values across the three experimental replicates was used to determine
average abundance (Supplementary Table B.5). In cases where an antibody detected mul-
tiple isoforms of a protein (e.g., ERK1 and ERK2) the average abundances of each isoform
were summed. Abundance values were scaled to concentrations using the average HEK cell
volume(Boss et al., 2013) of 1996 µm3. These values were used to estimate the average
concentration x̄j of each protein j in a cell. Protein measurements were then linearly scaled
as follows:
Given a protein j, its associated average concentration x̄j and its measured steady state







This implementation represents a linear scaling factor of the experimentally measured
steady-state distribution of protein j such that the mean of the steady-state distribution
E[Dxj|ss ] is equal to the population average x̄j estimated from the quantitative abundance
measurements in MaxQB. For all experimental measurements, e.g., after a perturbation,
each total protein j was scaled using the corresponding zj .
Steady-state levels of phosphoproteins clearly cannot not be greater than those of the
corresponding total protein pools. Additionally, if steady-state phospho-protein levels are
too high relative to total protein, the relative increase in phosphorylation levels in the
model would be capped due to a lack of unphosphorylated protein. To avoid these issues,
phospho-protein distributions were scaled such that the average steady-state value of a
phospho-protein was a fractional value of the total protein level. The additional scaling
factors for active MEK, ERK and p90RSK were 0.08, 0.08 and 0.05, respectively. These
values were chosen to reduce the number of cells in violation of the “active cannot be greater
than total” constraint at steady state. In the special case that individual cells violated this
constraint, these cells were excluded from the sample for analysis.
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B.4 Model of EGF signaling in the MAPK/ERK cascade
In this section, we describe the mathematical formulation of our model of EGF signaling in
the MAPK/ERK cascade.
B.4.1 State variables
The model uses eight state variables to describe changes in ERK pathway signaling com-
ponents.










Active and total MEK, ERK and p90RSK were measured. After scaling (section SB.3.2),
inactive forms were calculated as Inactive = Total−Active. As cells were grown in a mono-
layer and EGF was rapidly mixed with medium, the input I was assumed to be the same for
all cells. The initial value of pRAF was also assumed to be the same for all cells. This choice
was made to reduce prior assumptions on the distribution of active RAF. The variation in
initial pRAF, as well as of other components upstream of MEK that were not explicitly in
the model, was captured by the single-cell parameters kd and k4, which were obtained from
steady-state measurements (as in section B.2.2).
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B.4.2 Kinetic parameters
Table B.2: Model parameters.
Parameter Description
kf Activation rate constant of pRAF by Input
kd Degradation rate constant of pRAF signal
gD Kinetic order of pRAF activation from Input
kFB Hill function inflection point of negative feedback from ppERK
fn Hill function order of negative feedback from ppERK
k3 Activation rate constant of ppMEK by pRAF
k4 Inactivation rate constant of ppMEK
g1 Kinetic order of ppMEK activation from MEK
g2 Kinetic order of ppMEK activation from pRAF
h1 Kinetic order of ppMEK inactivation from ppMEK
k5 Activation rate constant of ppERK by ppMEK
k6 Inactivation rate constant of ppERK
g3 Hill function order of ppERK activation from ERK
g4 Kinetic order of ppERK activation from ppMEK
h2 Kinetic order of ppERK inactivation from ppERK
k7 Activation rate constant of pP90 by ppERK
k8 Inactivation rate constant of pP90
g5 Kinetic order of pP90 activation from P90
g6 Kinetic order of pP90 activation from ppERK
h3 Kinetic order of pP90 inactivation from pP90
The rate constants kd, k4, k6 and k8 were in Φk and computed from the steady-state
equations as shown in section B.2.2. All other parameters were in Θ and, therefore, equal
across all cells and used as decision variables in the optimization algorithms.
B.4.3 Inputs
The MAPK/ERK pathway components considered in our model were in a pseudo-steady
state at time scale of our experiments (less than one hour). Thus, our model must also be
at steady state before simulated addition of EGF. We arbitrarily chose the input value of
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Table B.3: Model inputs.
Input Description
I Input (EGF)
Iss Input at steady state (before EGF addition)
Ifinal Minimal EGF level after EGF addition
τ Time delay between addition of EGF and initial pRAF signaling
I = Iss = 1 as the pre-stimulation steady state input I to our model. Addition of EGF
was simulated as an instantaneous increase in the input to I = 10. We used a time delay τ
to represent the delay between experimental addition of EGF to the medium and the time
when the signal reached the MAPK/ERK cascade. In other words, τ represents the time
it takes for “signal” to pass be transmitted by reactions, such as receptor-ligand binding,
receptor activation, etc., and reach RAF activation. Although the exact value of τ for each
cell is undoubtedly variable across the population, as not all cells will encounter the EGF
signal at the same moment, we assumed each cell to have the same delay (τ) to maintain
the entirely deterministic nature of our model. We used τ = 2 minutes based on live cell
studies of ERK activation(Ryu et al., 2015). Thus, in the model, if time t < τ , then Input
I = Iss = 1. Once time t = τ , then input is reset to represent EGF addition and Input
I = 10. At all times otherwise, input I is a dependent variable and determined by solution
of the ODE system. Finally, we found steady-state signaling after addition of EGF was
marginally increased compared to pre-stimulation conditions. Thus, for values of t > τ we
used the value Iss = Ifinal = 1.2 (see model equations, below) to limit the depletion of
input signal. Expressed differently, before the addition of EGF, the minimum signal can
be 1, but after addition of EGF the minimum signaling can be 1.2. This choice was an
approximation based on data and fixed before parameter optimization.
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B.4.4 Equations
İ = −kf ∗ (I − Iss)




˙ppMEK = k3 ∗MEKg1 ∗ pRAF g2 − k4 ∗ ppMEKh1
˙MEK = − ˙ppMEK
˙ppERK = k5 ∗ ERKg3 ∗ ppMEKg4 − k6 ∗ ppERKh2
˙ERK = − ˙ppERK
˙pP90 = k7 ∗ P90g5 ∗ ppERKg6 − k8 ∗ pP90h3
˙P90 = − ˙pP90
B.5 Modeling ERK overexpression
B.5.1 Addition of saturating functions
The only saturating reaction in our original model was the negative feedback from active
ERK to active RAF, which degrades the input signal. The choice to use saturation in
negative feedback was due to strong negative feedback effects leading to mild oscillations.
Otherwise, however, for the range of expression we observed in “normal” cells, saturating
reactions were not necessary to achieve good fits to experimental data characterizing the
signaling dynamics. As cancers are often caused by protein expression beyond “normal”
ranges, however, it became necessary to examine MAPK/ERK pathway signaling outside
of these ranges.
To allow this extrapolation, we first modeled ERK activation as a saturating (ultrasen-





∗ ppMEKg4 − k6 ∗ ppERKh2 ,
which added the kinetic parameter kERK that determines the inflection point of the Hill
function. Indeed, this inflection point lies beyond the maximal expression range of total
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ERK in “normal” cells.
To reasonably model reaction kinetics during overexpression, which should eventually
saturate, we also allowed ERK expression levels to modify kinetic parameters. This ap-
proach is justified by the view of a power function as a local approximation to the “true”
kinetic function at an operating point. The validity of such an approximation depends on
the function and the operational range of the system. For example, based on our results,
all “normal” cells within the context of our system and conditions seem to operate within
a range where the reaction kinetics is well approximated by the originally chosen, non-
saturating power functions. To represent changes in the kinetics related to ERK expression
beyond the ranges of “normal” cells, we used the following functions:












Reduction in negative feedback strength












Saturation of inactivating reaction (i.e., phosphatase)












Slow activation of MERK












Slow activation of ERK












Slow activation of p90RSK
Each function modifies the parameter in question as a function of total ERK where the
power nxx reflects the steepness and kxx the inflection point of the Hill function. All values
of nxx where less than zero, thus the function values ranged from the original parameter
value to zero. As reaction velocities should not go to zero, we used the final parameter
mxx as the floor of the parameter modification, so that the modified parameters could take
values from their original value to mxx, with the actual value a function of ERK.
B.5.2 Simulating ERK overexpression
Cells used in simulating ERK overexpression were subsampled from experimental measure-
ments of control (not ERK2-GFP transfected, not EGF stimulated) conditions. To simulate
ERK overexpression resulting from transient transfection, the relative increase in total ERK
(ERKtotal) associated with ERK2-GFP (ERK2-GFP ) expression was modeled as a cen-
sored gamma distribution with shape parameter A = 0.154, scale parameter B = 86.9 and
lower and upper censoring parameters l = 0.271 and u = 61.4, respectively. The total ERK
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ERKtotaloverexpression = ERKtotal · (1 + ERK2-GFP )
Rate constant parameters were determined from the steady state after the simulated ad-
dition of ERK. This choice was made to maintain the steady state and did not qualitatively
change the parameter distribution.
B.6 Modeling MEK inhibition
B.6.1 Initial model of CI-1040
The benzhydroxamate compound CI-1040 inhibits MEK non-competitively and thereby
reduces the enzymatic vmax (maximum velocity) of ERK activation by MEK(Sebolt-Leopold
et al., 1999). Originally, we modeled this effect by reducing the rate constant k5 of ERK
activation by MEK. As described in the main text, a simulated dose-response experiment,
where the response was defined as a fold-increase of active ERK, revealed a range of CI-1040
sensitivity within the cell populations (Supplementary Figure B.3).
B.6.2 Reconciled model of CI-1040
Experimental treatment of cells with CI-1040 confirmed a range of inhibitor sensitivities
within the cell population, but also revealed EGF signaling dynamics at a slower time scale
than our initial representation of CI-1040 predicted.
To study the consequences of CI-1040, we fit a model of CI-1040 to a time course of
EGF signaling in cells pretreated for 30 minutes with CI-1040 (see Methods). The resulting
model of CI-1040 was based on reduction of not only k5 (ERK activation), but also k6
(ERK inactivation), k3 (MEK activation) and k4 (MEK inactivation). Thus, the effect of
CI-1040 was modeled to slow down the activation and inactivation dynamics of both MEK
and ERK. While our model successfully captured the delay in ERK activation in the data,
it appeared to overestimate the slowing of ERK inactivation in many cases (Supplementary
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Figure B.4). This overestimation is likely a consequence of the simplified one-step rather
than two-step reaction scheme of ERK activation and CI-1040 inhibition, and one might
expect that a more detailed model of the mechanism would be able to fit the data better.
Such a model, however, would contain additional parameters and a number of variables not
directly measurable in our experiments, such as singly phosphorylated ERK. Importantly,
our specific conclusion that initial MEK activity is most predictive of CI-1040 sensitivity
depends on the model of CI-1040, and it is conceivable that a different model of CI-1040
could lead to a different conclusion. We did not pursue this aspect of the model in more
detail because this portion of our study was meant to represent a proof of principle that
single-cell ODE models may be used to analyze and explain differences in response across a
population, rather than a detailed model of CI-1040 action. As such, our primary conclusion,
that analysis of single-cell ODE models can reveal cooperative combinations of inhibitors,
still holds.
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B.7 Supplementary Figures and Tables
Figure B.1: Correlation between GAPDH and cell volume. (a) Confocal images
of cells stained for GAPDH (green). Nuclear staining by hoechst 33342 (blue) and Alexa
Fluor 647 carboxylic acid succinimidyl ester to determine cell outline (red). (b) Three-
dimensional reconstruction of cells based on cell outline staining. (c) Regression of GAPDH
versus reconstructed cell volume.
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Figure B.2: Total protein abundance does not change during experiment. Snap-
shots of total protein distributions during a 60 minute time course of EGF stimulation.
Units: scaled concentrations.
131
Figure B.3: Simulated dose-response experiment using initial model of CI-1040
MEK inhibitor. Inhibitor acts on parameters in red. (a) Model diagram of CI-1040
inhibition. (b) Dose response results. Response was defined as fold-increase of signal
after EGF simulated stimulation. Color represents amount of inhibitor (red: high; gray:
low). (Left) Response distribution of cell population for different levels of simulated CI-
1040 inhibition. (Right) Average of response distribution (y-axis) versus level of CI-1040
treatment (x-axis). Model units: scaled concentrations.
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Figure B.4: Full simulation results of CI-1040 inhibitor. (a) Full model description
of CI-1040 inhibitor after fitting to experimental data. Inhibitor acts on parameters in
red. (b) Simulated single-cell trajectories of cells stimulated with EGF after 30 minute
pre-treatment with CI-1040. (c) Simulated and measured snapshots of the same. Model
units: scaled concentrations.
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Figure B.5: Additional views of ERK overexpression simulations from Figure
3.6 of the main text. (a) Simulated single-cell trajectories for active proteins compared
to measured population statistics. Yellow and green circles (or lines) are mean and standard
deviation of the data (or the simulations) at each presented time point. Orange boxplots
are middle 50 (bar) and 90 (line) percent of data with a horizontal line at median, while
events outside 90% range are dots. (b) Marginal (one-dimensional) distribution of data
(green) and simulation (orange). Model units: scaled concentrations.
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Table B.4: Antibody panel. *Idu is not an antibody.
Channel Element Antibody Clone
170 Er RAS Ras10
150 Nd MEK D1A5
144 Nd pMEK1/2 166F8
143 Nd ERK1/2 137F5
154 Sm pERK1/2 20A
149 Sm P90RSK2 D21B2
163 Dy pP90RSK D5D8
175 Lu S6 54D2
171 Yb pS6 N7-548
164 Dy AKT C67E7
153 Eu pAKT D9E
89 Yb pHH3 HTA28
156 Gd CYCLIN B1 GNS-11
127 I Idu*
172 Yb cleaved PARP F21-852
159 Tb GAPDH 6C5
Table B.5: Average expression of total protein x̄j in HEK cells (Boss et al.,











SUPPLEMENTARY MATERIALS: MECHANISTIC MODEL
RECONCILES SIGNALING DYNAMICS ACROSS AN EPITHELIAL
MESENCHYMAL TRANSITION
C.0.1 Data exclusion criteria
Antibody labeling and cell staining was optimized to minimize the number of cell events
with zero or low ion counts in measurement channels used for modeling (e.g., total Erk).
Furthermore, measured cell events with fewer than 5 ion counts in total protein channels
used in the model were excluded. The choice of five counts was made as a trade-off between
the number of discarded events, which increases as the threshold increases, and the uncer-
tainty of single-cell measurements, which is a decreasing function of ion counts. This cutoff
excluded fewer than 1% of cells per sample.
C.0.2 Data scaling for use in modeling
Mass cytometry provides relative values of protein abundance. Absolute values depend
on factors such as antibody labeling efficiency, antibody staining and detection sensitivity.
Although relative differences between measured protein abundances can often be subsumed
into reaction parameters in a model, we also rescaled measured protein levels for use in
modeling. As absolute values of protein abundance were not available for Py2T cells, total
protein abundance values were taken to be 500 in arbitrary units. These values were used
to estimate the average concentration x̄j of each protein j in a cell. Protein measurements
were then linearly scaled as follows:
Given a protein j, its associated average concentration x̄j and its measured steady state








This implementation represents a linear scaling factor of the experimentally measured
steady-state distribution of protein j such that the mean of the steady-state distribution
E[Dxj|ss ] is equal to the population average x̄j arbitrarily set at 500. For all experimental
measurements, e.g., after a perturbation, each total protein j was scaled using the corre-
sponding zj .
Steady-state levels of phosphoproteins clearly cannot not be greater than those of the
corresponding total protein pools. Additionally, if steady-state phosphoprotein levels are
too high relative to total protein, the relative increase in phosphorylation levels in the
model would be capped due to a lack of unphosphorylated protein. To avoid these issues,
phosphoprotein distributions were scaled such that the average steady-state value of a phos-
phoprotein was a fractional value of the total protein level. The additional scaling factors
for phophoproteins were set to 0.06. These values were chosen to reduce the number of cells
in violation of the ”active cannot be greater than total” constraint at steady state. In the
special case that individual cells violated this constraint, these cells were excluded from the
sample for analysis.
C.1 Model of EGF signaling in the MAPK/ERK cascade
In this section, we describe the mathematical formulation of our model of EGF signaling in
the MAPK/ERK cascade.
C.1.1 State variables
The model uses eight state variables to describe changes in ERK pathway signaling com-
ponents.
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Table C.1: Model variables.
State variable Description
















Active and total Mek, Erk, Rsk, S6, Akt and Gsk3β were measured. After scaling,
inactive forms were calculated as Inactive = Total − Active. The inputs I1, I2 and initial
values of pRaf and PI3K were assumed to be the same for all cells. These choices were made
to reduce prior assumptions. The variation in these components that were not explicitly
measured were captured by the single-cell parameters kd1, k4, kd2 and k10, which were
obtained from steady-state measurements (as in section B.2.2).
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C.1.2 Kinetic parameters
Table C.2: Model parameters.
Parameter Description
kf1 Activation rate constant of pRaf by Input1
grac Kinetic order of crosstalk between PI3K and pRaf
kd1 Degradation rate constant of pRaf signal
gD1 Kinetic order of pRaf inactivation
k3 Activation rate constant of ppMek
k4 Inactivation rate constant of ppMek
g1 Kinetic order of ppMek activation by Mek
g2 Kinetic order of ppMek activation by pRAF
h1 Kinetic order of ppMek inactivation by ppMek
k5 Activation rate constant of ppErk
k6 Inactivation rate constant of ppErk
g3 Kinetic order of ppErk activation by Erk
g4 Kinetic order of ppErk activation from ppMek
h2 Kinetic order of ppErk inactivation from ppErk
k7 Activation rate constant of pRsk
k8 Inactivation rate constant of pRsk
g5 Kinetic order of pP90 activation by Rsk
g6 Kinetic order of pP90 activation by ppErk
h3 Kinetic order of pP90 inactivation by pRsk
kf2 Activation rate constant of PI3K by Input2
kd2 Degradation rate constant of PI3K signal
gD2 Kinetic order of PI3K inactivation
kfb1 Hill function inflection point of negative feedback from ppErk
k9 Activation rate constant of pAkt
k10 Inactivation rate constant of pAkt
g7 Kinetic order of pAkt activation by Akt
g8 Kinetic order of pAkt activation by PI3K
h4 Kinetic order of pAkt inactivation by pAkt
k11 Inctivation rate constant of Gsk3b
k12 Activation rate constant of Gsk3b
g9 Kinetic order of pGsk3b inactivation by Gsk3b
g10 Kinetic order of pGsk3b inactivation by pRsk crosstalk
g11 Kinetic order of pGsk3b inactivation by pAkt
h5 Kinetic order of pGsk3b activation by pGsk3b
k13 Activation rate constant of pS6
k14 Inactivation rate constant of pS6
g12 Kinetic order of pS6 activation by S6
g13 Kinetic order of pS6 activation by pRsk
g14 Kinetic order of pS6 activation by pAkt
h6 Kinetic order of pS6 inactivation by pS6
The rate constants {kd1, k4.k6, k8, kd2, k10, k12, k14} were in Φk and computed from
the steady-state equations as shown in section B.2.2. All other parameters were in Θ and,
therefore, equal across all cells and used as decision variables in the optimization algorithms.
C.1.3 Inputs
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Table C.3: Model inputs.
Input Description
I1 Input (EGF) to pRaf
I2 Input (EGF) to PI3K
Iss Input at steady state (before EGF addition: t < τ)
τ1 Time delay between addition of EGF and initial pRaf signaling
τ2 Time delay between addition of EGF and initial PI3K signaling
The ERK/AKT pathway components considered in our model were in a pseudo-steady
state at time scale of our experiments (one hour). Thus, our model must also be at steady
state before simulated addition of EGF. We arbitrarily chose the input value of I1 = I2 =
Iss = 1 as the pre-stimulation steady state inputs to our model. We used the time delays
τ1 and τ2 to represent the delay between experimental addition of EGF to the medium and
the time when the signal reached the ERK and AKT signaling branches, respectively. In
other words, τ1 represents the time it takes for ”signal” to pass be transmitted by reactions,
such as receptor-ligand binding, receptor activation, etc., and reach Raf activation. The
same for τ2 and PI3K activation. Although the exact values of τ1 and τ2 for each cell are
undoubtedly variable across the population, as not all cells will encounter the EGF signal
at the same moment, we assumed each cell to have the same delays (τ) to maintain the
entirely deterministic nature of our model. Thus, in the model for each i ∈ {1, 2}, if time
t < τi, then Input I = Iss = 1. Once time t = τi, then input is reset to represent EGF
addition and Input I = Ii. At all times otherwise, input Ii is a dependent variable and
determined by solution of the ODE system.
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C.1.4 Equations
İ1 = −kf1 ∗ (I1 − Iss)




˙Mek = −k3 ∗Mekg1 ∗ pRafg2 + k4 ∗ ppMekh1
˙ppMek = k3 ∗Mekg1 ∗ pRafg2 − k4 ∗ ppMekh1
˙Erk = −k5 ∗ Erkg3 ∗ ppMekg4 + k6 ∗ ppErkh2
˙ppErk = k5 ∗ Erkg3 ∗ ppMekg4 − k6 ∗ ppErkh2
˙Rsk = −k7 ∗Rskg5 ∗ ppErkg6 + k8 ∗ pRskh3
˙pRsk = k7 ∗Rskg5 ∗ ppErkg6 − k8 ∗ pRskh3
İ2 = −kf2 ∗ (I2 − Iss)
˙PI3K = kf2 ∗ I2 − kd2 ∗ pPI3KgD2 ∗ ppErkgfb2
˙Akt = −k9 ∗Aktg7 ∗ PI3Kg8 + k10 ∗ pAkth4
˙pAkt = k9 ∗Aktg7 ∗ PI3Kg8 − k10 ∗ pAkth4
˙Gsk3b = −k11 ∗Gsk3bg9 ∗ pRskg10 ∗ pAktg11 + k12 ∗ pGsk3bh5
˙pGsk3b = k11 ∗Gsk3bg9 ∗ pRskg10 ∗ pAktg11 − k12 ∗ pGsk3bh5
Ṡ6 = −k13 ∗ S6g12 ∗ pRskg13 ∗ pAktg14 + k14 ∗ pS6h6
˙pS6 = k13 ∗ S6g12 ∗ pRskg13 ∗ pAktg14 − k14 ∗ pS6h6
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C.2 Supplementary Figures and Tables
Figure C.1: Microscopy images of TGF-β treatment inducing an EMT. At day 0
all cells grow in a monolayer with a cobblestone epithelial morphology. By day 3, a subset of
cells are no longer constrained to monolayer growth and have transitioned to an elongated
mesenchymal morphology.
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Figure C.2: Partial Correlation of phospho- and total signaling kinases. Partial
correlation has been Fisher z-transformed. Both heatmaps are ordered by clustering the
partial correlations of epithelial cells as shown in the dendrogram.
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Figure C.3: Distribution of partial correlations. (a) All partial correlation values
for epithelial cells as in Figure 4.2b. The cutoffs for network edges of |0.1| are marked by
the red lines. (b) The distribution of partial correlation values for epithelial cells in Figure
C.2. Red lines at |0.1| as in (a).
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Figure C.4: Model and data covariance over time for all total and phospho
pairs. Extended figure from Figure 4.3 to include total proteins. Dots are data. Colored
lines are model. Black lines are range of data across replicates.
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Figure C.5: Grid-based sensitivity of model to both cell phenotypes. Consid-
eration of both phenotypes adds additional constraints to model parameters. (a) Model
sensitivities calculated using epithelial cells as in Figure 4.4. (b) Model sensitivities calcu-
lated using Mesenchymal cells. Both plots show parameter values as log2 fold change from
the optimal parameter values for epithelial cells.
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Table C.4: Antibody Panel. Measured phosphoproteins that did not show robust dy-
namics in response to EGF stimulation were omitted from modeling.
Element Antibody Clone [µg/mL]
139La pCREB J151-21 1.50
141Pr pSTAT1 4a 2.00
142Nd PTEN 138G6 0.75
143Nd ERK1/2 137F5 1.00
144Nd pMEK1/2 166F8 1.00
146Nd pSTAT5 47 2.00
147Sm GSk3β D5C5Z 1.25
148Nd pS6K 1A5 1.25
149Sm P90RSK2 D21B2 0.75
150Nd MEK D1A5 2.25
151Eu pEGFR Y38 1.50
152Sm pAMPKα 40H9 1.50
153Eu pAKT D9E 1.00
154Sm pERK1/2 20A 0.75
155Gd STAT1 SM1 2.00
156Gd CYCLIN B1 GNS-11 1.00
158Gd pGSK3 D85E12 0.25
159Tb GAPDH 6C5 0.50
160Gd mTOR 7C10 1.00
161Dy pPDPK1 pS241 0.05
162Dy Vimenten D21H3 0.75
163Dy pP90RSK D5D8 1.25
164Dy AKT C67E7 0.50
165Ho non-p-β-CATENIN D13A1 0.75
166Er pSTAT3 4/pSTAT3 1.50
167Er STAT3 124H6 0.75
168Er pPLCγ2 K86-689.37 1.00
169Tm EGFR AY13 1.00
170Er pHH3 HTA28 0.50
171Yb pS6 N7-548 0.10
172Yb cleaved PARP F21-852 2.00
173Yb pMTOR D9C2 2.00
174Yb E-CADHERIN 36/E 0.50
175Lu S6 54D2 0.25
176Yb p4EBP1 236B4 0.25
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Cell signaling pathways are complex biochemical systems at the core of cellular information
processing. The dynamics of these signaling systems in response to internal and extracellular
cues plays a critical role for proper cell functioning. While we have learned much about
signaling at the cell population level, no two cells are the same, and cell-to-cell variability
can have complex and important consequences for signaling in both individual cells and the
cell population as a whole. In many contexts, cells perform essentially identical functions
despite their differences, whereas in other contexts, especially in cancer, cell-cell differences
in state propagate to differences in function.
The overall goal of this dissertation was the creation of mathematical and computational
tools for the study of cell-to-cell variation in signaling and to use these tools to increase
our understanding of when single cell differences do, or do not, make a meaningful differ-
ence. To address this goal we designed new methods of single-cell analysis, including a
computational framework termed single-cell ordinary differential equation modeling (SCO-
DEM) that overcomes the prior experimental trade-off between continuous and multiplexed
single-cell measurements of signaling. We tested SCODEM against increasingly demanding
datasets, which were all represented in a satisfactory fashion. After the initial analysis
of cell-to-cell variability, we analyzed targeted inhibition, protein overexpression and an
epithelial-mesenchymal transition. Throughout this process, we provided illustrative exam-
ples of how our modeling framework may be used to identify operating principles and limits
of signaling systems, which is a first step toward proposing novel therapeutic targets.
The work presented here provides new tools for analyzing cellular heterogeneity and
increases our understanding of how differences in cell state effect function by showing in-
tracellular signaling is primarily deterministic at the single cell level. The application of
these tools to the dramatic phenotype shift during an epithelial-mesenchymal transition in
murine breast cancer cells confirmed that stochasticity plays a much smaller role than had
been assumed and that cells modulate signaling without the need of rewiring their signaling
network.
